Subject index: Abstracts  by unknown
JACC Vol. 11, No.2 
February 1988;273A-306A 
Subject Index: Abstracts 
Ablation procedures 
See also Lasers; Surgery, ablation 
Catheter ablation of refractory ventricular 
arrhythmias: long term follow-up, 179A 
Catheter ablation of right bundle branch: a 
highly effective technique for control of 
bundle branch reentrant ventricular 
tachycardia, 114A 
Chronic incomplete atrioventricular block 
induced by ndiofrequency catheter 
ablation,I77A 
Clinical outcome of patients with intact 
atrioventricular conduction after 
atrioventricular junction ablation for 
refractory supraventricular 
tachyarrhythmias, 177 A 
Controlled growth of radiofrequency lesions by 
power regulation, 16A 
Determinants of lesion size after DC shock 
ablation: influence of electrode-wall 
contact and preexisting fibrosis, 178A 
His bundle ablation using impulses below one 
joule,16A 
Identification and catheter ablation of a zone of 
slow conduction in the reentry circuit of 
ventricular tachycardia, 16A 
Predictors of successful His bundle ablation: a 
report of the Percutaneous Cardiac 
Mapping and Ablation Registry, 17 A 
Radiofrequency ablation with a cooled porous 
electrode catheter, 17 A 
Radiofrequency current: frequency dependence 
of the impedance of different cardiac 
tissues, 59A 
Randomized study comparing catheter ablation 
to medical therapy in patients with 
ventricular tachycardia. Preliminary 
results, 179A 
Ventricular ablation with radiofrequency 
energy: comparison of different catheter 
energy delivery systems, 17 A 
Academic cardiology 
Academic cardiology: the views of division 
chiefs,82A 
Accessory pathways 
See Surgery, ablation; Wolff-Parkinson-White 
syndrome 
ACE inhibitors 
See Angiotensin-converting enzyme inhibitors 
Acetate 
Regional myocardial oxidative metabolism 
assessed non-invasively with C-l1 acetate 
and dynamic positron emission 
tomography, lOA 
Tissue kinetics of C-II acetate as a tracer of 
myocardial oxidative metabolism in 
canine myocardium, 37A 
Acetylcholine 
Acetylcholine induced epicardial 
vasoconstriction does not reduce 
coronary flow, 48A 
Bronchial cholinergic hyperresponsiveness in 
patients with variant angina, 46A 
In vivo identification of normal and damaged 
endothelium by quantitative coronary 
angiography and infusion of acetylcholine 
and bradykinin, 29A 
Indomethancin attenuates acetylcholine-
induced canine epicardial coronary artery 
constriction in vivo, 47 A 
Influence of acetylcholine on splanchnic 
volume in the intact dog, 123A 
Response of atrial natriuretic polypeptide to 
isoproterenol and acetylcholine infusion in 
humans, 238A 
Vagal denervation of canine sinus and 
atrioventricular nodes creates 
supersensitive response to acetylcholine, 
39A 
Acetylcysteine 
Glutathione redox pathway and reperfusion 
injury. The effect of N-acetylcysteine 
(NAC) on infarct size and ventricular 
function, 88A 
Acidosis 
Is the reduced maximal exercise capacity of 
patients with left ventricular dysfunction 
due to intramuscular lactic acidosis? 73A 
Acquired immunodeficiency syndrome 
AIDS heart disease: results in 85 patients, 
195A 
Myocarditis in acquired immunodeficiency 
syndrome (AIDS): etiology and prognosis, 
I%A 
Action potentials 
Adenosine produces different effects on 
monophasic action potentials in human 
atrium and ventricle, 227 A 
Assessment of atrial vulnerability using 
dynamic changes in endocardial 
monophasic action potential duration, 
114A 
Dispersion of left ventricular repolarization in 
man,II3A 
Adenosine 
Adenosine produces different effects on 
monophasic action potentials in human 
atrium and ventricle, 227 A 
Differential influence of beta-adrenoreceptor 
activation on the negative chronotropic 
effect of adenosine on the canine sinus 
node and ventricular pacemakers in vivo, 
39A 
Adenosine monophosphate 
Effects of dibutyryl cyclic AMP on coronary 
hemodynamics in ischemic heart disease: 
comparison with dopamine and 
dobutamine, 241A 
Adenosine triphosphate 
Dissociation of myocardial free energy of ATP 
hydrolysis, pH, and inorganic phosphate 
levels from mechanical function after in 
vivo regional ischemia, 71A . 
Gradients of myocardial adenine nucleotide 
degradation during total ischemia, 37 A 
Negative chronotropic effects of adenosine 
triphosphate on the sinus node are 
273A 
mediated by muscarinic cholinergic and 
not purinergic receptors, 227 A 
Regional ~adrenergic receptors and adenylate 
cyclase activity after healing of 
myocardial infarction in cats, 252A 
Adriamycin 
Adriamycin limits the consequences of sodium 
mediated calcium gain in the isolated rat 
heart, 141A 
Afterdepolarizations 
Differential response of early 
afterdepolarizations and ventricular 
tachycardia during right and left stellate 
stimulation in the dog treated with 
cesium, 254A 
Effect of the thyroid state on ouabain-induced 
delayed afterdepolarizations, 255A 
Magnesium abolishes afterdepolarizations 
induced by cesium, 4-aminopyridine or 
quinidine in canine Purkinje fibers, 254A 
Magnesium suppresses early 
afterdepolarizations and ventricular 
tachyarrhythmias induced in dogs by 
cesium, 254A 
Sodium current modifications by 
anthopleurin-A and their role in early 
afterdepolarizations, 253A 
2: I block of an early afterdepolarization as a 
mechanism of TV alternans, 254A 
Age factors 
See also Elderly 
Age is an independent prognostic factor in 
determining long-term outcome in patients 
with congestive heart failure, 160A 
Age-related changes in normal cardiac valve 
dimensions, 244A 
Comparison of left ventricular mass and 
systolic and diastolic function in young 
and old normals, 244A 
Effects of aging on subjects with normal 
hearts. A seven-year prospective study, 
244A 
Effects of aging on the venodilatory response 
to nitroglycerin, 160A 
Normal aging is accompanied by 
disproportionate thickening of the 
ventricular septum, 243A 
AH23848 
Effect of thromboxane A2 receptor inhibition 
on myocardial blood flow during three 
grades of coronary occlusion, 140A 
AIDS 
See Acquired immunodeficiency syndrome 
Albumin 
Behavior of sonicated albumin microbubbles in 
the microcirculation: a basis for their use 
as myocardial echo contrast agents, 75A 
Pathological effects of sonicated albumin 
microbubbles on the myocardium, brain 
and kidneys: How much is safe? 76A 
Alcohol 
See Ethanol 
Allopurinol 
Enhanced function recovery in the stunned 
274A SUBJECT INDEX 
canine myocardium by pretreatment with 
oxypurinol, 20SA 
Alpha-adrenergic blocking agents 
See also specific agent 
In vivo e1ectrophysiologic effects of alpha 
blockade in neonatal and adult canines, 
154A 
Alpha-adrenergic receptors 
Alpha-adrenergic coronary vasoconstrictor 
receptor subtypes in awake dogs, 23A 
Differences in alpha adrenergic responsiveness 
between human internal mammary 
arteries and saphenous veins, 2A 
Alpha-adrenergic stimulation 
Nicardipine but not verapamil antagonizes 
forearm vasoconstriction to endogenous 
a-adrenergic stimulation by lower body 
suction, 205A 
Amiloride 
Can ACE-inhibitors replace diuretics as sole 
therapy for mild heart failure?, 73A 
Aminophylline 
Negative chronotropic effects of adenosine 
triphosphate on the sinus node are 
mediated by muscarinic cholinergic and 
not purinergic receptors, 227 A 
4-Aminopyridine 
Ca + + activated transient outward current in 
the rabbit atrioventricular node, 59A 
Electrophysiologic effects of different K + 
concentrations on the rabbit 
atrioventricular node, 58A 
Magnesium abolishes early afterdepolarizations 
induced by cesium, 4-aminopyridine or 
quinidine in canine Purkinje fibers, 254A 
Amiodarone 
Actuarial analysis of the efficacy of 
electrophysiologic testing in selecting drug 
therapy for ventricular tachyarrhythmias, 
6A 
Class III effects of amiodarone depend on 
intact thyroid function, 41A 
Clinical features of amiodarone pulmonary 
toxicity, 169A 
Clinical significance of changes in 
intralymphocytic potassium and sodium 
contents in amiodarone therapy, 55A 
Combined ambulatory ECG and 
electrophysiologic approach to patients on 
amiodarone for ventricular tachycardia, 
66A 
Effect of amiodarone therapy on ventricular 
function: serial, long-term assessment, 
91A 
Parenteral magnesium therapy in intractable 
ventricular tachyarrhythmias, 169A 
Rate-dependent effects of amiodarone on 
conduction and recovery in vivo, 256A 
Ventricular function predicts drug response of 
ventricular tachycardia, 168A 
Ammonia 
Noninvasive quantification of coronary reserve 
by N-13 ammonia and positron emission 
tomography (PET), IlA 
Noninvasive quantification of regional 
myocardial blood flow with N-13 
ammonia and dynamic positron 
tomography, lOA 
Amrinone 
Direct vasodilatory actions of amrinone 
demonstrated in humans with total 
artificial hearts, l40A 
Amyloidosis 
Doppler assessment of right ventricular 
diastolic function in cardiac amyloidosis, 
120A 
Anaphylaxis 
Effects of 5-lipoxygenase inhibition on cardiac 
anaphylaxis in isolated guinea pig hearts, 
203A 
Aneurysm 
Ventricular aneurysm after an acute 
myocardial infarction, l88A 
Angina pectoris 
See also Antianginal therapy 
Bronchial cholinergic hyperresponsiveness in 
patients with variant angina, 46A 
Can coronary disease location be determined 
by location and radiation of chest pain? 
15lA 
Does Holter monitoring have clinical utility in 
the evaluation of patients with chest 
pain?,66A 
Esophageal disorders as cause of chest pain in 
symptomatic patients with documented 
coronary artery disease, l84A 
Early post-infarction angina is a predictor of 
poor long-term prognosis after acute 
non-Q wave myocardial infarction: the 
Diltiazem Reinfarction Study, 25A 
Esophageal disorders as cause of chest pain in 
symptomatic patients with documented 
coronary artery disease, l84A 
Long term effects of low fat diet and intensive 
physical exercise on serum cholesterol 
and myocardial ischemia in patients with 
stable angina pectoris, 233A 
Prognostic outcomes in angina vs. myocardial 
infarction, 153A 
Transdermal nitroglycerin may activate 
adrenergic and renin-aldosterone systems. 
Effect on effort tolerance in angina 
pectoris, l84A 
Angina pectoris, unstable 
Beneficial effect of heparin therapy on PICA 
outcome in unstable angina, 132A 
Fifteen-year survival after coronary bypass 
surgery for unstable angina, I06A 
Flestolol, a titratable, short-acting beta 
adrenergic antagonist in the management 
of unstable angina, 233A 
Ischemic ST changes on admission ECG and 
24 hour Holter predict unfavorable 
outcome, multivessel disease, and left 
main stenosis in unstable angina, 233A 
Plasma fibrinopeptide A levels in the various 
clinical forms of unstable angina: relation 
to early prognosis, 233A 
Prognostic value of symptom-limited exercise 
testing following medical stabilization of 
unstable angina, l23A 
Quality of life after treatment for unstable 
angina pectoris: the V A Cooperative 
Study of medical vs surgical therapy for 
unstable angina pectoris, 234A 
Thrombolysis in patients with unstable angina 
refractory to maximal medical therapy, 
233A 
Thrombolytic therapy (TT) in unstable angina 
(UA),49A 
Thrombus and complex lesions at early 
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angiography in unstable ischemic 
syndromes, 232A 
Angiogenesis 
Effect of heparin on the angiogenesis response 
to experimental myocardial ischemia, 
253A 
Angiography 
See also Arteriography 
Comparison of vessel appearance following 
PICA and coronary flow reserve by 
digital angiography, 130A 
Determination of coronary flow reserve by 
digital angiography: validation of a 
practical method not requiring power 
injection or ECG gating, 62A 
Importance of angiography in assessment and 
follow-up of coronary abnormalities in 
Kawasaki's disease, 29A 
Potential risk of thrombosis during angiography 
using non-ionic contrast media, 55A 
Second Mt. Sinai-NYU reprefusion trial: 
relatively late thrombolytic therapy is 
beneficial in patients with collaterals, but 
not in those with subtotal lesion, I04A 
Thermal coronary angiography: a new method 
for assessing coronary bypass graft 
patency, I05A 
Thermal coronary angiography: a new method 
for intraoperative real-time assessment of 
coronary anatomy and blood flow, 46A 
Validation of a digital angiographic model to 
assess autoregulatory vasodilation of the 
coronary system in response to stenosis 
at rest, 62A 
Angiography, radionuclide 
Detection and assessment of severity of 
tricuspid regurgitation using first pass 
radionuclide angiography: a comparison 
with pulsed Doppler echocardiography, 
64A 
Exercise radionuclide angiography after non-Q 
wave myocardial infarction, 2l6A 
Myocardial oxygen consumption can be 
predicted by radionuclide angiographic 
left ventricular Emax pressure-volume 
areas in dogs, 215A 
Angioplasty 
See also Lasers: Restenosis 
Are adjunctive therapies needed when t-PA is 
used? Summary results of TAMI I, II, 
and III trials, l86A 
Cardiac metabolism during coronary 
angioplasty with fluosol protection: 
discordance between LV systolic function 
and lactate metabolism, l49A 
Combined angioplasty and vascular stenting by 
a novel heat-expandable thromboplastic 
device,65A 
Coronary angioplasty in patients with 
increasing disease burden: success rate 
and acute complications, l28A 
Dose dependent inhibition by heparin of acute 
platelet -thrombus deposition during 
angioplasty, 30A 
Durability of coronary angioplasty: clinical and 
angiographic outcome at 5 to 8 years 
following successful dilatation, 60A 
Five to seven year follow-up after coronary 
angioplasty: outcome in simple and 
complex anatomy, 128A 
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Histopathology after rotational angioplasty of 
peripheral arteries in human beings, I09A 
Impedance measurement of absolute arterial 
diameter using a standard angioplasty 
catheter, 130A 
Left main coronary angioplasty-a caution, 
61A 
Multiple vessel angioplasty: experience in 1071 
cases,60A 
Percutaneous "hot-tip" angioplasty in man by 
a radio frequency catheter system, 108A 
Peripheral angioplasty: below the 
knee-tibioperoneal vessels-acute 
outcome, 129A 
Strategy of incomplete revascularization in 
multivessel PTCA: is it justified? 61A 
Triple vessel coronary angioplasty: immediate 
and long term results, 60A 
Angioplasty, balloon 
Autoperfusion balloon angioplasty catheter 
limits myocardial necrosis during 90 
minutes of balloon inflation, 149A 
Balloon angioplasty and rotational tip (Kensey) 
atherectomy catheter in the rabbit model 
of atherosclerosis: acute and chronic 
results, I08A 
Balloon probe: a new ultra low profile 
coronary angioplasty system/concept, 
129A 
Experimental argon laser thermal angioplasty 
as an adjunct to balloon angioplasty, I08A 
Percutaneous balloon angioplasty of left-main 
coronary stenosis: acute and long-term 
results, 61A 
Selection of optimal balloon size for coronary 
angioplasty by cinevideodensitometric 
measurements, 130A 
Angioplasty, percutaneous trausluminal coronary 
Abrupt reclosure: predictors, therapeutic 
options, and long-term outcome, 132A 
Adequate heparinization during PTCA: 
assessment using activated clotting time, 
237A 
Beneficial effect of heparin therapy on PTCA 
outcome in unstable angina, 132A 
Clinical evaluation of hibernating 
myocardium-short term effect of 
coronary angioplasty on regional left 
ventricular wall motion, 133A 
Comparison of vessel appearance following 
PTCA and coronary flow reserve by 
digital angiography, 130A 
Coronary angioplasty for acute myocardial 
infarction: a report of the 1985 NHLBI 
PTCA Registry, 13IA 
Coronary angioplasty performed at the time of 
diagnostic catheterization: safety and 
efficacy, 129A 
Cost -effective evaluation of thrombolytic 
therapy: comparison of current modalities 
and identification of critical cost factors. 
A Canadian perspective, 186A 
Does the addition of dipyridamole to aspirin 
decrease acute coronary angioplasty 
complications? The results of a 
prospective randomized clinical trial, 
237A 
Early and longterm patency rate of the infarct 
artery after tissue plasminogen activator 
(t-PA) and coronary angioplasty for acute 
myocardial infarction, 192A 
ECG and 2D echo assessment of myocardial 
protection achieved by diastolic sinus 
retroperfusion (DSR) during LAD 
angioplasty, 132A 
Effect of aspirin (ASA) on complications 
during transluminal coronary angioplasty 
(TCA) , 132A 
Efficacy of a new PTCA catheter for severely 
narrowed coronary lesions, 129A 
Emergency resuscitation with extracorporeal 
membrane oxygenation for failed 
angioplasty, 149A 
Factors influencing outcome with coronary 
angioplasty: 1985-1986 NHLBI PTCA 
Registry, 148A 
Failure of percentage diameter stenosis 
measurement to reflect changes in the 
dilated lesion following PTCA, \31A 
Gradual balloon inflation protocol reduced 
arterial damage following percutaneous 
transluminal coronary angioplasty, 131 A 
How cumulative is the risk of restenosis with 
multilesion dilatation?, 235A 
Is there really a difference in the incidence of 
restenosis after PTCA with stable and 
unstable angina?, 236A 
Long-term decrease in the severity of residual 
stenosis after coronary angioplasty, 236A 
Long term follow up after successful coronary 
angioplasty in patients of age 2:70 years, 
51A 
Major complications during PTCA: an analysis 
of 5413 cases, 237A 
Prevention of regional wall motion 
abnormalities during coronary angioplasty 
(PTCA), 195A 
Prophylactic use of combined 
heparine-urokinase for the prevention of 
coronary artery occlusion following 
percutaneous transluminal coronary 
angioplasty, 128A 
PTCA in acute myocardial infarction: early 
versus late reperfusion, 187 A 
PTCA vs. rotational atherectomy (PTRA) in 
rabbit atherosclerosis: early and late 
effects, 173A 
Randomized trial of aspirin in PTCA: effect of 
high vs low dose aspirin on major 
complications and restenosis, 236A 
Reversibility of segmental left ventricular 
dysfunction following coronary 
angioplasty: echocardiographic evidence 
of hibernating myocardium, 133A 
Role of antiplatelet agents in reducing 
periprocedural coronary angioplasty 
complications, 238A 
Safe and effective treatment of acute MI 
requires TPA and elective PTCA, not 
early heparin or emergency PTCA, 191A 
Salvage of hibernating myocardium after 
transluminal coronary angioplasty (TCA), 
148A 
Sustained arterial patency after thrombolysis 
and angioplasty therapy of inferior 
myocardial infarction results in late 
improvement in ejection fraction, 192A 
TAMI I vs TAMI II: does choice of initial 
thrombolytic therapy influence outcome 
of salvage angioplasty, 193A 
Therapy of large intracoronary thrombi in 
SUBJECT INDEX 275A 
candidates for percutaneous transluminal 
coronary angioplasty, 238A 
Use of noninvasive temporary pacemaker 
during percutaneous transluminal 
coronary angioplasty, 165A 
Angioscopy 
Angioscopic micropathology of coronary 
atherosclerosis in unstable angina and 
acute myocardial infarction, 65A 
Percutaneous coronary angioscopy during 
cardiac catheterization, 65A 
Percutaneous coronary angioscopy using a 
steerable microangioscope, 173A 
Serial observation of coronary thrombosis in 
vivo by a new angioscope, 30A 
Angioteusin 
See also Renin-angiotensin system 
Systemic and cardiac neurohormonal changes 
during myocardial ischemia in humans: is 
there a rationale for converting-enzyme 
inhibition?,38A 
Angioteusin-converting enzyme inhibitors 
Absence of coronary and systemic 
hemodynamic effects during intravenous 
converting-enzyme inhibition in 
normotensive patients with coronary 
artery disease despite significant 
neurohumoral changes, 243A 
Beneficial effects of {3\ adrenoreceptor 
stabilization and /32-adrenoreceptors 
blockade with xamoterol in severe 
ischemic heart failure treated with 
ACE-inhibitors, 116A 
Can ACE inhibitors replace diuretics as sole 
therapy for mild heart failure?, 73A 
Massive reperfusion injury: paradoxical effect 
of combined angiotensin-converting 
enzyme inhibitor plus myocardial 
reperfusion, 50A 
Anipamil 
Anipamil may limit myocardial necrosis by 
preserving blood flow to ischemic 
myocardium, 88A 
Anisotropy 
Effect of increasing junctional resistivity on 
anisotropic conduction in canine 
myocardium, 197A 
Anthopleurin A 
Sodium current modifications by 
anthopleurin-A and their role in early 
afterdepolarizations, 253A 
Antiaggregating agents 
Thrombolysis in patients with unstable angina 
refractory to maximal medical therapy, 
233A 
Antianginal therapy 
Antianginal therapy directed towards symptom 
control does not abolish silent ischemic 
events,47A 
Antiarrhythmic drug therapy 
See also specific agent 
Analysis of antiarrhythmic drug levels during 
electrophysiologic drug testing, 228A 
Antiarrhythmic drug-induced torsade de 
pointes: lack of relationship to marked 
QT prolongation, 56A 
Antiarrhythmic drug treatment in high risk 
patients with sustained ventricular 
tachycardia following myocardial 
infarction, 190A 
Evaluation of patients at risk after first acute 
276A SUBJECT INDEX 
myocardial infarction by programmed 
ventricular stimulation: influence of 
antiarrhythmic drug therapy, l83A 
Frequency-dependence of antiarrhythmic drug 
effect on post -repolarization refractoriness 
in vivo, 255A 
Improved ventricular performance following 
arrhythmia control in children with 
automatic atrial tachycardia and dilated 
cardiomyopathy, 155A 
Loss of antiarrhythmic efficacy in the chronic 
treatment of patients with benign and 
potentially lethal ventricular arrhythmias, 
56A 
Maintenance of sinus rhythm in patients with 
atrial fibrillation and a dilated left atrium, 
l69A 
Syncope during treatment with antiarrhythmic 
drugs in patients with LTIVF, 182A 
Ventricular function predicts drug response of 
ventricular tachycardia, l68A 
Anticardiolipin antibody 
Elevated anti cardiolipin antibody and coronary 
artery bypass graft occlusion-a 
prospective, randomized trial of low dose 
aspirin,31A 
Antihypertensive drug therapy 
See also specific agent 
Different influence of antihypertensive drugs 
on the secretion of atrial natriuretic factor 
(ANF) in man, 197A 
Electrophysiologic effects, efficacy, and patient 
tolerance of class IC antiarrhythmic 
agents in Wolff-Parkinson-White 
syndrome, 78A 
Long-term diagnosis of patients with acute 
type B aortic dissection treated medically, 
162A 
Regression of ventricular hypertrophy in 
cardiac transplant recipients under 
effective antihypertensive therapy, 151A 
Antimyosin 
Anti-myosin reactive immune response in 
cardiac disease, 95A 
Combined thallium and antimyosin SPECT 
imaging in patients with acute myocardial 
infarction, 213A 
Tissue injury in reperfused and non-reperfused 
experimental myocardial infarction 
characterized with F-18 deoxyglucose and 
in III antimyosin antibodies, lOA 
Antiplatelet agents 
See also specific agent 
Effect of antiplatelet therapy on late graft 
patency after coronary artery bypass 
grafting: VA Cooperative Study #207, 
152A 
Failure of antiplatelet agents to reduce 
restenosis after PTCA in a double blind 
placebo controlled trial, 236A 
Role of antiplatelet agents in reducing 
periprocedural coronary angioplasty 
(PTCA) complications, 238A 
Anxiety 
Does the state of anxiety decrease in patients 
with the automatic internal cardioverter 
defibrillator?, 19A 
Aortic dissection 
Long-term diagnosis of patients with acute 
type B aortic dissection treated medically, 
162A 
Aortic pressure 
Aortic pressure waveform analysis in heart 
failure: age differences and nitroprusside 
response, 90A 
Aortic root dilatation 
Aortic root dilatation in the Marfan syndrome: 
patterns, familiality and short-term 
clinical course, 74A 
Aortic valve area 
Early and late evaluation of percutaneous 
aortic valvuloplasty. A combined 
hemodynamic and Doppler 
echocardiographic study, 14A 
Evaluation and the Doppler continuity 
equation for measuring aortic valve area 
in two settings: mechanical dilatation of 
the stenotic valve and increase in cardiac 
output,2lA 
Aortic valve disease 
See also Surgery, valve; Valve disease 
Assessment of myocardial mass in chronic 
aortic insufficiency using magnetic 
resonance imaging, 157 A 
Asymptomatic severe aortic regurgitation: a 
prospective follow-up of 60 patients, 159A 
Balloon aortic valvuloplasty of calcific aortic 
stenosis: results in 130 cases, 16A 
Characteristic mitral inflow Doppler velocity 
pattern in severe aortic insufficiency, 
175A 
Combined use of continuous wave and color 
flow Doppler for the estimation of the 
regurgitant volume in aortic regurgitation, 
176A 
Contrasting histoarchitecture of calcific 
deposits in leaflets from bicuspid versus 
tricuspid aortic valves, 231A 
Correlation of distance from subaortic 
membrane to aortic valve and the 
development of aortic regurgitation in 
mild discrete aortic stenosis, 74A 
Determinant of best results of balloon aortic 
valvuloplasty in adults, 14A 
Diagnostic accuracy of auscultation in aortic 
regurgitation, 175A 
Early rise in aortic gradient following aortic 
valvuloplasty is due to improved left 
ventricular performance, 220A 
Effect of aortic compliance on left ventricular 
volume and function in patients with 
aortic insufficiency, 160A 
Evaluation of aortic regurgitation by 
cinemagnetic resonance imaging, 155A 
Gorlin valve area varies with cardiac output in 
aortic stenosis, 63A 
Impact of Doppler assessment of aortic 
stenosis on clinical management: 
experience in 500 patients, 176A 
Isoproterenol infusion increases Gorlin formula 
aortic valve area in isolated aortic 
stenosis, 63A 
Long term changes in left ventricular 
dimensions in patients with aortic 
regurgitation with and without vasodilator 
therapy, 159A 
Natural history of asymptomatic patients with 
chronic aortic regurgitation: serial 
long-term changes in left ventricular 
function, 159A 
Quantitative evaluation of aortic regurgitation 
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after anatomic correction of transposition 
of the great arteries, 135A 
Severity of stenosis, degree of clacifications 
and balloon diameter are determinants of 
successful aortic valvuloplasty in vitro, 
221A 
Time course of left ventricular hypertrophy 
and wall stress in aortic regurgitation, 
92A 
Apolipoprotein 
Apolipoprotein B and Al changes induced by 
cholesterol-lowering diet in patients with 
hyperapobetalipoproteinemia (hyperapob), 
207A 
APSAC 
Multicenter double-blind trial of intravenous 
APSAC versus heparin in acute 
myocardial infarction. Final report of 
APSIM study, 232A 
Arginine vasopressin 
Atrial natriuretic factor and arginine 
vasopressin after Fontan procedure, 134A 
Arrhythmias 
See also Antiarrhythmic drug therapy 
Can EPS predict subsequent arrhythmic events 
in WPW patients with infrequent or no 
arrhythmias?, 79 A 
Relationship of automatic implantable 
cardioverter-defibrillator shocks to 
arrhythmia characteristics, 18A 
Arrhythmias, atrial 
Assessment of atrial vulnerability using 
dynamic changes in endocardial 
monophasic action potential duration, 
114A 
Arrhythmias, ventricular 
Are patients with mild heart failure at risk of 
malignant ventricular arrhythmias and 
sudden death?, 72A 
Atropine reduced ventricular arrhythmias 
during coronary arteriography, 185A 
Catheter ablation of refractory ventricular 
arrhythmias: long term follow up, 179A 
Chronic oral sotalol for patients with sustained 
ventricular arrhythmias, 167 A 
Comparative SPECT 1-123 
metaiodobenzylguanidine (MIBG) and 
thallium 201 cardiac imaging following 
myocardial infarction in patients, 81A 
Dispersion of left ventricular repolarization in 
man, 113A 
Does the state of anxiety decrease in patients 
with the automatic internal cardioverter 
defibrillator?, 19A 
Heart innervation and dysrhythmias elicited by 
sympathetic stimulation in two different 
canine infarct models, 38A 
Neurophysiologic accompaniments of 
ventricular arrhythmias producing 
syncope,7A 
Profound reduction in ventricular arrhythmias 
during blood-free reperfusion with 
oxygenated Fluosol-DA, 87A 
Programmed ventricular stimulation in patients 
with dilated cardiomyopathy: effect of 
hemodynamic instability on inducibility of 
ventricular arrhythmias, 72A 
Ventricular arrhythmias in patients on 
antiarrhythmic drugs-proarrhythmia or 
drug failure?, 182A 
Ventricular arrhythmias in post-operative 
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tetralogy of Fallot-(collaborative study), 
155A 
Arterial dimensions 
Impedance measurement of absolute arterial 
diameter using a standard angioplasty 
catheter, l30A 
Arterial patency 
Sustained arterial patency after thrombolysis 
and angioplasty therapy of inferior 
myocardial infarction results in late 
improvement in ejection fraction, 192A 
Arteriography 
See also Angiography 
Comparative clinical assessment of quantitative 
coronary arteriography using digital and 
film-based methods, 63A 
Aspirin 
Does the addition of dipyridamole to aspirin 
decrease acute coronary angioplasty 
complications? The results of a 
prospective clinical trial, 237 A 
Effect of antiplatelet therapy on late graft 
patency after coronary artery bypass 
grafting: V A Cooperative Study #207, 
152A 
Effect of aspirin (ASA) on complications 
during transluminal coronary angioplasty 
(TCA),132A 
Elevated anti cardiolipin antibody and coronary 
artery bypass graft occlusion-a 
prospective, randomized trial of low dose 
aspirin,3lA 
Failure of antiplatelet agents to reduce 
restenosis after PTCA in a double blind 
placebo controlled trial, 23M 
Inhibition of thrombus formation: blockage of 
adhesive glycoprotein mechanisms versus 
blockage of the glycooxygenase pathway, 
30A 
Randomized trial of aspirin in PTCA: effect of 
high vs low dose aspirin on major 
complications and restenosis, 236A 
Recurrent ischemia without warning: inability 
to predict ischemic events from residual 
stenosis after successful coronary 
thrombolysis, 105A 
Results of large randomized trial of 
intravenous streptokinase and oral aspirin 
in acute myocardial infarction, 232A 
Role of antiplatelet agents in reducing 
periprocedural coronary angioplasty 
(PTCA) complications, 23SA 
Asystole 
Cardiac asystole in patients with 
neurally-mediated hypotension-
bradycardia syndrome, 115A 
Lidocaine induced malignant ventricular 
asystole in anesthetized dogs with recent 
myocardial infarction, 39A 
Atenolol 
Different influence of antihypertensive drugs 
on the secretion of atrial natriuretic factor 
(ANF) in man, 197A 
Effects of acute and chronic 
beta-adrenoceptor blockade on 
baroreflex sensitivity, 148A 
Effects of therapeutic interventions on the 
distribution of silent ischaemic episodes 
throughout the day, 97A 
Exercise induced platelet activation in angina 
pectoris-reduction by combination therapy 
by {3 blocker with calcium blocker, 211A 
Atherectomy 
Balloon angioplasty and rotational tip (Kensey) 
atherectomy catheter in the rabbit model 
of atherosclerosis: acute and chronic 
results, 10SA 
Histopathology after rotational angioplasty of 
peripheral arteries in human beings, 109A 
In-vitro and in-vivo experimental results using 
a new wire guided concentric atherectomy 
device, 109A 
Percutaneous coronary atherectomy, 110A 
Primary stenosis and restenosis excised by 
peripheral atherectomy: a histologic 
study, 173A 
PTCA vs rotational atherectomy (PTRA) in 
rabbit atherosclerosis: early and late 
effects, 173A 
Short term follow up of patients treated with a 
recently developed rotational atherectomy 
device and in vivo assessment of the 
particles generated, 109A 
Transluminal atherectomy: early results in the 
treatment of atherosclerosis, 109A 
Transluminal atherectomy: hemodynamic 
follow-up by Doppler analysis, 172A 
Atherosclerosis 
See also Atherectomy; Coronary artery disease 
Alteration of artery wall fluorescence due to 
excessive laser irradiation, 49A 
Angioscopic micro pathology of coronary 
atherosclerosis in unstable angina and 
acute myocardial infarction, 65A 
Are mast cells the culprit in coronary plaque 
destabilization?, 52A 
Color NMR microscopy of atheromatous 
plaques within human coronary arteries, 
61A 
Detection of early atherosclerosis by 
quantitative ultrasonic methods, lOOA 
Dipyridamole radionuclide ventriculography 
has high sensitivity for detecting severe 
multivessel coronary atherosclerosis, 
216A 
Effects of dietary supplementation with 
cod-liver oil on impaired 
endothelial-dependent relaxations in 
atherosclerotic porcine coronary arteries, 
191A 
Effects of variable ultrasonic energy duration, 
application mode and energy on 
atherosclerotic plaque ablation, 172A 
Fluorescence spectroscopy guidance of laser 
ablation of atherosclerotic plaque, 107A 
Impaired endothelium-dependent relaxation to 
aggregating platelets and related 
vasoactive substances in porcine coronary 
arteries in hypercholesterolemia and in 
atherosclerosis, 2A 
In-vivo fluorescence spectroscopy of normal 
and atherosclerotic arteries, 173A 
Inhibition of atherosclerosis by fish oil in 
cholesterol fed rabbits, 50A 
Intravascular ultrasound imaging catheter 
assessment of normal and atherosclerotic 
arterial wall thickness, 22A 
Morphologic and dynamic changes of 
atherosclerotic plaque at the carotid 
artery bifurcation: sequential imaging by 
real time B-mode ultrasonography, 52A 
SUBJECT INDEX 277A 
Percutaneous pulsed laser angioplasty with 
atheroma detection in humans, 107A 
Phycocyanin cytotoxic effects and uptake in 
human atherosclerotic plaques, 22A 
Quantitative validation of atherosclerotic 
coronary arterial lumen and wall 
measurements by high frequency 
echocardiography, 194A 
Athletes 
Radionuclide assessment of regional wall 
motion abnormalities in healthy master 
athletes, 212A 
Atresia 
Preoperative assessment of right ventricular 
size and morphology in tricuspic atresia, 
29A 
Atrial fibrillation 
Atrial mapping fails to demonstrate a 
conduction defect accounting for atrial 
fibrillation in Wolff-Parkinson-White 
syndrome,79A 
Early clinical results of corridor surgery for 
treatment of chronic atrial fibrillation, IIA 
Effect of atrial fibrillation on plasma atrial 
natriuretic factor response to changes in 
atrial pressure, 117A 
Flecainide for prevention of symptomatic 
paroxysmal atrial fibrillation: a 
multicenter, double-blind 
placebo-controlled, crossover study, 77 A 
Flecainide for recurrent atrial fibrillation: 
predictors of efficacy, 228A 
Reproducibility of the heart rate response to 
exercise in patients with atrial fibrillation, 
247A 
Signal-averaged electrocardiogram as a 
screening test for occurrence of 
paroxysmal atrial fibrillation, 116A 
Systemic deviations between the ventricular 
response to atrial fibrillation and 
antegrade accessory pathway refractory 
period in WoIII-Parkinson-White 
syndrome,78A 
Atriaillutter 
Direct catheter fulguration of atrial flutter in 
man, 221A 
Atrial natriuretic factor 
ANP directly dilates forearm arterioles in man, 
147A 
Atrial natriuretic factor and arginine 
vasopressin after Fontan procedure, 134A 
Atrial natriuretic peptide in congenital heart 
defects with right heart volume overload, 
I37A 
Atrial natriuretic peptide increases cardiac 
output in normal humans, 239A 
Atrial natriuretic peptide in surgically-induced 
hypertensive ventricle of rats, 71A 
Different influence of antihypertensive drugs 
on the secretion of atrial natriuretic factor 
(ANF) in man, 197A 
Effect of atrial fibrillation on plasma atrial 
natriuretic factor response to changes in 
atrial pressure, 117 A 
Effects of atrial natriuretic peptide on left 
ventricular performance in man, 89A 
Elevated atrial natriuretic peptide in chronic 
biventricular failure due to dilated 
cardiomyopathy: evidence for 
predominant contribution from the left 
heart, 118A 
278A SUBJECT INDEX 
Elevated serum atrial natriuretic peptide in 
premature infants with respiratory distress 
and patent ductus arteriosus, 136A 
Hemodynamic, hormonal, and renal changes 
following incremental infusions of atrial 
natriuretic peptide before and after the 
induction of congestive heart failure, 
119A 
Increased release of atrial natriuretic factor 
during sustained ventricular tachycardia, 
240A 
Is atrial natriuretic peptide a guide to the 
adequacy of cardiac pacing mode?, 167A 
Low dose atrial natriuretic factor is a selective 
renal vasodilator in humans with 
congestive heart failure, 239A 
Morphometric analysis of atrial natriuretic 
peptide granularity in patients with heart 
failure, 118A 
Pharmacodynamics and pharmacokinetics of 
atrial natriuretic peptide in severe 
congestive heart failure, 239A 
Physiologic role of endogenous atrial 
natriuretic factor during acute congestive 
heart failure, 118A 
Plasma atrial natriuretic polypeptide (ANP) 
and plasma norepinephrine (NE) during 
exercise in essential hypertension, 146A 
Potential contribution of ANF to renal and 
hemodynamic responses following volume 
expansion in conscious dogs, 146A 
Release of human atrial natriuretic factor is 
related to increase in atrial dimension, 
89A 
Renal and hemodynamic effects of low and 
high dose ANF bolus doses in congestive 
heart failure, 118A 
Response of atrial natriuretic polypeptide to 
isoproterenol and acetylcholine infusion in 
humans, 238A 
Role of right and left atria in the regulation of 
ANF concentration, 70A 
Transpulmonary degradation and left atrial 
secretion of atrial natriuretic factor in 
man, 239A 
Atrial septal defects 
Color Doppler assessment of shunt flow across 
large atrial septal defects, 240A 
Spontaneous closure rate of atrial septal 
defects diagnosed in infancy, 249A 
Atrial tachyarrhythmias 
Efficacy of flecainide in the treatment of atrial 
tachyarrhythmias, 228A 
Atrial volume 
Left atrial compression: a neglected sign of 
tamponade,84A 
Left atrial size and pressure reflects the 
"history" of chronic mitral regurgitation, 
219A 
Left atrial volume measurement: cine 
computed tomography and 
echocardiography,217A 
Atrioventricular canal defects 
Color Doppler flow mapping shunt patterns in 
AV canal defects: comparison with 
angiography, 241A 
Atrioventricular tachycardia 
Characterization and differentiation of reset 
response curves in automaticity and 
reentry, 115A 
Cryosurgical modification of atrioventricular 
node conduction for treatment of 
atrioventricular node reentrant 
tachycardia, IlIA 
Drug of choice for acute management of 
paroxysmal atrioventricular reentrant 
tachycardia: ATP? verapamil?, 170A 
Effects of oral flecainide on atrioventricular 
reciprocating tachycardia refractory to 
procainamide, 169A 
Noninvasive termination of atrioventricular 
reciprocating tachycardia with external 
cardiac programmed stimulation, 167A 
Unmasking and modulation of the excitable 
gap in atrioventricular nodal reentrant 
tachycardia: new insight into the 
microentry circuit, 115A 
Atropine 
Atropine reduces ventricular arrhythmias 
during coronary arteriographY, 185A 
Automaticity 
Characterization and differentiation of reset 
response curve in automaticity and 
reentry, 115A 
Autoperfusion preparation 
Study of heart function curing a 24-hour 
preservation in a new autoperfusion 
preparation, 103A 
Azapropazone 
Reduced infarction in dogs given azapropazone 
prior to coronary thrombolysis, 208A 
Azathioprine 
Cardiac growth after orthotopic heart 
transplantation in early infancy, 138A 
Immunosuppression in cardiac transplantation 
. without prednisone: a comparison of 
cyclosporine/prednisone to 
cyclosporine/azathioprine, I04A 
Ba++ 
Antiarrhythmic and electrophysiologic effects 
of Ba++ IKI blockade, 59A 
Baroreftex sensitivity 
Effect of chronic inferoposterior myocardial 
infarction on arterial baroreflex 
sensitivity, 88A 
Effects of acute and chronic 
beta-adrenoreceptor blocker on baroreflex 
sensitivity, 148A 
Bayes theorem 
Is Bayesian analysis valid for the interpretation 
of the exercise thallium-201 test, or 
should another approach be tried?, 80A 
Beta-adrenergic blocking agents 
See also specific agent 
f3 blockade results in decreased coronary blood 
flow due to unapposed mediated 
vasoconstriction, 23A 
Effects of acute and chronic 
beta-adrenoreceptor blockade on 
baroreflex sensitivity, 148A 
Exercise induced platelet activation in angina 
pectoris-reduction by combination 
therapy of f3 blocker with calcium 
blocker, 211A 
Flecainide for recurrent atrial fibrillation: 
predictors of efficacy, 228A 
Beta-adrenergic receptors 
f3-receptor density and vascularity vary 
markedly in skeletal muscles with high 
and low respiratory capacities, 247 A 
Beta adrenoreceptor up regulation in human 
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circulating lymphocytes after oral 
treatment by propafenone, 256A 
Beta receptor and mechanical function in the 
failing heart of the spontaneously 
hypertensive rat, 71A 
Distribution of f3-adrenergic receptors in failing 
human myocardium: implications for 
mechanisms of down-regulation, 116A 
Down-regulation of skeletal muscle 
f3-adrenergic receptors in experimental 
canine heart failure, 116A 
Effects of acute and chronic beta-adrenoceptor 
blockade on baroreflex sensitivity, 148A 
Exercise induced abnormalities in cAMP 
response in congestive heart failure, 96A 
Intracellular f3-adrenergic distribution in the 
failing human myocardium, 117A 
Is f31 receptor down-regulation in the failing 
human heart the result of exposure to 
cardiac-derived norepinephrine?, 117 A 
Myocardial ~ receptor subsensitivity in the 
failing human heart, 117 A 
Negative left ventricular pressure during 
beta-adrenergic stimulation in human 
subjects: evidence for diastolic "suction" 
in the normal heart, 34A 
Regional f3-adrenergic receptors and adenylate 
cyclase activity after healing of 
myocardial infarction in cats, 252A 
Role of beta-adrenergic stimulation in 
induction of sustained atrioventricular 
nodal reentry in patients with dual 
atrioventricular nodal pathways, 180A 
Biopsy 
Complications of endomyocardial biopsy of the 
transplanted human heart-a review of 
6,200 biopsies in 550 patients, 174A 
Endomyocardial biopsy in cardiac 
hemochromatosis, 85A 
Bisyncytium 
Electrical behavior of a cardiac bisyncytium 
during defibrillation, 58A 
Bleeding time 
Bleeding time measurement predicts 
spontaneous bleeding during thrombolysis 
with recombinant tissue-type plasminogen 
activator (rt-PA), 231A 
Blood flow 
See Coronary flow 
Blood pressure 
See also Hypertension; Hypotension 
Direct and indirect diastolic blood pressure 
measurements on exercise before and 
after coronary artery surgery, 102A 
Sex specific regulation of BP development 
throughout puberty, 222A 
Blood temperature 
Autonomic effects of stress and exercise on 
intracardiac blood temperature: 
implications for thermodilution 
measurement and rate-adaptive pacing, 
lOlA 
Study of blood temperature for physiologic 
control of heart rate in paced patients, 
I66A 
BM13.505 
Abolishment of cyclic flow variations in 
constricted carotid arteries of conscious, 
chronically instrumented dogs with the 
thromboxane receptor antagonist 
BM13.505, 53A 
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Bradycardia 
See Hypotension-bradycardia syndrome 
Bradykinin 
In vivo identification of normal and damaged 
endothelium by quantitative coronary 
angiography and infusion of acetylcholine 
and bradykinin, 29A 
Bretylium 
Parenteral magnesium therapy in intractable 
ventricular tachyarrhythmias, l69A 
Buffer agents 
Effects of buffer agents on myocardial 
resuscitability after cardiac arrest, 89A 
Bunazosin 
Antiarrhythmic actions of bunazosin, an alpha, 
adrenoceptor antagonist in the guinea pig 
cardiac muscle, 40A 
Bundle branch block 
Modifications of the mitral flow due to the 
presence of a left bundle branch block 
(LBBB),174A 
Caffeine 
Cocaine potentiated caffeine-induced 
contractions in the coronary arteries, 50A 
Calcium 
See also Sodium-calcium exchange 
Ca ++ activated transient outward current in 
the rabbit atrioventricular node, 59A 
Effect of MCI-154 on Ca2+ -activation on 
skinned human and ferret cardiac muscle, 
139A 
Calcium chaunel blockers 
See also specific agent 
Different influence on antihypertensive drugs 
on the secretion of atrial natriuretic factor 
(ANF) in man, 197A 
Diltiazem attenuates the hemodynamic effects 
of cardiac glycosides, 205A 
Exercise induced platelet activation in angina 
pectoris-reduction by combination 
therapy of f3 blocker and calcium blocker, 
211 A 
Maintentance of sinus rhythm in patients with 
atrial fibrillation and a dilated left atrium, 
169A 
Recurrent ischemia without warning: inability 
to predict ischemic events from residual 
stenosis after successful coronary 
thrombolysis, 105A 
Thrombolysis in patients with unstable angina 
refractory to maximal medical therapy, 
233A 
Calcium heparin 
Prevention of left ventricular mural thrombosis 
in acute myocardial infarction: a 
double-blind trial comparing high dose 
with lose dose calcium heparin, 26A 
Capsaicine 
Peptidergic neurotoxin causes alterations of 
mitral valve motion, 125A 
Captopril 
Can ACE-inhibitors replace diuretics as sole 
therapy for mild heart failure?, 73A 
Hemodynamic effects of captopril in children 
with congestive or restrictive 
cardiomyopathy,28A 
Pharmacologic modification of left ventricular 
remodeling during healing after 
myocardial infarction in the dog, 252A 
Which objective measurements parallel the 
course of disease progression in patients 
with congestive heart failure?, 202A 
Cardiac arrest 
See Sudden death 
Cardiac catheterization 
Changing patterns of referral after diagnostic 
cardiac catheterization, 127 A 
Coronary angioplasty performed at the time of 
diagnostic catheterization: safety and 
efficacy, 129A 
Regional arterial compliance in vivo in man 
and nonhuman primates: a new 
catheterization application, 83A 
Should cardiac catheterization be performed 
preoperatively in echo-diagnosed 
intracardiac tumors?, 163A 
Cardiac conduction 
Anomalous ventriculo-atrial conduction which 
shows vagal independence yet retains 
rate-dependence, 196A 
Areas of slow conduction common to 
ventricular tachycardias of different 
morphologies, 114A 
Clinical outcome of patients with intact 
atrioventricular conduction after 
atrioventricular junction ablation for 
refractory supraventricular 
tachyarrhythmias, 177 A 
Concealed antegrade accessory pathway 
conduction during induction of 
orthodromic tachycardia, 180A 
Different sites of accessory pathway 
conduction block in patients with right 
and left sided accessory pathways, 78A 
Differentiation of conduction over a posterior 
paraseptal accessory pathway versus 
normal ventriculoatrial conduction system 
by retrograde atrial activation sequence at 
the atrioventricular groove, lilA 
Effect of increasing junctional resistivity on 
anisotropic conduction in canine 
myocardium, 197A 
Electrophysiologic spectrum of concealed 
intranodal conduction during atrial rate 
acceleration in a model of 2:1 
atrioventricular block, ll5A 
Identification and catheter ablation of a zone of 
slow conduction in the reentry circuit of 
ventricular tachycardia, 16A 
Inhibition of procainamide use dependent 
conduction delay by lidocaine, 181A 
Propagation patterns across anatomic barriers 
in anisotropic tissue, 197 A 
Quantitative modelling of antiarrhythmic 
drug-induced conduction slowing in vivo, 
255A 
Rate-dependent effects of amiodarone on 
conduction and recovery in vivo, 256A 
Time delays in the propagation of cardiac 
action potentials, 197A 
Cardiac g1ycosides 
Diltiazem attenuates the hemodynamic effects 
of cardiac glycosides, 205A 
Cardiac muscles 
Effect of exercise conditioning on action 
potential duration and norepinephrine 
content in heart muscle from senescent 
rats, 246A 
Cardiac output 
Atrial natriuretic peptide increases cardiac 
output in normal humans, 239A 
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Effect of ECG-gated high frequency ventilation 
in cardiac output in dogs, 246A 
Effect of cardiac output of a cardiac 
rehabilitation program in children after 
surgical repair of congenital heart disease, 
250A 
Instantaneous and continuous cardiac output 
using a Doppler pulmonary artery 
catheter, 5A 
Preservation of diastolic function and cardiac 
output during PTCA with distal coronary 
perfusion of Fluosol-SA 20%, 133A 
Cardiac pressure 
Effects of atrial fibrillation on plasma atrial 
natriuretic factor response to changes in 
atrial pressure, 117A 
Cardiac rupture 
Clinicopathologic study of cardiac rupture 
following acute myocardial infarction in 
the elderly, 51A 
Cardiac size 
ECG and X-ray estimates of cardiac size and 
the risk of cardiovascular mortality among 
women in the NHANES I followup study, 
224A 
Cardiac tamponade 
Cardiac tamponade: pulsed wave Doppler 
findings, 75A 
Importance of atrial contraction in 
experimental cardiac tamponade-a 
Doppler echocardiographic study, 84A 
Left atrial compression: a neglected sign of 
tamponade,84A 
Cardiac transplantation 
Arterial hypertension after cardiac transplant 
with triple-drug immunosuppressive 
therapy, 150A 
Cardiac growth after orthotopic heart 
transplantation in early infancy, 138A 
Cardiac transplantation from live donors, 102A 
Cinevideodensitometric quantification of 
coronary artery disease following cardiac 
transplantation, 150A 
Complications of endomyocardial biopsy of the 
transplanted human heart-a review of 
6,200 biopsies in 550 patients, 174A 
Cyclosporine-mediated hypercholesterolemia in 
cardiac transplant patient, 153A 
Decrease in 2-dimensional echocardiographic 
ejection fraction during transplant 
rejection: a study of 400 biopsies, 121A 
Differences in diastolic function indices 
between non-rejecting cardiac transplants 
and age matched normals: importance for 
evaluation of heart allografts acute 
rejection, 36A 
Early and medium term results of cardiac 
transplantation in the seventh decade of 
life,45A 
Exercise capacity following cardiac 
transplantation, 45A 
Heart transplantation in patients requiring 
preoperative inotropic and mechanical 
support, 44A 
Hemodynamic abnormalities following cardiac 
transplantation: relationship to 
hypertension and survival, 103A 
Hyperlipoproteinemia following heart 
transplantation: natural history and 
intervention with Lovastatin and 
Gemfibrozin, 44A 
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Immunosuppression in cardiac transplantation 
without prednisone: a comparison of 
cyclosporine/prednisone to 
cyclosporine/azathioprine, I04A 
Influence of cyclosporin A on mortality after 
orthotopic heart transplantation, 150A 
Influence of diabetes mellitus on the course of 
cardiac transplantation, 103A 
Psychosocial functioning after heart 
transplantation, 150A 
Regression of ventricular hypertrophy in 
cardiac transplant recipients under 
effective antihypertensive therapy, 151A 
Serial changes in left ventricular mass of the 
donor's heart early after transplantation, 
149A 
Sinus node dysfunction in heart transplant 
recipients, I03A 
Study of heart function during a 24-hour 
preservation in a new autoperfusion 
preparation, 103A 
Transplant coronary artery disease: 
histopathologic correlations with 
angiographic morphology, 153A 
Use of trans pulmonary pressure gradient in the 
selection of cardiac transplantation 
candidates,45A 
Cardiomyopathy 
See also Hypertrophy 
Arrhythmogenic right ventricular dysplasias: 
histological and electro microscopy study 
of five cases, 181A 
Assessment of left ventricular contractility in 
dilated cardiomyopathy: comparison of 
non-ejection phase indices, 142A 
Chordal geometry determines the shape and 
extent of systolic anterior mitral motion: 
in vitro studies, 251A 
Color flow and spectral Doppler evaluation of 
midventricular obstruction, hypertrophic 
obstructive cardiomyopathy and cavity 
obliteration, 74A 
Diastolic function and structure abnormalities 
in dilated cardiomyopathy, 36A 
Doppler velocity and cineangiovolumetric 
measurements in fixed and dynamic 
obstruction, 251A 
Electrocardiogram as a predictor of 
development and progression of left 
ventricular hypertrophy in hypertrophic 
cardiomyopathy, 252A 
Hemodynamic effects of captopril in children 
with congestive or restrictive 
cardiomyopathy, 28A 
High prevalence of familial cardiomyopathy in 
a transplant center population: implication 
for management of idiopathic dilated 
cardiomyopathy, 154A 
Hypertrophic cardiomyopathy in the elderly-
clinical course and prognostic indices, 
243A 
Hypertrophic cardiomyopathy in the elderly: 
distinctions from the young based on 
cardiac shape, 243A 
Is early diastolic ventricular filling impaired in 
amyloid restrictive cardiomyopathy?, 86A 
Late potentials can indicate a degree of 
myocardial scar assessed by thallium-20I 
myocardial perfusion imaging in patients 
with idiopathic dilated cardiomyopathy, 
85A 
Limitations of the coefficient of passive 
chamber stiffness in dilated 
cardiomyopathy,36A 
Mildly dilated congestive cardiomyopathy: 
clinical course without heart 
transplantation, 85A 
Noninvasive determination of late systolic 
indices of inotropy in congestive 
cardiomyopathy, 245A 
Obstructive hypertrophic cardiomyopathy in 
the elderly: a unique group of patients 
with small left ventricular outflow tract, 
mitral anular calcification and late onset 
of severe symptoms, 251A 
Postpartum cardiomyopathy: clinical, 
morphologic and follow-up aspects, 86A 
Programmed ventricular stimulation in 
patients with dilated cardiomyopathy: 
effect of hemodynamic instability on 
inducibility of ventricular arrhythmias, 
72A 
Relationship between the location of 
hypertrophy and diastolic function in 
patients with hypertrophic 
cardiomyopathy,250A 
Subendocardial coronary flow is decreased in 
Syrian cardiomyopathic hamsters, 85A 
Verapamil improves myocardial perfusion 
abnormalities in asymptomatic 
hypertrophic cardiomyopathy, 251A 
Cardioplegia 
Benefit of retrograde coronary sinus 
cardioplegia during revascularization for 
acute myocardial infarction, I06A 
Can intermittent bolus oxygenated crystalloid 
cardioplegia maintain aerobic metabolism 
of the arrested heart, I72A 
Exogenous creatine phosphate: favorable 
calcium-altering effects in St. Thomas's 
Hospital cardioplegic solution, 170A 
Importance of topical hypothermia during 
heterogenous distribution of cardioplegia, 
I72A 
Improved cardioplegic protection with a new 
lecithin-based perfluorocarbon emulsion, 
171A 
Protective effects of retrograde versus 
ante grade cardioplegia on biventricular 
function during coronary bypass surgery, 
I7IA 
Cardiopulmonary resuscitation 
Continuous transtracheal oxygen delivery: a 
new alternative method of ventilation 
during cardiopulmonary resuscitation, 
83A 
Dose-dependent vasopressor response to 
epinephrine during CPR in humans, 42A 
Echocardiographic and Doppler analysis of 
cough cardiopulmonary resuscitation 
(CPR) during asystole, 219A 
Effects of buffer agents on myocardial 
resuscitability after cardiac arrest, 89A 
Emergency resuscitation with extracorporeal 
membrane oxygenation for failed 
angioplasty, 149A 
Should elderly be resuscitated following 
out-of-hospital cardiac arrest?, 52A 
Cardioversion 
Initial patient experience with telephone 
remotely controlled cardioversion and 
defibrillation, 66A 
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Cardioverter defibrillator 
Atrial sensing to enhance ventricular 
tachycardia detection by the automatic 
implantable cardioverter defibrillator: a 
utility study, 209A 
Automatic anti tachycardia pacemaker and the 
automatic implantable cardioverter 
defibrillator as therapy for recurrent drug 
refractory ventricular tachycardia, 17 A 
Automatic implantable cardioverter 
defibrillator discharges and acute 
myocardial infarction, 56A 
Clinical performance of automatic implantable 
cardioverter defibrillator: 
electrocardiographic documentation of 82 
spontaneous discharges, 18A 
Determinates of defibrillation threshold, 57 A 
Does the state of anxiety decrease in patients 
with the automatic internal cardioverter 
defibrillator?, 19A 
High defibrillation threshold with the AICD: 
management with right atrial patch 
electrode, 209A 
IACD-patient and device longevity, 178A 
Impact of automatic implantable cardioverter 
defibrillators on survival of patients with 
left ventricular dysfunction and malignant 
ventricular arrhythmias, 179A 
Implantation of a 
pacemaker/cardioverter/defibrillator in 
man: initial results of a new generation 
device, 208A 
Importance of patch electrode placement and 
size on defibrillation: a finite-element 
analysis, 57 A 
Improved internal defibrillation efficacy in 
patients with biphasic shocks, 209A 
Inappropriate and appropriate discharges of the 
automatic implantable cardioverter 
defibrillator, 210A 
Rapid transverse cardioversion of sustained 
ventricular tachycardia by programmable 
implantable cardioverters/defibrillators, 
209A 
Relationship of automatic implantable 
cardioverter-defibrillator shocks to 
arrhythmia characteristics, 18A 
Time to first shock and long-term outcome in 
patients with automatic implantable 
defibrillators, 18A 
Why does transthoracic impedance decline 
after direct countershock?, 210A 
Carotid artery 
Abolishment of cyclic flow variation in 
constricted carotid arteries of conscious, 
chronically instrumented dogs with the 
thromboxane receptor antagonist 
BM.I3.505,53A 
Carotid artery disease 
Prevalence of extra-cranial carotid artery 
disease in elderly patients undergoing 
cardiac surgery, 161A 
Catalase 
Long-term recovery of LV wall thickening 
after one hour of ischemia is not affected 
when superoxide dismutase and catalase 
are administered during the 1st 45 minutes 
of reperfusion, 163A 
Catecholamines 
Effects of pre-ischemic catecholamine 
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depletion on myocardial metabolism and 
tolerance to total ischemia, 37A 
Ventricular tachycardia in patients without 
underlying structural heart disease: 
evidence for triggered activity in humans, 
113A 
Catheter(s) 
See also Ablation procedures; under Doppler 
ultrasound; under Echocardiography; 
under Valvuloplasty 
Comparison of left ventricular volumes derived 
from an impedance catheter with that 
derived from the dynamic spatial 
reconstructor, 200A 
Direct catheter fulguration of atrial flutter in 
man, 221A 
Efficacy of a new PTCA catheter for severely 
narrowed coronary lesion, 129A 
Impedance measurement of absolute atrial 
diameter using a standard angioplasty 
catheter, 130A 
Percutaneous "hot-tip" angioplasty in man by 
a radio frequency catheter system, 108A 
Real-time, two dimensional catheter 
ultrasound: a new technique for 
high-resolution intravascular imaging, 
130A 
Right ventricular stroke volume assessment 
using an impedance catheter, 166A 
Catheterization 
See Cardiac catheterization 
Cesium 
Differential response of early 
afterdepolarizations and ventricular 
tachycardia during right and left stellate 
stimulation in the dog treated with 
cesium, 254A 
Magnesium abolishes early afterdepolarizations 
induced by cesium, 4-aminopyridine, or 
quinidine in canine Purkinje fibers, 254 A 
Magnesium suppresses early 
afterdepolarizations and ventricular 
tachyarrhythmias induced in dogs by 
cesium, 254A 
Cholesterol 
Clinical outcome ten years after coronary 
bypass: effects of cholesterol and 
triglycerides in 4913 pts., 7A 
Effects of simvastatin versus probucol. 
Simvastatin multicenter group II, 207 A 
Epidemiology of total-cholesterol-to-HDL 
(ratio) in 11 ,669 air force personnel and 
coronary artery anatomy in 305 healthy 
aviators, 222A 
Exercise, lowfat diet, and a high 
polyunsaturated:saturated fat ratio do not 
prevent the cholesterol raising effects of 
dietary cholesterol, 206A 
Hypercholesterolemia following heart 
transplantation: natural history and 
intervention with Lovastatin and 
Gemfibrozil, 44A 
Impaired endothelium-dependent relaxation to 
aggregating platelets and related 
vasoactive substances in porcine coronary 
arteries in hypercholesterolemia and in 
atherosclerosis, 2A 
Saphenous vein graft patency after 2 years is 
related to preoperative serum cholesterol 
and triglyceride levels, 7 A 
Serum cholesterol and coronary heart disease 
mortality over 23 years: implications for 
primary prevention, 126A 
Cholinergic hypersensitivity 
Bronchial cholinergic hyperresponsiveness in 
patients with variant angina, 46A 
Cimetidine 
Cimetidine, but not ranitidine, alters nifedipine 
elimination kinetics and effects, 44A 
Cinevideodensitometry 
Selection of optimal balloon size for coronary 
angioplasty by cinevideodensitometric 
measurements, 130A 
Clofilum 
Electrophysiologic actions of clofilum in 
ischemically-injured myocardium, in vivo 
and in vitro studies, 40A 
Coarctation of the aorta 
Echocardiographic study of the morphology 
and growth of the aortic arch in the 
human fetus: observations related to 
prenatal diagnosis of coarctation, lOA 
Cocaine 
Cocaine potentiates caffeine-induced 
contractions in coronary arteries, 50A 
Direct but reversible effects of cocaine on the 
myocardium,71A 
Electrophysiologic effects of high-dose 
intravenous cocaine in dogs, 60A 
Intravenous cocaine causes epicardial coronary 
vasoconstriction in the intact dog, 49 A 
Transient ischemic episodes among cocaine 
users: evidence of coronary vasospasm, 
204A 
Collagen 
Influence of increased myocardial collagen on 
active and passive stiffness in left 
ventricular hypertrophy, 12A 
Collateral vessels 
Left ventricular wall motion after coronary 
artery bypass graft surgery in patients 
with collaterals, 7 A 
Commissurotomy 
Percutaneous mitral commissurotomy: a report 
of 90 cases, 220A 
Percutaneous transvenous mitral 
commissurotomy: early clinical outcome, 
14A 
Compliance 
Regional arterial compliance in vivo in man 
and nonhuman primates: a new 
catheterization application, 83A 
Computed tomography 
See Tomography 
Computers 
Automated analysis of arterial geometry: in 
vivo validation using intraoperative 
high-frequency epicardial 
echocardiography, 46A 
Conduction 
See Cardiac conduction 
Congenital heart defects 
See also Surgery, pediatric 
Atrial natriuretic peptide in congenital heart 
defects with right heart volume overload, 
137A 
Effects of pulmonary hypertensive congenital 
heart disease on the post -natal remodeling 
of the pulmonary vasculature, 135A 
Mitral regurgitation induced by congenital 
"absence of the commissural chordae": a 
new etiology, 230A 
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Congestive heart failure 
Age is an independent prognostic factor in 
determining long-term outcome in patients 
with congestive heart failure, 160A 
Aortic pressure waveform analysis in heart 
failure: age differences and nitroprusside 
response, 90A 
Are patients with mild heart failure at risk of 
malignant ventricular arrhythmias and 
sudden death, 72A 
Can ACE inhibitors replace diuretics as sole 
therapy for mild heart failure, 73A 
Differential effects of experimental heart failure 
on baroreflex control of heart rate and 
vascular resistance, 142A 
Do plasma levels of flosequinan correlate with 
its hemodynamic effects in severe chronic 
heart failure?, 42A 
Does converting-enzyme inhibition improve 
liver function abnormalities in patients 
with heart failure?, 73A 
Down-regulation of skeletal muscle 
beta-adrenergic receptors in experimental 
canine heart failure, 116A 
Elevated atrial natriuretic peptide in chronic 
biventricular failure due to dilated 
cardiomyopathy: evidence for 
predominant contribution from the left 
heart, 118A 
Heart failure in the elderly: diastolic 
dysfunction with preserved systolic 
function and normal coronary arteries, 
160A 
Hemodynamic, hormonal, and renal changes 
following incremental infusions of atrial 
natriuretic peptide before and after the 
induction of congestive heart failure, 
1I9A 
Intracellular /3-adrenergic distribution in the 
failing human myocardium, 1I7A 
Is mitral regurgitation necessary for 
hydralazine to be an effective agent in 
congestive heart failure?, 143A 
Lack of chronotropic supersensitivity to 
isoproterenol post cardiac transplantation 
and subsensitivity in CHF, 143A 
Maximal conductance versus maximal oxygen 
uptake in patients with congestive heart 
failure, 22A 
Morphometric analysis of atrial natriuretic 
peptide granularity in patients with heart 
failure, ll8A 
Myocardial f3z receptor subsensitivity in the 
failing human heart, 1I7A 
Pathophysiologic significance of hyponatremia 
in experimental pacing-induced heart 
failure, 202A 
Physiologic role of endogenous atrial 
natriuretic factor during acute congestive 
heart failure, 1I8A 
Renal and hemodynamic effects of low and 
high dose ANF bolus doses in congestive 
heart failure, 1I8A 
Submaximal but not maximal exercise 
improvement immediately after therapy 
for congestive heart failure, 20lA 
Vasoactive intestinal peptide receptor in failing 
and nonfailing human ventricular 
myocardium: supersensitivity of failing 
heart due to increased receptor affinity: 
282A SUBJECT INDEX 
diminished maximal inotropic response 
from decreased receptor density, IA 
Which objective measurements parallel the 
course of disease progression in patients 
with congestive heart failure?, 202A 
Xamoterol in the management of patients with 
exertional breathlessness and fatigue due 
to cardiac disease, 143A 
Contractile function 
See also Myocardium, stunned 
Delineation of improved contractile 
performance after thrombolysis in acute 
myocardial infarction with real-time two 
dimensional ultrasonic integrated 
backscatter, 99A 
Despite superoxide dismutase treatment, 
postischemic contractile dysfunction 
persists after 4 hrs of reperfusion, I64A 
Enhanced function recovery in the stunned 
canine myocardium by pretreatment with 
oxypurinol, 208A 
Evaluation of the hemodynamic effects of 
calcium channel antagonists by exercise 
Doppler: comparison of verapamil and 
nifedipine, 122A 
Importance of atrial contraction in 
experimental cardiac tamponade-a 
Doppler echocardiographic study, 84A 
Reversible abolition of cardiaI' contraction by 
ethanol is associated with depletion of 
sarcoplasmic reticulum calcium content, 
203A 
Contractility 
Assessment of left ventricular contractility in 
dilated cardiomyopathy: comparison on 
nonejection phase indices, 142A 
End-systolic pressure-dimension relation: a 
reliable measure of left ventricular 
contractility in myopathic ventricles, 
244A 
Time related changes in left ventricular 
contractility after balloon aortic 
valvuloplasty, 235A 
Contrast media 
See also specific agent 
Potential risk of thrombosis during angiography 
using non-ionic contrast media, 55A 
Control 
Pharmacologic modification of left ventricular 
remodeling during healing after 
myocardial infarction in the dog, 252A 
Converting enzyme inhibition 
Absence of coronary and systemic 
hemodynamic effects during intravenous 
converting enzyme inhibition in 
normotensive patients with coronary 
artery disease despite significant 
neurohumoral changes, 243A 
Does converting-enzyme inhibition improve 
liver function abnormalities in patients 
with heart failure?, 73A 
Evidence of local intracardiac action and 
metabolism of converting enzyme 
inhibitors, 141A 
Systemic and cardiac neurohumoral changes 
during myocardial ischemia in humans. Is 
there a rationale for converting-enzyme 
inhibition?,38A 
Coronary arteries 
Automated analysis of arterial geometry: in 
vivo validation using intraoperative 
high-frequency epicardial 
echocardiography, 46A 
Exercise training and responsiveness of 
coronary arteries, 246A 
Coronary artery disease 
See also Angina pectoris; Atherosclerosis; 
under Elderly 
Analysis of SPECT thallium septal perfusion 
defects assists in distinguishing isolated 
LAD or PDA disease from disease of 
both vascular beds, 80A 
Can coronary disease location be determined 
by location and radiation of chest pain?, 
151A 
Cinevideodensitometric quantification of 
coronary artery disease following cardiac 
transplantation, 150A 
Clinical significance of isolated conus artery as 
a principal collateral pathway in patients 
with total left anterior descending artery 
occlusion, 83A 
Cocaine potentiates caffeine-induced 
contractions in coronary arteries, 50A 
Comparison of dipyridamole echocardiography 
test and exercise thallium-201 scanning 
for diagnosis of coronary artery disease, 
218A 
3D reconstruction of native diseased human 
coronary arteries and grafts by 
noninvasive resolution-enhanced NMR, 
22A 
Diagnosis of coronary artery disease by 
positron imaging: large scale clinical trial, 
IIA 
Do coronary artery stenoses oscillate during a 
cardiac cycle?, 48A 
Esophageal pill atrial pacing with quantitative 
two-dimensional echocardiography in 
detecting coronary artery disease, 46A 
Evidence of endothelial dysfunction in 
angiographically normal coronary arteries 
of patients with coronary artery disease, 
204A 
Evidence that high-normal levels of 
glycosylated hemoglobin correlate with 
the severity of coronary artery disease, 
12SA 
Exercise thallium-201 scintigraphy for 
detecting coronary artery disease in 
asymptomatic young men, 80A 
Heart rate adjusted indices of ST segment 
depression identify coronary artery 
disease in patients with negative standard 
exercise test responses, 24A 
Heart rate adjustment of exercise-induced ST 
segment depression for predicting triple 
vessel and left main coronary artery 
disease: a meta-analysis, 24A 
High dose dipyridamole-echocardiography test 
in women: correlation with exercise 
electrocardiography test and coronary 
arteriography, 152A 
In vitro analysis of backscattered amplitude 
from normal and diseased arteries using a 
new intraluminal ultrasonic catheter, 4A 
Indomethacin attenuates acetylcholine-induced 
canine epicardial coronary artery 
constriction in vivo, 47 A 
Ischemic ST changes on admission ECG and 
24 hour Holter predict unfavourable 
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outcome, multivessel disease, and left 
main stenosis in unstable angina, 233A 
Long-term decrease in the severity of residual 
stenosis after coronary angioplasty, 236A 
Morning increase of platelet aggregability in 
patients with coronary artery disease, 
204A 
Prediction of cross sectional area of a coronary 
stenosis from the continuity equation 
using a pulsed-wave Doppler catheter, 
151A 
Predictors of cardiac death in patients with 
coronary artery anomalies, 154A 
Prognostic significance of left anterior 
descending disease in asymptomatic 
patients after acute uncomplicated inferior 
myocardial infarction, 194A 
Quantitative dilineation of diminished resting 
myocardial perfusion in patients with 
critical coronary stenosis assessed with 
positron emission tomography and H2
150, 
152A 
Right coronary artery disease and inferoseptal 
ischemia: evaluation by tomographic 
thallium-201 exercise myocardial imaging, 
213A 
Serum cholesterol and coronary heart disease 
mortality over 23 years: implications for 
primary prevention, 126A 
ST-T configuration in V4R in acute inferior 
infarction and the site of occlusion in the 
coronary artery, 68A 
Transplant coronary artery disease: 
histopathologic correlations with 
angiographic morphology, 153A 
Visual versus quantitative analysis of 
dipyridamole thallium-201 scintigraphy, 
80A 
Visualization of coronary arteries and 
detection of coronary blood flow using 
transesophageal echolDoppler, 152A 
Coronary artery dissection 
Gradual balloon inflation protocol reduces 
arterial damage following percutaneous 
transluminal coronary angioplasty, I3IA 
Coronary circulation 
See Hemodynamics; Coronary flow; Coronary 
flow reserve 
Coronary flow 
See also Doppler color flow imaging: Shunt 
flow 
Acetylcholine induced epicardial 
vasoconstriction does not reduce 
coronary flow, 48A 
f3 blockade results in decreased coronary blood 
flow due to unopposed ex mediated 
vasoconstriction, 23A 
Collateral flow preserves left ventricular 
function during acute ischemia in man, 
187A 
Contrast echocardiography: assessment of 
endocardial to epicardial blood flow 
relation-during dipyridamole induced 
hyperemia in experimental coronary 
stenosis, 75A 
Coronary blood flow and hemodynamics during 
experimental aortic valvuloplasty: 
beneficial effects of dual catheter method, 
I3A 
Coronary venous retroperfusion-effects on 
myocardial nutritive blood flow, 65A 
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Doppler studies of fetal vena cava flow yield 
insights into physiology of arrhythmias, 
9A 
Effect of pericardial pressure elevation on 
blood flow independent of changes in 
coronary perfusion pressure in canine 
hearts, 20lA 
Effect of thromboxane A2 receptor inhibition 
on myocardial blood flow during three 
grades of coronary occlusion, 140A 
Exercise left ventricular performance in heart 
failure using continuous wave Doppler 
measurements of aortic blood flow, 102A 
Improved monitoring of laser angioplasty with 
laser Doppler echocardiography, 4A 
Influence of alterations in loading upon aortic 
blood flow acceleration produced by 
lower body negative pressure, 120A 
Laser Doppler measurement of canine 
coronary flow using a sheath-guided 
optical fiber, 174A 
Measurement of absolute coronary blood flow 
using a Doppler catheter: validation in an 
animal model, 45A 
Modifications of the mitral flow due to the 
presence of a left bundle branch block 
(LBBB), 174A 
Myocardial distribution of gadolinium-DTPA: a 
potential agent for quantitative flow 
assessment by magnetic resonance 
imaging, 225A 
Potentiation of serotonin induced vasospasm 
by indomethacin in isolated perfused 
coronary arteries, 124A 
Pulmonary vein blood flow in normals and in 
cardiac disease, 162A 
Rapid transit measurement of coronary blood 
flow with intracoronary 99m 
technetium-DTPA,2I3A 
Subendocardial coronary flow is decreased in 
Syrian cardiomyopathic hamsters, 85A 
Visualization of coronary arteries and 
detection of coronary blood flow using 
transesophageal echolDoppler, 152A 
Coronary flow resene 
Comparison of vessel appearance following 
PTCA and coronary flow reserve by 
digital angiography, 130A 
Coronary reserve in normal and hypertrophic 
hearts during cardiac maturation and 
aging,19OA 
Demonstration of coronary flow reserve with 
contrast echocardiography, 75A 
Determination of coronary flow reserve by 
digital angiography: validation of a 
practical method not requiring power 
injection or ECG gating, 62A 
Hyperemic flow versus pressure slope index: 
an improved method of measuring flow 
reserve that is independent of perfusion 
pressure and heart rate, 191A 
Noninvasive quantification of coronary reserve 
by N-13 ammonia and positron emission 
tomography (PET), IIA 
Variability in the measurement of coronary 
flow reserve from digitized coronary 
cineangiograms, 62A 
Coronary occlusion 
See also Myocardial infarction 
Coronary vascular injury after short -term 
coronary artery occlusion and 
reperfusion, 87 A 
Effect of brief coronary occlusions on 
interstitial pH and myocardial function, 
253A 
Elevated anticardiolipin antibody and coronary 
artery bypass graft occlusion-a 
prospective, randomized trial of low dose 
aspirin, 31A 
Prevention of coronary vascular injury induced 
by transient myocardial ischemia, 124A 
Prophylactic use of combined 
heparine-urokinase for the prevention of 
coronary artery occlusion following 
percutaneous transluminal coronary 
angioplasty, 128A 
Recovery of left ventricular function following 
chronic sustained coronary occlusion, 
252A 
Regional diastolic dysfunction is prevented by 
fluosol-DA perfusion during coronary 
artery occlusion, 12A 
Coronary perfusion 
See also under Technetium 99m 
Coronary transit kinetics may hinder accurate 
measurement of perfusion with ultrafast 
computed tomography, 226A 
Detection of regional myocardial 
underperfusion by contrast-echo 
functional imaging, 76A 
Quantitative delineation of diminished resting 
myocardial perfusion in patients with 
critical coronary stenosis assessed with 
positron emission tomography and H2
150, 
152A 
Right ventricular "steal" during 
hyperperfusion of the left anterior 
descending artery in swine, 23A 
Coronary pressure 
Thromboxane and serotonin mediate 
reocclusion after thrombolysis in a canine 
model of coronary thrombosis, 30A 
Coronary reperfusion 
Coronary artery reperfusion: successful 
response with thrombolytic therapy 
detected by signal averaged 
electrocardiograms during acute 
myocardial infarction, 200A 
Detection of myocardial ischemia and 
reperfusion in intact dogs with real-time 
ultrasonic backscatter imaging, 5A 
Dissociation between recovery of ventricular 
geometry and systolic function following 
reperfusion, 195A 
Importance of leukocyte demargination and 
chemotaxis suppression in myocardial 
reperfusion injury, 207 A 
Influence of severity of ischemia on the 
magnitude of myocardial reperfusion 
injury, 191A 
Massive reperfusion injury: paradoxical effect 
of combined angiotensin-converting 
enzyme inhibitor plus myocardial 
reperfusion, 50A 
Oxygen radical mediated membrane lipid 
peroxidation after post -ischemic 
reperfusion, 208A 
Paradoxical effect of post -ischemic low-calcium 
reperfusion in rat heart: a 31-P study, 
226A 
Preventive effects of human serum dismutase 
SUBJECT INDEX 
activity on reperfusion injury with 
successful thrombolysis in acute 
myocardial infarction, 187 A 
283A 
PTCA in acute myocardial infarction: early 
versus late reperfusion, 187 A 
Reoxygenation enhances neutrophil mediated 
injury to anoxic endothelial cells, 48A 
Reperfusion of ischemic canine hearts prevents 
pressure mediated left ventricular 
dilatation, 253A 
Successful reperfusion of infarcting 
myocardium is associated with reversal of 
electrical predictors of sudden cardiac 
death, 183A 
Coronary venous retroperfusion 
Amelioration of ischemia during TCA with 
diastolic coronary venous retroperfusion, 
64A 
Coronary venous retroperfusion-effects on 
myocardial nutritive blood flow, 65A 
Coupling 
Ventricular/vascular coupling dynamics in a 
chronically hypertensive baboon model, 
93A 
Creatine kinase 
Preservation of left ventricular function and 
topography with combined reperfusion 
and intravenous nitroglycerin in acute 
myocardial infarction, 90A 
Rapid diagnosis by analysis of plasma MM 
creatine kinase isoforms in patients with 
suspected acute myocardial infarction, 
26A 
Creatine phosphate 
Exogenous creatine phosphate: favorable 
calcium-altering effects in St. Thomas' 
Hospital cardioplegic solution, 170A 
Crossover 
Cross and double cross: should clinical trials 
be analyzed by the principle of intention 
to treat?, 127A 
Cryoablation 
Efficacy of cryoablation alone for refractory 
ventricular tachycardia related to inferior 
infarction, 112A 
Cryosurgery 
Cryosurgical modification of atrioventricular 
node conduction for treatment of 
atrioventricular node reentrant 
tachycardia, lilA 
CyanopindoloI 
Distribution of ,B-adrenergic receptors in failing 
human myocardium: implications for 
mechanisms of down-regulation, 116A 
Cyclosporine 
Arterial hypertension after cardiac transplant 
with triple-drug immunosuppression 
therapy,15OA 
Cinevideodensitometric quantification of 
coronary artery disease following cardiac 
transplantation, 150A 
Cyclosporine-mediated hypercholesterolemia in 
cardiac transplant patients, 153A 
Immunosuppressin in cardiac transplantation 
without prednisone: a comparison of 
cyclosporine/prednisone to 
cyclosporine/azathioprine, I04A 
Influence of cyclosporin A on mortality after 
orthotopic heart transplantation, 150A 
Verapamil increases cyclosporin-A blood 
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trough levels in cardiac transplant 
recipients, 206A 
Debridement 
Aortic valve salvage utilizing high frequency 
vibratory debridement, 3A 
Deferoxamine 
Deferoxamine reduces neutrophil-mediated free 
radical production during 
cardiopulmonary bypass in man, 171A 
Reduction of free radical injury at reperfusion 
by intra-ischemic treatment with 
deferoxamine, 48A 
Defibrillation 
Comparison of monophasic, biphasic and 
triphasic truncated pulses for 
non-thoracotomy internal defibrillation, 
57A 
Comparison of 3-patch sequential and 
simultaneous pulses in 2-patch single 
pulse defibrillation thresholds in canines, 
145A 
Defibrillation efficacy in man after 5 vs 15 
seconds of ventricular fibrillation, 18A 
Does defibrillation raise the ventricular pacing 
threshold?, 144A 
Electrical behavior of a cardiac bisyncytium 
during defibrillation, 58A 
Importance of phase duration for biphasic 
defibrillation shocks, 144A 
Initial patient experience with telephone 
remotely controlled cardioversion and 
defibrillation, 66A 
Measurement of three dimensional potential 
gradients generated by transthoracic 
shocks, 210A 
New defibrillation electrode configuration: 
validation of a mathematical prediction, 
145A 
Optimized electrode configuration for 
defibrillation using sequential pulse in 
pigs,I45A 
Optimizing biphasic nonthoracotomy internal 
defibrillation, 57 A 
Optimizing defibrillation efficacy in a 
nonthoracotomy electrode system in the 
dog,I45A 
Superiority of biphasic shocks in the 
defibrillation of dogs via epicardial 
patches and catheter electrode, 58A 
Volume conductor model of the thorax for the 
study of defibrillation, 2lOA 
Defibrillator 
See also Cardioverter defibrillator 
Automatic external defibrillators can be used 
by first responders to improve survival 
rates in patients with out-of-hospital 
cardiac arrest, 161A 
Deoxyglucose 
Tissue injury in reperfused and non-reperfused 
experimental myocardial infarction 
characterized with F-18 deoxyglucose in 
lll-antimyosin antibodies, lOA 
Diabetes 
Influence of diabetes mellitus on the course of 
cardiac transplantation, 103A 
Prediction of cardiovascular risk in diabetic 
vascular surgery requires quantitative 
dipyridamole thallium scintigraphy, 185A 
Prospective prediction of clinical coronary 
disease in patients with Type I diabetes 
mellitus by exercise radionuclide 
ventricuiography,215A 
Silent myocardial ischaemia in diabetes 
mellitus, 23A 
Diastolic function 
Comparative effects of verapamil and 
nitroprusside on left ventricular function 
in patients with hypertension, 37 A 
Detection of diastolic dysfunction in borderline 
hypertensives by measurement of supine 
blood pressure, 147A 
Diastolic function and structure abnormalities 
in dilated cardiomyopathy, 36A 
Differences in diastolic function indices 
between non-rejecting cardiac transplants 
and age matched normals: importance for 
evaluation of heart allografts acute 
rejection, 36A 
Doppler assessment of left ventricular filling: 
improvement in the age-related decrease 
of early diastolic filling with oral 
diltiazem, 120A 
Doppler assessment of right ventricular 
diastolic function in cardiac amyloidosis, 
120A 
Early alteration in diastolic inflow pattern in 
response to progressive left ventricular 
hypertrophy, 35A 
Effects of filling interval on rapid and slow 
filling dynamics: role of slow filling, IIA 
Effects of verapamil on left ventricular 
diastolic function in patients with 
coronary artery disease, 36A 
Filling rate integral: a non-invasive index of 
diastolic function normalized for heart 
rate and chamber volume, 120A 
Impaired left ventricular diastolic filling in 
symptomatic compared to asymptomatic 
hypertensive patients, 81A 
Is early diastolic ventricular filling impaired in 
amyloid restrictive cardiomyopathy?, 86A 
New method to measure direct diastolic 
ventricular gain in the intact dog using 
single beat hemodynamic perturbations, 
12A 
Noninvasive estimation of left ventricular 
end-diastolic pressure by Doppler, 175A 
Preservation of diastolic function and cardiac 
output during PTCA with distal coronary 
perfusion of F1uosol-DA 20%, 133A 
Regional diastolic dysfunction is prevented by 
Fluosol-DA perfusion during coronary 
artery occlusion, 12A 
Relation of diastolic subendocardial tissue 
pressure to coronary pressure at zero flow 
in dogs, 13A 
Relation of Doppler indices to other measures 
of diastolic left ventricular function, 119A 
Relationship between the location of 
hypertrophy and diastolic function in 
patients with hypertrophic 
cardiomyopathy, 250A 
Reliability of Doppler derived indices of left 
ventricular diastolic function in patients 
with dilated cardiomyopathy: comparison 
with simultaneously obtained left atrial 
and ventricular micromanometer 
pressures, 119A 
Viscous properties of the in-situ completely 
relaxed left ventricle are insignificant at 
normal strain rates, 12A 
Diastolic "suction" 
]ACC Vol. 11, No.2 
February 1988;273A-306A 
Negative left ventricular pressure during 
beta-adrenergic stimulation in human 
subjects: evidence for diastolic "suction" 
in the normal heart, 34A 
Diet 
Apolipoprotein band Al changes induced by 
cholesterol-lowering diet in patients with 
hyperapobetalipoproteinemia (hyperapob), 
207A 
Effect of dietary intervention on response to 
pravastatin in hypercholesterolemic 
patients,41A 
Increased complications and prolonged hospital 
stay in elderly cardiac surgical patients 
with low serum albumin, 161A 
Influence of diet on the LDL-cholesterol 
lowering effect of the HMG COA 
reductase inhibitor pravastatin, 223A 
Long term effects of low fat diet and intensive 
physical exercise on serum cholesterol 
and myocardial ischemia in patients with 
stable angina pectoris, 223A 
Digitalis 
Diltiazem attenuates the hemodynamic effects 
of cardiac glycosides, 205A 
Digoxin 
Pharmacokinetic interaction between 
propafenone and digoxin, 168A 
Dihydroalprenolol 
Regional ,B-adrenergic receptor and adenylate 
cyclase activity after healing of 
myocardial infarction in cats, 252A 
Dihydropyridine 
Thyroxine regulates the dihydropyridine 
calcium antagonist receptor in rat 
myocardium, 140A 
Dilation, balloon 
Caveats of balloon dilatation of conduits and 
grafts,28A 
Diltiazem 
Diltiazem attenuates the hemodynamic effects 
of cardiac glycosides, 205A 
Diltiazem reduces left ventricular mass but 
does not change diastolic filling in mild 
hypertension, 82A 
Doppler assessment of left ventricular filling: 
improvement in the age-related decrease 
of early diastolic filling with oral 
diltiazem, 120A 
Intravenous diltiazem for atrial fibrillation and 
flutter: a multicenter trial, 170A 
Intravenous diltiazem for termination of 
reentrant supraventricular tachycardia: a 
placebo-controlled randomized, 
double-blinded study, 77 A 
Long-term effect of diltiazem on mortality and 
reinfarction after myocardial infarction 
(MI}-the MDPIT study, 27A 
Profound infarct size reduction with coronary 
venous retroinfusion of diltiazem in pigs, 
87A 
Diprafenone 
Intravenous and oral diprafenone for treatment 
of patients with the Wolff-Parkinson-
White syndrome, 77A 
Dipyridamole 
Aminophylline administration after 
dipyridamole stress as a trigger of 
coronary vasospasm in variant angina, 
205A 
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Comparison of dipyridamole echocardiography 
test and exercise thallium-201 scanning 
for diagnosis of coronary artery disease, 
21SA 
Contrast echocardiography: assessment of 
endocardial to epicardial blood flow 
relation during dipyridamole induced 
hyperemia in experimental coronary 
stenosis, 75A 
Dipyridamole-induced increase in pulmonary 
thallium uptake: a marker of transient 
global left ventricular dysfunction in 
patients unable to exercise, 214A 
Dipyridamole radionuclide ventriculography 
has high sensitivity for detecting severe 
multivessel coronary atherosclerosis, 
216A 
Does the addition of dipyridamole to aspirin 
decrease acute coronary angioplasty 
complications? The results of a 
prospective clinical trial, 237 A 
Effect of antiplatelet therapy on left graft 
patency after coronary artery bypass 
grafting: VA Cooperative Study #207, 
152A 
Electrocardiographic and blood flow effects of 
rapid atrial pacing and dipyridamole 
infusion in dogs with chronic coronary 
artery occlusion, 68A 
High dose dipyridamole-echocardiography test 
in women: correlation with exercise 
electrocardiography test and coronary 
arteriography, 152A 
Safety of high dose dipyridamole-
echocardiography test, 217A 
Visual versus quantitative analysis of 
dipyridamole thallium-201 scintigraphy, 
80A 
Dipyridamole thallium imaging 
Dipyridamole thallium imaging predicts 
intraoperative ischemia in patients 
undergoing major vascular surgery, 
l62A 
Prediction of cardiovascular risk in diabetic 
vascular surgery requires quantitative 
dipyridamole thallium scintigraphy, 185A 
Disseminated intravascular coagulation 
Leufotoxin, 9,1 0-epoxy-12-octadecenoate, 
causes disseminated intravascular 
coaguiation,54A 
Diuretics 
See also specific agent 
Exercise testing in diuretic treated 
hypertensive patients, 198A 
Which objective measurements parallel the 
course of disease progression in patients 
with congestive heart failure?, 202A 
Dobutamine 
Assessment of cardiac risk by exercise 
echocardiography prior to peripheral 
vascular surgery, 218A 
Effects of dibutyryl cyclic AMP on coronary 
hemodynamics in ischemic heart disease: 
comparison with dopamine and 
dobutamine, 241A 
Influence of dobutamine on function of the 
total artificial heart, 35A 
Docosahexanoic acid 
Effect of dietary Omega-3 fatty acid 
supplementation on platelet survival in a 
hyperlipidemic population, 8A 
Dopamine 
Cardiovascular response to physical stress: 
evidence for an independent role of 
peripheral dopamine DAz receptors, 42A 
Catecholamine suppression of myocardial 
glucose uptake in vivo: a metabolic effect 
mediated by substrate availability, JlA 
Effects of dibutyryl cyclic AMP on coronary 
hemodynamics in ischemic heart disease: 
comparison with dopamine and 
dobutamine, 241A 
Doppler color flow imaging 
Color Doppler flow mapping: intra and 
intermachine variability for low flow 
velocities in an in vitro model, 98A 
Color encoding of in-vitro regurgitant jets by 
color Doppler flow mapping: an index of 
velocity, flow rate, or regurgitant volume, 
97A 
Color guided continuous wave Doppler 
assessment of effective prosthetic valve 
area, 177A 
Combined use of continuous wave and color 
flow Doppler for the estimation of the 
regurgitant volume in aortic regurgitation, 
176A 
Comparison of amplitude and velocity modes 
in low flow states by color Doppler, 98A 
Comparison of color flow Doppler and 
microcavitations for the detection of 
intraatrial flow communications, 240A 
Comparison of intraoperative transesophageal 
and epicardial color flow Doppler in 
mitral valve repair, 20A 
Contrast color coded Doppler flow images for 
evaluation of right heart disease, 240A 
Determinants of color flow Doppler imaging of 
regurgitant flows in a physiological in 
.Yi!m model of mitral insufficiency 
evaluated by digital computer analysis of 
color coded velocities, 19A 
Effect of scanning direction and frame rate on 
the area of flow image in phased-array 
color Doppler echocardiography, 98A 
Heterogeneity of shape and direction of mitral 
regurgitant jets: characterization by color 
Doppler flow imaging, 20A 
In vitro relationship of jet flow with area by 
Doppler color flow: are there 
correlations?, 19A 
Low flow velocity sensitivity in color flow 
mapping Doppler: power mode vs 
dynamic range reallocation for display, 
98A 
Periprosthetic mitral and aortic regurgitation: 
utility of pre- and intraoperative Doppler 
color flow mapping, 20A 
Quantitation of color Doppler images with the 
color image processor, 99A 
Reparative surgery for tricuspid regurgitation: 
operative and follow-up evaluation by 
Doppler color flow mapping, 3A 
Volume of a color flow jet varies directly with 
flow rate and inversely with orifice size: a 
hemodynamic in vitro assessment, 19A 
Doppler ultrasound 
See also Echocardiography; Lasers 
Cardiac tamponade: pulsed wave Doppler 
findings, 75A 
Characteristic mitral inflow Doppler velocity 
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pattern in severe aortic insufficiency, 
175.;\ 
Color flow and spectral Doppler evaluation of 
midventricular obstruction, hypertrophic 
obstructive cardiomyopathy and cavity 
obliteration, 74A 
Coronary by-pass flow assessment and 
quantification by intraoperative Doppler. 
177A 
Detection and assessment of severity of 
tricuspid regurgitation using first pass 
radionuclide angiography: a comparison 
with pulsed Doppler echocardiography. 
64A 
Does clinical Doppler ultrasound induce free 
radical production and lipid peroxidation 
of retinal cells and heart muscles?, 176A 
Doppler assessment of left ventricular filling: 
improvement in the age-related decrease 
of early diastolic filling with oral 
diltiazem,12OA 
Doppler assessment of right ventricular 
diastolic function in cardiac amyloidosis, 
120A 
Effect of mean pressure gradient, chamber 
compliance, and orifice size upon the 
Doppler halftime method, 20A 
Effects of the shape of pre- and post-stenotic 
regions on the accuracy of Doppler in 
measuring pressure gradients across long 
segment stenosis, 21A 
Evaluation of the Doppler continuity equation 
for measuring aortic valve area in two 
settings: mechanical dilatation of the 
stenotic valve and increase in cardiac 
output,21A 
Impact of Doppler assessment of aortic 
stenosis on clinical management: 
experience in 500 patients, 176A 
In vitro validation of the assessment by 
Doppler ultrasound of normal biprosthetic 
function, 22A 
Instantaneous and continuous cardiac output 
using a Doppler pulmonary artery 
catheter, 5 A 
Is Doppler accurate for measuring 
trans-stenotic coronary pressure 
gradients? An in vitro study, 174A 
Is it possible to obtain an accurate Doppler 
estimate of stroke volume in patients with 
decreased forward flow?, 121A 
Management decisions in aortic stenosis: use 
of receiver-operator characteristic curves, 
63A 
Measurement of absolute coronary blood flow 
using a Doppler catheter: validation in an 
animal model, 45A 
Mitral valve pressure halftime: accuracy at six 
months after mitral balloon valvotomy, 
21A 
Noninvasive estimation of left ventricular 
end-diastolic pressure by Doppler, 175A 
Quantification of valvular regurgitation by 
gain-corrected Doppler in a pulsatile flow 
model,99A 
Relation of Doppler indices to other measures 
of diastolic left ventricular function, 119A 
Reliability of Doppler derived indices of left 
ventricular diastolic function in patients 
with dilated cardiomyopathy: comparison 
with simultaneously obtained left atrial 
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and ventricular micromanometer 
pressures, 119A 
Thrombus formation after acute myocardial 
infarction predicted by left ventricular 
spatial flow pattern, 175A 
Doxorubicin 
Late cardiac effects of doxorubicin in 
childhood acute lymphoblastic leukemia, 
I35A 
Drug therapy 
See also specific drug; specific type 
Actuarial analysis of the efficacy of 
eJectrophysiologic testing in selecting drug 
therapy for ventricular tachyarrhythmias, 
6A 
Pharmacologic modification of left ventricular 
remodeling during healing after 
myocardial infarction in the dog, 252A 
Echocardiography 
See also Dipyridamole; Doppler ultrasound 
Automated analysis of arterial geometry: in 
vivo validation using intra-operative 
high-frequency epicardial 
echocardiography,46A 
Blood pressure levels and echocardiographic 
functions in children: the Bogalusa Heart 
Study,82A 
Comparison of transesophageal 
echocardiographic and scintigraphic 
estimate of left ventricular end-diastolic 
volume and ejection fraction, 219A 
Detection of early atherosclerosis by 
quantitative ultrasonic methods, 100A 
Detection of myocardial ischemia and 
reperfusion in intact dogs with real-time 
ultrasonic backscatter imaging, 5A 
Echocardiographic findings in patients with 
tuberous sclerosis, 73A 
Fetal echocardiography: outcome of pregnancy 
as a function of the indication for referral, 
I37A 
Hemodilution does not affect ultrasonic 
myocardial backscatter, 100A 
Implantation and follow-up of ultrasonically 
marked pacing system, 4A 
In vitro analysis of backscattered amplitude 
from normal and diseased arteries using a 
new intraluminal ultrasonic catheter, 4A 
Intravascular ultrasound imaging catheter 
assessment of normal and atherosclerotic 
arterial wall thickness, 22A 
Is transesophageal echocardiography a risk for 
patients with cardiac disease?, 219 A 
Left atrial volume measurement: cine 
computed tomography and 
echocardiography,217A 
Quantitative validation of atherosclerotic 
coronary arterial lumen and wall 
measurements by high frequency 
echocardiography, 194A 
Real-time detection of moving 
echocardiographic borders with 
automated velocity derivation: description 
of a new algorithm, 5A 
Role of intraoperative echocardiography during 
cardiac valvular surgery, 217 A 
Spatiotemporal Fourier filtration for improved 
accuracy of echocardiographic 
endocardial profiles: optimization of 
filtering cutoff frequencies, 2A 
Superior reproducibility of serial left 
ventricular mass measurements by 
two-dimensional vs. M-mode 
echocardiography, 146A 
Echocardiography, contrast 
Behavior of succinated albumin microbubbles 
in the microcirculation: a basis for their 
use as myocardial echo contrast agents, 
75A 
Contrast echocardiography: assessment of 
endocardial to epicardial blood flow 
relation during dipyridamole induced 
hyperemia in experimental coronary 
stenosis, 75A 
Demonstration of coronary flow reserve with 
contrast echocardiography, 75A 
Detection of regional myocardial under 
perfusion by contrast -echo functional 
imaging, 76A 
Success of internal mammary bypass grafting 
can be assessed intraoperatively using 
myocardial contrast echocardiography, 
76A 
Echocardiography, exercise 
Assessment of cardiac risk by exercise 
echocardiography prior to peripheral 
vascular surgery, 218A 
Echocardiography, two-dimensional 
Decrease in 2-dimensional echocardiographic 
ejection fraction during transplant 
rejection: a study of 400 biopsies, 121A 
Delineation of improved contractile 
performance after thrombolysis in acute 
myocardial infarction with real-time two 
dimensional ultrasonic integrated 
backscatter, 99A 
Diagnostic labeling in echocardiography: an 
apparent epidemic of valvular 
regurgitation, 127A 
Initial clinical experience with an ultrasound 
stethoscope (a hand-held 2D cardiac 
ultrasound device), 100A 
Prospective study of mitral valve prolapse: 
further evidence for "normality" of 
displacement in the apical 4-chamber view 
only,125A 
Real-time, two dimensional catheter 
ultrasound: a new technique for 
high-resolution intravascular imaging, 
l30A 
Right ventricular infarction: area at risk by 
contrast myocardial 2D echocardiography 
predicts eventual infarct size, 194A 
Two-dimensional echocardiographic 
assessment of changes in mitral valve 
morphology and left atrial volumes 3 
months after catheter balloon 
valvuloplasty for mitral stenosis, 21A 
Edema 
See also Flash pulmonary edema 
Why does transthoracic impedance decline 
after direct current countershock?, 210A 
Effusions 
See also Pericardial effusions 
Treatable anatomic causes of persistent 
effusions and/or protein-losing 
enteropathy after modified Fontan 
operation, 135A 
Ejection fraction 
Are radionuclide left ventricular global and 
regional ejection fractions reproducible 
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during exercise in patients with ischemic 
heart di sease?, 122A 
ECG gating improves the accuracy of 
radio nuclide right ventricular ejection 
fraction determinations, 215A 
Improved LV ejection fraction at 21 days 
following coronary occlusion treated by 
early intravenous rt-PA infusion, 105A 
Sustained arterial patency after thrombolysis 
and angioplasty therapy of inferior 
myocardial infarction results in late 
improvement in ejection fraction, 
192A 
Elderly 
Aortic balloon valvuloplasty: therapy of choice 
for the very old symptomatic patient with 
aortic stenosis, 161A 
Clinicopathologic study of cardiac rupture 
following acute myocardial infarction in 
the elderly, 51A 
Early and medium term results of cardiac 
transplantation in the seventh decade of 
life,45A 
Heart failure in the elderly: diastolic 
dysfunction with preserved systolic 
function and normal coronary arteries, 
I60A 
Hypertrophic cardiomyopathy in the elderly-
clinical course and prognostic indices, 
243A 
Hypertrophic cardiomyopathy in the elderly: 
distinctions from the young based on 
cardiac shape, 243A 
Incidence and prognosis of unrecognized 
myocardial infarction in the elderly: The 
Framingham Study, 51A 
Increased complications and prolonged hospital 
stay in elderly cardiac surgical patients 
with low serum albumin, 161A 
Isolated systolic hypertension in the elderly, 
198A 
Long term follow up after successful coronary 
angioplasty in patients of age ;;::70 years, 
51A 
Mid-term follow-up after percutaneous 
transluminal aortic valvuloplasty in the 
elderly, 234A 
Obstructive hypertrophic cardiomyopathy in 
the elderly: a unique group of patients 
with small left ventricular outflow tract, 
mitral anular calcification, and late onset 
of severe symptoms, 251A 
Outlook after acute myocardial infarction in 
patients over age 75 years, 51A 
Painless myocardial ischemia in elderly 
patients with coronary heart disease 
compared with middle-aged patients and 
its relation to treadmill testing and 
coronary hemodynamics, 50A 
Post-valvuloplasty follow-up of elderly patients 
with severe aortic stenosis and low 
ejection fraction, 15A 
Prevalence-.Of extra-cranial carotid artery 
disease in elderly patients undergoing 
cardiac surgery, 161A 
Should elderly be resuscitated following 
out-of-hospital cardiac arrest?, 52A 
Electrical stimulation 
Programmed electrical stimulation of the right 
ventricle-role of risk stratification 
following infarction, I90A 
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Electrocardiography 
See also specific wave, specific interval 
Coronary artery reperfusion: successful 
response with thrombolytic therapy 
detected by signal averaged 
electrocardiograms during acute 
myocardial infarction, 200A 
Decreased heart rate variability predicts late 
mortality in patients undergoing 
diagnostic coronary angiography, 198A 
Effect of procainamide on atrial electrograms 
during atrial fibrillation: a potential 
drug-device interaction, 165A 
Electrocardiographic manifestations, 
in-hospital and late prognosis of transient 
acute myocardial ischemia at rest, 47 A 
Frequency characteristics of unipolar cardiac 
electrograms and activation sequence, 
211 A 
Signal-averaged electrocardiogram as a 
screening test for occurrence of 
paroxysmal atrial fibrillation, 116A 
Use of the signal averaged electrocardiogram 
to predict electrophysiologic study results 
in unexplained syncope, 183A 
Electrocardiography, ambulatory 
Ambulatory ECG monitoring for the detection 
of ischemic events and ventricular 
arrhythmia: differential utility of event 
recording versus conventional monitoring 
systems,67A 
Circadian variation in the heart rate occurring 
during transient myocardial ischemia 
recorded with daily activity, 96A 
Does Holter monitoring have clinical utility in 
the evaluation of patients with chest 
pain?,66A 
Effects of therapeutic intervention of silent 
ischemic episodes throughout the day, 
97A 
Frequent ischemic episodes during the morning 
hours in coronary patients: a result of 
decreased ischemic threshold or increased 
myocardial oxygen demand, 96A 
Ischemic ST changes on admission ECG and 
24 hour Holter predicts unfavourable 
outcome, multivessel disease, and left 
main stenosis in unstable angina, 233A 
Predischarge Holter monitoring predicts 
postinfarction treadmill ischemia, 67 A 
Silent ischemia in survivors of out-of-hospital 
ventricular fibrillation, 96A 
Validation of ambulatory ECG for detecting 
ischemia in hypertensive patients with left 
ventricular hypertrophy, 97 A 
Electrophysiologic studies 
Actuarial analysis of the efficacy of 
electrophysiologic testing in selecting drug 
therapy for ventricular tachyarrhythmias, 
6A 
Analysis of antiarrhythmic drug levels during 
electrophysiologic drug testing, 228A 
Ca + + activated transient outward current in 
the rabbit atrioventricular node, 59A 
Can EPS predict subsequent arrhythmic events 
in WPW patients with infrequent or no 
arrhythmias?,79A 
Clinical, electrophysiological determinants and 
survival of patients with sustained 
ventricular tachycardia early 
post-myocardial infarction, 182A 
Combined ambulatory ECG and 
electrophysiologic approach to patients on 
amiodarone for ventricular tachycardia, 
66A 
Common clinical and electrophysiologic 
characteristics in patients with bundle 
branch reentrant ventricular tachycardia, 
114A 
Differential influence of beta-adrenoreceptor 
activation on the negative chronotropic 
effect of adenosine on the canine sinus 
node and ventricular pacemakers in vivo, 
39A 
Electrophysiologic effects in vivo of biphasic 
and monophasic stimuli, I44A 
Electrophysiologic effects of different K + 
concentrations on the rabbit 
atrioventricular node, 38A 
Electrophysiologic and morphologic 
determinants of intramural reentry in 
human ventricular tachycardia, II3A 
Evaluation of patients at risk after first acute 
myocardial infarction by programmed 
ventricular stimulation: influence of 
antiarrhythmic drug therapy, 183A 
Identification of ventricular late potential 
activity in single cardiac cycles using 
spatial averaging and advanced filtering 
techniques, 183A 
Influence of isoproterenol on the left 
ventricular response to extrastimuli 
applied to the right ventricle, 182A 
Mechanisms of cardiac memory, 39A 
Modulation of the summation of atrial inputs to 
the atrioventricular node during increased 
vagal tone, 40A 
Multiple atrioventricular bypass tracts: 
presence vs participation in tachycardia, 
180A 
Relationship between drive cycle length and 
return cycle length in ventricular reentry: 
mechanistic implications, 180A 
Role of beta-adrenergic stimulation in 
induction of sustained atrioventricular 
nodal reentry in patients with dual 
atrioventricular nodal pathways, 180A 
Role of silent ischemia and the 
electrophysiologic substrate in the genesis 
of sudden cardiac death, 6A 
Use of the signal averaged electrocardiogram 
to predict electrophysiologic study results 
in unexplained syncope, 183A 
Vagal denervation of canine sinus and 
atrioventricular nodes create 
supersensitive response to acetylcholine, 
39A 
Electrophysiologic studies, pediatric 
Developmental differences in susceptibility of 
the cardiac conduction system to global 
ischemia, 154A 
Evolving concepts in the management of 
congenital junctional ectopic tachycardia: 
a multicenter study, 155A 
Improved ventricular performance following 
arrhythmia control in children with 
automatic atrial tachycardia and dilated 
cardiomyopathy, 155A 
In vivo electrophysiologic effects of alpha 
blockade in neonatal and adult canines. 
154A 
Ventricular arrhythmia in post-operative 
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tetralogy of Fallot-(collaborative study), 
155A 
Embolism 
Effects of pericardial constraint on left 
ventricular function in acute pulmonary 
embolism, 200A 
New treatment for non-massive pulmonary 
embolism and acute deep-vein 
thrombosis: low molecular weight 
heparin,54A 
Embolization 
Pre- and postoperative coil embolization of 
aortopulmonary and arteriovenous 
collaterals and shunts, 28A 
Endocardial borders 
Real-time detection of moving 
echocardiographic borders with 
automated velocity derivation: description 
of a new algorithm, 5A 
Endocarditis 
Leaflet thickening increases the risk of 
endocarditis in patients with mitral valve 
prolapse, 126A 
p-Endorphin 
Measurement of experimental pain and serum 
p-endorphin in patients with symptomatic 
(SM!) and asymptomatic myocardial 
ischemia (AMI}-modification by 
naloxone,47A 
Endothelial function 
Evidence of endothelial dysfunction in 
angiographically normal coronary arteries 
of patients with coronary artery disease, 
204A 
Endothelium 
In-vivo identification of normal and damaged 
endothelium by quantitative coronary 
angiography and infusion of acetylcholine 
and bradykinin in pigs, 29A 
Energy 
Cardiac energy metabolism and performance 
during acute hypoglycemia and 
hyperketonemia: biochemical and NMR 
studies, 224A 
Enteropathy 
Treatable anatomic causes of persistent 
effusions and/or protein-losing 
enteropathy after modified Fontan 
operation, 135A 
Epinephrine 
Dose-dependent vasopressor response to 
epinephrine during CPR in humans, 42A 
Systemic and cardiac neurohumoral changes 
during myocardial ischemia in humans. Is 
there a rationale for converting-enzyme 
inhibition?,38A 
Ventricular tachycardia in patients without 
underlying structural heart disease: 
evidence for triggered activity in humans, 
J13A 
Esmolol 
Esmolol elevates the ventricular fibrillation 
threshold in humans during automatic 
defibrillator testing, 181A 
Esmolol vs verapamil for the treatment of 
recent-onset atrial fibrillation/flutter: a 
multicenter study, 170A 
Ethanol 
Acute alcohol cardiac depression is associated 
with a decrease in intracellular water and 
a reduction of the redox state, 224A 
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Metabolic, functional, and antiarrhythmic 
effects of acute ethanol exposure in the 
isolated rat heart, 203A 
Reversibility of acute alcohol cardiac 
depression and the protective effect of 
verapamil, 202A 
Reversible abolition of cardiac contraction by 
ethanol is associated with depletion of 
sarcoplasmic reticulum calcium content, 
203A 
Exercise 
Long term effects of low fat diet and intensive 
physical exercise on serum cholesterol 
and myocardial ischemia in patients with 
stable angina pectoris, 223A 
Exercise performance 
Submaximal but not maximal exercise 
improvement immediately after therapy 
for congestive heart failure, 201A 
Exercise rehabilitation 
Aerobic capacity, short-term dynamic muscle 
power and effects of exercise 
rehabilitation in cardiac patients, lOlA 
Exercise testing 
See also Stress testing 
Abnormal left ventricular volume response 
predicts impaired exercise performance in 
hypertension, 198A 
Altered sympathetic nervous system function 
in obese adolescents: baseline 
overactivity but diminished 
responsiveness to stress, 147 A 
Are radionuclide left ventricular global regional 
ejection fractions responsible during 
exercise in patients with ischemic heart 
disease?, 122A 
Assessment of screening exercise treadmill 
testing prior to initiating an exercise 
program: results of 2973 apparently 
healthy individuals, 123A 
Cardiovascular response to physical stress: 
evidence for an independent role of 
peripheral dopamine DA2 receptors, 42A 
Contribution of the peripheral circulation to 
maximal oxygen consumption, lOlA 
Direct and indirect diastolic blood pressure 
measurements on exercise before and 
after coronary artery surgery, I02A 
Does exercise intensity influence the ischemic 
threshold?,24A 
Effect of cardiac function on hemodynamic, 
hormonal and metabolic responses to 
dynamic exercise, 246A 
Effects of maximal and submaximal exercise 
on myocardial IIC-palmitate clearance 
associated with positron emission 
tomography,211A 
Exercise assessment after myocardial 
infarction-long-term changes in patient 
selection, 122A 
Exercise capacity following cardiac 
transplantation, 45A 
Exercise induced abnormalities in cAMP 
response in congestive heart failure, 96A 
Exercise left ventricular performance in heart 
failure using continuous wave Doppler 
measurements of aortic blood flow, 102A 
Exercise radionuclide angiography after non-Q 
wave myocardial infarction, 216A 
Exercise testing in diuretic treated 
hypertensive patients, 198A 
Exercise treadmill test is a poor predictor of 
the risk of nonfatal myocardial infarction, 
212A 
Heart rate adjusted indices of ST segment 
depression identify coronary artery 
disease in patients with negative standard 
exercise test responses, 24A 
Heart rate adjustment of exercise-induced ST 
segment depression for predicting triple 
vessel and left main coronary artery 
disease: a meta-analysis, 24A 
Hemodynamic response of the denervated 
human heart to dynamic exercise, 20lA 
High dose dipyridamole echocardiography test 
in women: correlation with 
exercise-electrocardiography test and 
coronary arteriography, 152A 
Impaired cardiopulmonary function with 
exercise in sickle cell anemia, 211A 
Impaired QT shortening is associated with 
exercised-induced ventricular tachycardia 
in normal subjects, 69A 
Importance of behavior of ST segment and T 
wave changes following exercise. A 
reliable aid towards eliminating false 
positives, 122A 
Influence of exercise level on normal 
myocardial thallium-201 uptake and 
clearance, 213A 
Is the maximal exercise capacity of patients 
with left ventricular dysfunction due to 
intramuscular lactic acidosis?, 73A 
Isometric exercise mediated hemodynamic 
worsening and its prevention with 
nitroglycerin in patients with chronic 
mitral regurgitation, 230A 
Maximal conductance versus maximal oxygen 
uptake in patients with congestive heart 
failure, 72A 
Modulation of vagal activity during and 
immediately after exercise: investigation 
with heart rate spectral analysis, 247 A 
Plasma atrial natriuretic polypeptide (ANP) 
and plasma norepinephrine (NE) during 
exercise in essential hypertension, 146A 
Prognostic significance of silent myocardial 
ischemia discovered during exercise 
testing, 24A 
Prognostic value of symptom-limited exercise 
testing following medical stabilization of 
unstable angina, 123A 
Prospective comparison of predischarge 
Persantine thallium and exercise treadmill 
tests for predicting early events after 
uncomplicated myocardial infarction, 
189A 
Reproducibility of the heart rate response to 
exercise in patients with atrial fibrillation, 
247A 
Right and left ventricular functional response 
to supine exercise in patients with 
asymptomatic mitral regurgitation, 229A 
Role of the Frank-Starling mechanism during 
upright exercise in severe left ventricular 
dysfunction, 212A 
Safety and effectiveness of immediate treadmill 
testing to shorten or eliminate hospital 
stay in selected "rule out myocardial 
infarction" patients, 123A 
Silent left ventricular dysfunction during 
ambulatory radionuclide monitoring 
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following thrombolysis: a potential 
predictor of subsequent cardiac 
morbiditY,25A 
What are the clinical implications of 
pseudonormalization of the T waves 
during ergometric studies, 25A 
Exercise training 
Effect of exercise conditioning on action 
potential duration and norepinephrine 
content in heart muscle from senescent 
rats, 246A 
Effect of exercise training on quality of life 
after transmural acute myocardial 
infarction, 189A 
Endurance training versus strength training in 
competitive athletes: adaptation of cardiac 
structures to normal predicted values, 
100A 
Exercise training and responsiveness of 
coronary arteries, 246A 
Exercise training early after valve replacement, 
102A 
Training effects of short versus long bouts of 
exercise, lOlA 
Fatty acids 
Dietary supplementation with N-3 fatty acids 
reduces the rate of restenosis after 
coronary angioplasty, 237 A 
Effect of dietary omega-3 fatty acid 
supplementation on platelet survival in a 
hyperlipidemic population, 8A 
Reduction in tissue-plasminogen activator 
inhibitor with omega-3 PUFA, 8A 
Fetal studies 
Depressed myocardial function precedes 
development of persistent truncus 
arteriosus in neural crest ablated chick 
embryos,9A 
Doppler studies of fetal vena cava flow 
yield insight into physiology of 
arrhythmias,9A 
Echocardiographic study of the morphology 
and growth of the aortic arch in the 
human fetus: observation related to 
prenatal diagnosis of coarctation, lOA 
Fetal heart disease with cardiomegaly may be 
associated with lung hyperplasia as a 
determinant of poor prognosis, 9A 
Metabolic control of oxygen consumption in 
the developing heart in vivo: a31 p NMR 
study,8A 
Validation of two-dimensional 
echocardiographic determination of 
left ventricular volumes in the fetal heart, 
9A 
Fibrillation 
See Atrial fibrillation; Ventricular fibrillation 
Fibrinolytic therapy 
See also Thrombolytic therapy 
Carcadian fluctuations in endothelium-derived 
fibrinolytic factors in relation to the time 
of onset of myocardial infarction and 
sudden cardiac death, 27 A 
Systemic fibrinolysis after recombinant human 
tissue-type plasminogen activator for 
acute myocardial infarction: influence on 
coronary patency and bleeding, 105A 
Fibrinopeptide A 
Plasma fibrinopeptide A levels in the various 
clinical forms of unstable angina: relation 
to early prognosis, 233A 
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Fibrosis 
Myocardial fibrosis in tetralogy of Fallot: effect 
of repair or part of natural history?, 138A 
Fish oils 
Cholesterol and saturated fat content of fish oil 
(FO) preparations influences the 
hypolipidemic response in type IV 
hyperlipidemic patients, 206A 
Comparison and combination of fish oil 
concentrate and neomycin as therapy of 
hyperlipidemia, 224A 
Effects of dietary supplementation with 
cod-liver oil on impaired 
endothelial-dependent relaxations in 
atherosclerotic porcine coronary arteries, 
191A 
Inhibition of atherosclerosis by fish oil in 
cholesterol fed rabbits, 50A 
Flash pulmonary edema 
Syndrome of flash pulmonary edema: clinical 
definition and angiographic findings, 151A 
Flecainide 
Effects of oral flecainide on atrioventricular 
reciprocating tachycardias refractory to 
procainamide, 169A 
Efficacy of flecainide in the treatment of atrial 
tachyarrhythmias, 228A 
Electrophysiologic effects, efficacy, and patient 
tolerance to class IC antiarrhythmic 
agents in Wolff-Parkinson-White 
syndrome, 78A 
Flecainide for prevention of paroxysmal 
supraventricular tachycardia: a 
multicenter, double-blind, 
placebo-controlled crossover study, 77 A 
Flecainide for prevention of symptomatic 
paroxysmal atrial fibrillation: a 
multicenter, double-blind, 
placebo-controlled, crossover study, 77 A 
Flecainide for recurrent atrial fibrillation: 
predictors of efficacy, 228A 
Intravenous flecainide versus verapamil for 
acute conversion of atrial fibrillation or 
atrial flutter to sinus rhythm, 76A 
Proarrhythmic potential of moderate-dose 
flecainide therapy for sustained 
ventricular tachycardia, 168A 
Prospective study of intravenous and oral 
flecainide in right ventricular arrhythmia, 
56A 
Flestolol 
F1estolol, a titratable, short-acting beta 
adrenergic antagonist in the management 
of unstable angina, 233A 
Flosequinan 
Do plasma levels of flosequinan correlate with 
its hemodynamic effects in severe chronic 
heart failure?, 42A 
Fluorometry 
Nicotinamide adenine dinucleotide fluorometry 
for evaluating pressure loading of the 
heart, 141A 
Fluosol 
Cardiac metabolism during coronary 
angioplasty with fluosol protection: 
discordance between LV systolic function 
and lactate metabolism, 149A 
Importance of leukocyte demargination and 
chemotaxis suppression in myocardial 
reperfusion injury, 207 A 
Perfluorochemical markedly reduces neutrophil 
adherence to cultured coronary artery 
endothelial cells subjected to anoxia and 
reoxia, 125A 
Preservation of diastolic function and cardiac 
output during PTCA with distal coronary 
perfusion of F1uosol-DA 20%, 133A 
Profound reduction in ventricular arrhythmias 
during blood-free reperfusion with 
oxygenated F1uosol-DA, 87 A 
Regional diastolic dysfunction is prevented by 
F1uosol-DA perfusion during coronary 
artery occlusion, 12A 
Fontan procedure 
Atrial natriuretic factor and arginine 
vasopressin after Fontan procedure, 134A 
Atrioventricular valve insufficiency: 
contraindications to the modified Fontan?, 
249A 
Relationship of pre-operative left ventricular 
muscle mass to the outcome of Fontan 
procedure in patients with tricuspid 
atresia, 249A 
Treatable anatomic causes of persistent 
effusions and/or protein losing 
enteropathy after modified Fontan 
operation, 135A 
Fourier filtration 
Spatiotemporal Fourier filtration for improved 
accuracy of echocardiographic 
endocardial profiles: optimization of 
filtering cutoff frequencies, 2A 
Frank-Starling curve 
Descending limb of the Frank-Starling curve is 
due to energy depletion and excess Ca2+ 
entry,72A 
Evaluation of ventricular function by 
Frank-Starling curves derived from 
Doppler-echo during lower body negative 
pressure, 245A 
Role of the Frank-Starling mechanism during 
upright exercise in severe left ventricular 
dysfunction, 212A 
Free radicals 
Deforoxamine reduces neutrophil-mediated 
free radical production during 
cardiopulmonary bypass in man, 17IA 
Does clinical Doppler ultrasound induce free 
radical production and lipid peroxidation 
ofretinal cells and heart muscles?, 176A 
Effect of superoxide dismutase on myocardial 
free radical concentrations during 
postischemic reperfusion, 164A 
Oxygen free radical scavengers do not reduce 
infarct size in baboons, 163A 
Gadolinium-DTPA 
Myocardial distribution of gadolinium-DIP A: a 
potential agent for quantitative flow 
assessment by magnetic resonance 
imaging, 225A 
Gallstones 
Asymptomatic gallstones are often present in 
hyperlipidemic patients prior to lipid 
lowering drug therapy, 223A 
Gemfibrozil 
Hyperlipoproteinemia following heart 
transplantation: natural history and 
intervention with Lovastatin and 
Gemfibrozil, 44A 
Glucose uptake 
Catecholamine suppression of myocardial 
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glucose uptake in vivo: a metabolic effect 
mediated by substrate availability, lIA 
Glutathione peroxidase 
Glutathione redox pathway and reperfusion 
injury. The effect of N-acetycysteine 
(NAC) on infarct size and ventricular 
function, 88A 
Glycosides 
See Cardiac glycosides 
Gorlin formula 
Gorlin 'constant' is not constant: a 
hydrodynamic in vitro assessment, 64A 
Gorlin valve area varies with cardiac output in 
aortic stenosis, 63A 
Isoproterenol infusion increases Gorlin formula 
aortic valve area in isolated aortic 
stenosis, 63A 
Grafts 
See also Surgery, coronary bypass 
Detection of vascular graft infection in human 
subjects with radiolabeled non-specific 
polyclonal IgG, 84A 
Effect of antiplatelet therapy on late graft 
patency after coronary artery bypass 
grafting: V A cooperative study, 152A 
Effect of donor specific transfusion on cardiac 
xenografts, 44A 
Fate of aortic homograft used for right 
ventricular outflow tract reconstruction 
for pulmonary atresia and severe Fallot: a 
21st birthday celebration, 69A 
Filler-free silicone rubber coated Dacron grafts 
for right ventricle to pulmonary artery 
conduits, 134A 
Success of internal mammary bypass grafting 
can be assessed intraoperatively using 
myocardial contrast echocardiography, 
76A 
Thermal coronary angiography: a new method 
for assessing coronary bypass graft 
patency, 105A 
Vasomotor properties of internal mammary 
artery grafts: a clue to their favorable 
long-term patency?, 106A 
Heart block 
Chronic incomplete atrioventricular block 
induced by radiofrequency catheter 
ablation,I77A 
Electrophysiologic spectrum of concealed 
intranodal conduction during atrial rate 
acceleration in a model of 2: I 
atrioventricular block, 115A 
2: I block of an early afterdepolarization as a 
mechanism for TV alternans, 254A 
Heart failure 
See Congestive heart failure 
Heart murmurs 
"Malade de Carpentier": loud murmurs 
following mitral valve repair, 3A 
Silent turbulence: an important source of 
systolic murmer, 83A 
Heart rate 
Differential effects of experimental heart failure 
on baroreflex control of heart rate and 
vascular reisistance, 142A 
Hemochromatosis 
Endomyocardial biopsy in cardiac 
hemochromatosis, 85A 
Hemodilution 
Hemodilution does not affect ultrasonic 
myocardial backscatter, lOOA 
290A SUBJECT INDEX 
Hemodynamics 
Absence of coronary and systemic 
hemodynamic effects during intravenous 
converting enzyme inhibition in 
normotensive patients with coronary 
artery disease despite significant 
neurohumoral changes, 243A 
Comparison of the effects of intravenous 
isradipine and verapamil on coronary and 
systemic hemodynamics in man, 242A 
Coronary and systemic hemodynamic effects of 
high- versus low-dose intravenous 
labetalol in patients with coronary artery 
disease, 242A 
Effects of dibutyryl cyclic AMP on coronary 
hemodynamics in ischemic heart disease: 
comparison with dopamine and 
dobutamine,24lA 
Hemodynamic abnormalities following cardiac 
transplantation: relationship to 
hypertension and survival, I03A 
Hemoglobin 
Evidence that high-normal levels of 
glycosylated hemoglobin correlate with 
the severity of coronary artery disease, 
128A 
Heparin 
See also Calcium heparin 
Adequate heparinization during PTCA: 
assessment using activated clotting time, 
237A 
Are adjunctive therapies needed when t -PA is 
used? Summary results of TAMI I, II, 
and III trials, 186A 
Beneficial effect of heparin therapy on PTCA 
outcome in unstable angina, 132A 
Does pretreatment with heparin prevent abrupt 
closure following PTCA? 238A 
Dose-dependent inhibition by heparin of acute 
platelet-thrombus deposition during 
angioplasty, 30A 
Effect of heparin on the angiogenesis response 
to experimental myocardial ischemia, 
253A 
Multicenter, randomized controlled trial of 
intravenous tissue plasminogen activator 
and early intravenous heparin in acute 
myocardial infarction, 232A 
Multicenter double-blind trial of intravenous 
APSAC versus heparin in acute 
myocardial infarction. Final report of 
APSIM study, 232A 
New treatment for non-massive pulmonary 
embolism and acute deep-vein 
thrombosis: low molecular weight 
heparin,54A 
Prophylactic use of combined 
heparine-urokinase for the prevention of 
coronary artery occlusion following 
percutaneous transluminal coronary 
angioplasty, 128A 
Radioimmunoimaging of experimental thrombi 
in dogs using monoclonal antibodies: 
effect of heparin on uptake by pulmonary 
emboli,53A 
Recurrent ischemia without warning: inability 
to predict ischemic events from residual 
stenosis after successful coronary 
thrombolysis, 105A 
Safe and effective treatment of acute MI 
requires TPA and elective PTCA, not 
early heparin or emergency PTCA, 191A 
Therapy of large intracoronary thrombi in 
candidates for percutaneous transluminal 
coronary angioplasty, 238A 
His-Purkinje system 
Effect of d-sotalol on the His-Purkinje system, 
227A 
Use-dependent effects of quinidine on the 
canine His-Purkinje system: onset, 
magnitude and recovery, 255A 
Histamine 
Myocardial ~ receptor subsensitivity in the 
failing human heart, 117 A 
Holter monitoring 
See Electrocardiography, ambulatory 
Hydralazine 
Is mitral regurgitation necessary for 
hydralazine to be an effective agent in 
congestive heart failure?, 143A 
Long term changes in left ventricular 
dimensions in patients with aortic 
regurgitation with and without vasodilator 
therapy, 159A 
Hypaque-76 
Potential risk of thrombosis during angiography 
using non-ionic contrast media, 55A 
Hypercholesterolemia 
Cyclosporine-mediated hypercholesterolemia in 
cardiac transplant patients, 153A 
Treatment of patients with high risk serum 
cholesterol levels, 223A 
Hyperemia 
Why does transthoracic impedance decline 
after direct durrent countershocks?, 210A 
Hyperketonemia 
Cardiac energy metabolism and performance 
during acute hypoglycemia and 
hyperketonemia: biochemical and NMR 
studies, 224A 
Hyperlipidemia 
Asymptomatic gallstones are often present in 
hyperlipidemic patients prior to lipid 
lowering drug therapy, 223A 
Cholesterol and saturated fat content of fish oil 
(FO) preparations influences the 
hypolipidemic response in type IV 
hyperlipidemic patients, 206A 
Hyperlipoproteinemia 
Hyperlipoproteinemia following heart 
transplantation: natural history and 
intervention with Lovastatin and 
Gemfibrozil, 44A 
Hypertension 
Abnormal left ventricular volume response 
predicts impaired exercise performance in 
hypertension, 198A 
Arterial hypertension after cardiac transplant 
with triple-drug immunosuppression 
therapy, 150A 
Beta receptors and mechanical function in the 
failing heart of the spontaneously 
hypertensive rat, 71A 
Cardiac function in hypertension: 
force-velocity relationship of the two 
ventricles and influences of preload, 147A 
Circadian variation of blood pressure and left 
ventricular hypertrophy in essential 
hypertension, 146A 
Comparative effects of verapamil and 
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nitroprusside on left ventricular function 
in patients with hypertension, 37 A 
Detection of diastolic dysfunction in borderline 
hypertensives by measurement of supine 
blood pressure, 147A 
Diltiazem reduces left ventricular mass but 
does not change diastolic filling in mild 
hypertension, 82A 
Early ventricular dysfunction in hypertensive 
patients with preserved aerobic capacity, 
142A 
Effect of arterial wave reflections on 
ventricular output, 35A 
Effect of pulmonary hypertensive congenital 
heart disease on the post-natal remodeling 
of the pulmonary vasculature, 135A 
Evidence for right ventricular ischemia during 
acute pulmonary hypertension, 93A 
Exercise testing in diuretic treated 
hypertensive patients, 198A 
Hypertension detection and control from 1973 
to 1986: the Minnesota Heart Study, 206A 
Impaired left ventricular diastolic filling in 
symptomatic compared to asymptomatic 
hypertensive patients, 81A 
Incremental value of clinical examination, 
echocardiography and cardiac 
catheterization in the evaluation of left 
ventricular dysfunction and pulmonary 
hypertension in valvular heart disease, 
64A 
Isolated systolic hypertension in the elderly, 
198A 
Left ventricular function in untreated 
hypertensive patients with normal 
ambulatory blood pressure, 81A 
Plasma atrial natriuretic polypeptide (ANP) 
and plasma norepinephrine (NE) during 
exercise in essential hypertension, 146A 
Systolic blood pressure, not age, mediates the 
age-related increase in ventricular wall 
thickness with a normotensive population, 
81A 
Ventricular/vascular coupling dynamics in a 
chronically hypertensive baboon model, 
93A 
Hypertrophy 
See also Cardiomyopathy 
Age related changes in left ventricular filling 
are related to compensating left 
ventricular hypertrophy, 34A 
Beta receptors and mechanical function in the 
failing heart of the spontaneously 
hypertensive rat, 71A 
Circadian variation of blood pressure and left 
ventricular hypertrophy in essential 
hypertension, 146A 
Clinical characteristics of subjects with left 
ventricular hypertrophy, 82A 
Coronary reserve in normal and hypertrophied 
hearts during cardiac maturation and 
aging,I90A 
Diltiazem reduces left ventricular mass but 
does not change diastolic filling in mild 
hypertension, 82A 
Early alteration in diastolic inflow pattern in 
response to progressive left ventricular 
hypertrophy, 35A 
Influence of increased myocardial collagen on 
active and passive stiffness in left 
ventricular hypertrophy, 12A 
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Regression of ventricular hypertrophy in 
cardiac transplant recipients under 
effective antihypertensive therapy, 151 A 
Reversal of left ventricular dilation, 
hypertrophy and contractile dysfunction 
by replacement of regurgitant aortic 
valves, 158A 
Systolic blood pressure, not age, mediates the 
age-related increase in ventricular wall 
thickness with a normotensive population, 
81A 
Time course of left ventricular hypertrophy 
and wall stress in aortic regurgitation, 
92A 
Validation of low-intensity zones in magnetic 
resonance images of hypertrophied 
myocardium: relaxation time 
characteristics, 158A 
Hypoglycemia 
Cardiac energy metabolism and performance 
during acute hypoglycemia and 
hyperketonemia: biochemical and nMR 
studies, 224A 
Hyponatremia 
Pathophysiologic significance of hyponatremia 
in experimental pacing-induced heart 
failure, 202A 
Hypoplastic left heart syndrome 
Atrial septal anomalies differentiate types of 
hypoplastic left heart syndrome, 136A 
Evolving pattern of survival following 
palliative surgery for hypoplastic left 
heart syndrome, 139A 
Hypotension 
Autonomic, not left ventricular dysfunction is 
the cause of haemodyalysis induced 
hypotension, 162A 
Hypotension-bradycardia syndrome 
Cardiac output in patients with 
neurally-mediated hypotension-
bradycardia syndrome, 115A 
Hypothermia 
Importance -of topical hypothermia during 
heterogeneous distribution of 
cardioplegia, I72A 
Hypoxemia 
Effects of nocturnal hypoxemia in patients with 
coronary artery disease and sleep apnea, 
184A 
Hypoxia 
Potassium efflux from the myocardium during 
early hypoxia: role of lactate, 49A 
Reoxygenation enhances neutrophil mediated 
injury to anoxic endothelial cells, 48A 
Immunoglobulins 
Detection of vascular graft infection in human 
subjects with radiolabeled non-specific 
polyclonal IgG, 84A 
Immunosuppression 
Arterial hypertension after cardiac transplant 
with triple-drug immunosuppression 
therapy, 150A 
Immunosuppression in cardiac transplantation 
without prednisone: a comparison of 
cyclosporineiprednisone to 
cyclosporineiazathioprine, I04A 
Indium-Ill 
Influence of clot age on the detection of left 
atrial appendage thrombi by indium-III 
platelet scintigraphy, 214A 
Positive indium-III platelet scans for left 
ventricular thrombi predict an increased 
embolic risk, 214A 
Indomethacin attenuates acetylcholine-induced 
canine epicardial coronary artery 
constriction in vivo, 47 A 
Potentiation of serotonin induced vasospasm 
by indomethacin in isolated perfused 
coronary arteries, 124A 
Relaxing factor released by phospholipase A2 
in the absence of endothelium, 124A 
Insulin 
Catecholamine supression of myocardial 
glucose uptake in vivo: a metabolic effect 
mediated by substrate availability, IIA 
Study of heart function during a 24-hour 
preservation in a new auto perfusion 
preparation, I03A 
Intention to treat 
Cross and double cross: should clinical trials 
be analyzed by the principle of intention 
to treat?, 127A 
Interleukin-I 
Interleukin-I induced inhibition of protein 
synthesis in neonatal rat heart cell via a 
nonmyocardial cell soluble mediator, 95A 
Intravascular volume 
Influence of acetylcholine on splanchnic 
volume in the intact dog, 123A 
Influence of verapamil on limb intravascular 
volume, 124A 
Iron overload syndromes 
Assessment of myocardial iron by nuclear 
magnetic resonance imaging, 226A 
Ischemia 
See also Coronary artery disease; Myocardial 
ischemia; Silent defects 
Ambulatory monitoring of left ventricular 
function post infarction predicts residual 
ischemia, 216A 
Amelioration of ischemia during PICA with 
diastolic coronary venous retroperfusion, 
64A 
Beneficial effects of {31 adrenoceptors 
stabilization and f32-adrenoceptors 
blockade with xamoterol in severe 
ischemic heart failure treated with 
ACE-inhibitors, 116A 
Developmental differences in susceptibility of 
the cardiac conduction system to global 
ischemia, 154A 
Dipyridamole thallium imaging predicts 
intraoperative ischemia in patients 
undergoing major vascular surgery, 162A 
Does exercise intensity influence the ischemic 
threshold?, 24A 
Effects of pre-ischemic catecholamine 
depletion on myocardial metabolism and 
tolerance to total ischemia, 37 A 
Effects of total ischemia on the neonatal heart, 
136A 
Evidence of right ventricular ischemia during 
acute pulmonary hypertension, 93A 
Exertional ischemia and prognosis in mildly 
symptomatic patients with single and 
double vessel coronary artery disease and 
left ventricular dysfunction at rest, 153A 
Frequent ischemic episodes during the morning 
hours in coronary patients: a result of 
decreased ischemic threshold or increased 
myocardial oxygen demand, %A 
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Gradients of myocardial adenine nucleotide 
degradation during total ischemia, 37A 
Hyperkinesis without Frank-Starling 
mechanism in a non-ischemic region of 
acutely ischemic canine heart, 92A 
Influence of severity of ischemia on the 
magnitude of myocardial reperfusion 
injury, 191A 
Ischemia and myocardial infarction during 
noncardiac surgery: preliminary results of 
the Poris Study, 97 A 
Metabolic pre loading reduces ischemia during 
prolonged angioplasty occlusions, 148A 
Predischarge Holter monitoring predicts 
postinfarction treadmill ischemia, 67 A 
Recurrent ischemia without warning: inability 
to predict ischemic events from residual 
stenosis after successful coronary 
thrombolysis, I05A 
Regional left ventricular wall stress: a new 
approach to detecting regional ischemia 
during exercise, 212A 
Repetitive ischemia delays recovery of 
regional myocardial function in awake 
dogs,94A 
Right coronary artery disease and inferoseptal 
ischemia: evaluation by tomographic 
thallium-201 exercise myocardial imaging, 
2l3A 
Simultaneous measurement of regional 
myocardial metabolism and function by 
multi-gated positron emission tomography 
(PET),38A 
Validation of ambulatory ECG for detecting 
ischemia in hypertensive patients 
with left ventricular hypertrophy, 
97A 
Isoproterenol 
Influence of isoproterenol on the left 
ventricular response to extrastimuli 
applied to the right ventricle, 182A 
Isoproterenol infusion increased Gorlin formula 
aortic valve area in isolated aortic 
stenosis, 63A 
Lack of chronotropic supersensitivity to 
isoproterenol post cardiac transplantation 
and subsensitivity in CHF, 143A 
Response of atrial natriuretic polypeptide to 
isoproterenol and acetylcholine infusion in 
humans, 238A 
Isradipine 
Comparison of the effects of intravenous 
isradipine and systemic hemodynamics in 
man, 242A 
Kawasaki's disease 
Importance of angiography in assessment and 
follow-up of coronary abnormalities in 
Kawasaki's disease, 29A 
Ketanserin 
Cardiac electrophysiologic effects of 
ketanserin, 140A 
Labetolol 
Coronary and systemic hemodynamic effects of 
high-versus low-dose intravenous 
Lactate 
labetolol in patients with coronary artery 
disease, 242A 
Measurement of lactate in skeletal muscle by 
proton NMR, 225A 
Potassium efflux from the myocardium during 
early hypoxia: role of lactate, 49A 
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Lasers 
Alteration of artery wall fluorescence due to 
excessive laser irradiation, 49A 
Effect of laser balloon angioplasty on normal 
dog coronary arteries in vivo, J08A 
Effect of neodymium-YAG lasing of the left 
posterior papillary muscle on mitral valve 
function, 178A 
Experimental argon laser thermal angioplasty 
as an adjunct to balloon angioplasty, 108A 
Fluorescence spectroscopy guidance of laser 
ablation of atherosclerotic plaque, 107 A 
Improved monitoring of laser angioplasty with 
laser Doppler echocardiography, 4A 
In-vivo fluorescence spectroscopy of normal 
and atherosclerotic arteries, 173A 
Laser Doppler measurement of canine 
coronary flow using a sheath-guided 
optical fiber, 174A 
Long-term clinical results of intraoperative 
mapping-guided argon laser ablation of 
malignant supraventricular and ventricular 
tachycardias, 178A 
Percutaneous pulsed and laser angioplasty with 
atheroma detection in humans, 107A 
Periphery artery laser recanalization: a clinical 
experience, 107A 
Leukocytes 
Importance of leukocyte demargination and 
chemotaxis suppression in myocardial 
reperfusion injury, 207 A 
Leukotoxin 
Leukotoxin, 9, 10-epoxy-12-octadecenoate, 
causes disseminated intravascular 
coagulation, 54A 
Lidocaine 
Combination of metoprolol plus lidocaine 
enhances antiarrhythmic effectiveness in a 
chronic canine infarct model, 41A 
Inhibition of procainamide use dependent 
conduction delay by lidocaine, 181A 
Lidocaine delivery via the coronary sinus 
results in high concentrations in ischemic 
myocardium, 87 A 
Lidocaine induced malignant ventricular 
asystole in anesthetized dogs with recent 
myocardial infarction, 39A 
Limited effectiveness of lidocaine in 
termination of sustained ventricular 
tachycardia, 55A 
Lipid(s) 
Epidemiology of total-cholesterol-to-HDL 
(ratio) in 11,669 air force personnel and 
coronary artery anatomy in 305 healthy 
aviators, 222A 
Lipid peroxidation 
Does clinical Doppler ultrasound induce free 
radical production and lipid peroxidation 
ofretinal cells and heart muscle?, 176A 
Oxygen radical mediated membrane lipid 
peroxidation after post -ischemic 
reperfusion, 208A 
5-Lipoxygenase 
Effects of 5-lipoxygenase inhibition of cardiac 
arrhythmias in isolated guinea pig hearts, 
203A 
Loading conditions 
Cardiac function in hypertension: 
force-velocity relationship of the two 
ventricles and influences of preload, 147 A 
Changes in left ventricular output and filling 
produced by preload reduction in patients 
with congestive heart failure, 121A 
Early increase of myosin light chain-2 mRNA 
in right ventricular pressure overload, 
141A 
Evaluation by color Doppler of the effects of 
loading alterations in mitral regurgitant jet 
in patients with mitral valve prolapse, 
21SA 
Influence of alterations in loading upon aortic 
blood flow acceleration produced by 
lower body negative pressure, 120A 
Metabolic preloading reduces ischemia during 
prolonged angioplasty occlusions, 148A 
Nicotinamide adenine dinucleotide fluorometry 
to evaluate pressure loading of the heart, 
141A 
Power-afterload relationship in the failing 
human ventricle, 245A 
Lovastatin 
Hyperlipoproteinemia following heart 
transplantation: natural history and 
intervention with Lovastatin and 
Gemfibrozil, 44A 
Magnesium 
Magnesium abolished afterdepolarizations 
induced by cesium, 4-aminopyridine or 
quinidine in canine purkinje fibers, 254A 
Magnesium suppresses early 
afterdepolarizations and ventricular 
tachyarrhythmias induced by cesium, 
254A 
Parenteral magnesium therapy in intractable 
ventricular tachyarrhythmias, 169A 
Magnetcardiography 
Non-invasive localization of accessory 
pathways using magnetcardiography, 59A 
Mapping procedures 
See also Doppler color flow imaging 
Computerized global mapping of the atrium in 
patients with supraventricular tachycardia 
(SVT),112A 
Computerized potential distribution mapping 
during ventricular tachycardia in 
experimental myocardial infarction, 
1I2A 
Does ventricular tachycardia mapping influence 
the success of antiarrhythmic surgery?, 
I12A 
Intraoperative atrial mapping for localization of 
septal accessory pathways, IlIA 
Spectro-temporal mapping: the next generation 
in late potential analysis, I99A 
Marfan syndrome 
Aortic root dilatation in the Marfan syndrome: 
patterns, familiarity and short-term 
clinical course, 74A 
Mast cells 
Are mast cells the culprit in colonary plaque 
destabilization?, 52A 
MCI-154 
Effect of MCI-154 on Ca2+ activation in 
skinned human and ferret cardiac muscle, 
139A 
Inotropic and lusitropic effects of MCI-154 on 
normal human myocardium, 139A 
Memory, cardiac 
Mechanisms of cardiac memory, 39A 
2-Mercaptopropionyl glycine 
Prevention of coronary vascular injury induced 
by transient myocardial ischemia, 124A 
Metabolism 
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Cardiac metabolism during coronary 
angioplasty with fluosol protection: 
discordance between LV systolic function 
and lactate metabolism, 149A 
Simultaneous measurement of regional 
myocardial metabolism and function by 
multi-gated positron emission tomography 
(PET),38A 
Tissue kinetics of C-II acetate as a tracer of 
myocardial oxidative metabolism in 
canine myocardium, 37A 
Metacholine 
Bronchial cholinergic hyperresponsiveness in 
patients with variant angina, 46A 
Metaiodobenzylgnanidine 
Comparative SPECT 1-123 
metaiodobenzylguanidine (MIBG) and 
thallium 201 cardiac imaging following 
myocardial infarction in patients, 81A 
Scintigraphic assessment of global adrenergic 
nerve density with MIBG washout maps, 
214A 
Scintigraphic and e1ectrophysiologic evidence 
of canine myocardial sympathetic 
denervation and reinnervation produced 
by myocardial infarction or phenol 
application, IA 
Methionine 
Methionine potentiates the vasodilatory effects 
of nitroglycerin, 43A 
Metoprolol 
f3 blockade results in decreased coronary blood 
flow due to mediated vasoconstriction, 
23A 
Combination of metoprolol plus lidocaine 
enhances antiarrhythmic effectiveness in a 
chronic canine infarct model, 41A 
Effect of metoprolol in acute coxsackievirus 
B3 murine myocarditis, 196A 
Sotalol and metoprolol in ventricular 
tachycardia: preliminary data of a 
double-blind prospective study, 227 A 
Microcavitation 
Comparison of color flow Doppler and 
microcavitation for the detection of 
intraatrial flow communications, 240A 
Milrinone 
Hemodynamic effects of chronic oral milrinone 
therapy: a multicenter controlled trial, 
144A 
Mitochondrial function 
Effects of reperfusion on mitochondrial 
function in heart muscle, 38A 
Mitral valve area 
Mitral valve pressure halftime: accuracy at six 
months after mitral balloon valvotomy, 
21A 
Spontaneous variation and exercise-induced 
changes in measurement of mitral valve 
area using the Gorlin formula: 
implications for evaluation of changes 
following catheter balloon valvuloplasty 
for mitral stenosis, 234A 
Mitral valve disease 
Anterior papillary muscle displacement causes 
systolic anterior motion of the mitral 
valve in absence of septal hypertrophy, 
74A 
Determinants of color flow Doppler imaging of 
regurgitant flows in a physiologic in-vitro 
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model of mitral insufficiency evaluated by 
digital computer analysis of color coded 
velocities, 19A 
Evaluation by color Doppler of the effects of 
loading alterations on mitral regurgitant 
jet in patients with mitral valve prolapse, 
21SA 
Is mitral regurgitation necessary for 
hydralazine to be an effective agent in 
congestive heart failure?, 143A 
Isometric exercise mediated hemodynamic 
worsening and its prevention with 
nitroglycerin in patients with chronic 
mitral regurgitation, 230A 
Left atrial size and pressure reflects the 
"history" of chronic mitral regurgitation, 
219A 
Left ventricular systolic function and diastolic 
filling characteristics in patients with 
severe mitral stenosis, 90A 
Mild mitral regurgitation impairs left 
ventricular performance in patients with 
aortic stenosis, 91A 
Mitral regurgitation induced by congenital 
"absence of the commisural chordae": a 
new etiology, 230A 
Right and left ventricular functional response 
to supine exercise in patients with 
asymptomatic mitral regurgitation, 229A 
Two-dimensional echocardiographic 
assessment of changes in mitral valve 
morphology and left atrial volumes 3 
months after catheter balloon 
valvuloplasty for mitral stenosis, 21A 
Mitral valve motion 
Chordal geometry determines the shape and 
extent of systolic anterior mitral motion: 
in vitro studies, 251A 
Mitral valve prolapse 
Direct demonstration of mitral leaflet annular 
relationships by three-dimensional 
echocardiography: implications for the 
diagnosis of mitral valve prolapse, 126A 
Leaflet thickening increases the risk of 
endocarditis in patients with mitral valve 
prolapse, 126A 
Mitral valve prolapse associated with sudden 
death: morphologic spectrum and 
distinguishing features, 125A 
Peptidergic neurotoxin causes alterations of 
mitral valve motion, 125A 
Prospective study of mitral valve prolapse: 
further evidence for "normality" of 
displacement in the apical 4-chamber view 
only,125A 
Relation of valvular anatomy and coaptation to 
mitral regurgitation in mitral valve 
prolapse: assessment by color Doppler 
flow imaging, 126A 
Monoclonal antibodies 
Monoclonal antibody therapy for prevention of 
acute coxsackie viral myocarditis in mice, 
196A 
Radioimmunoimaging of experimental thrombi 
in dogs using monoclonal antibody: effect 
of heparin or uptake by pulmonary 
emboli,53A 
Visualization of clots in experimental venous 
thrombi using monoclonal antibodies, 52A 
Morphologic studies 
Morphologic changes in the normally 
developing canine conducting system, 
93A 
Morphologic findings at necropsy after 
recombinant tissue plasminogen activator 
therapy for acute myocardial infarction, 
193A 
Murmurs 
See Heart murmurs 
Muscle fatigue 
Down-regulation of skeletal muscle 
beta-adrenergic receptors in experimental 
canine heart failure, 116A 
Myocardial blood flow 
Noninvasive quantification of regional 
myocardial blood flow with N-13 
ammonia and dynamic positron 
tomography, lOA 
Myocardial function 
Relationship of regional myocardial function to 
regional tomographic thallium-201 
perfusion, 90A 
Repetitive ischemia delays recovery of regional 
myocardial function in awake dogs, 94A 
Unloaded sarcomere shortening velocity and 
amplitude are unaltered with age, 92A 
Myocardial hibernation 
Clinical evaluation of hibernating 
myocardium-short term effects of 
coronary angioplasty on regional left 
ventricular wall motion, 133A 
Reversibility of segmental left ventricular 
dysfunction following coronary 
angioplasty: echocardiographic evidence 
of hibernating myocardium, 133A 
Salvage of hibernating myocardium after 
transluminal coronary angioplasty, 148A 
Myocardial infarction 
See also Coronary occlusion 
Addition of intracoronary prostaglandin E I to 
streptokinase improves thrombolysis and 
left ventricular function in acute 
myocardial infarction, I04A 
Cardiac event rate following anterior non-Q 
wave myocardial infarction, 189A 
Changes between 1978 and 1985 in fatal and 
non fatal myocardial infarction in blacks 
and whites in rural South Carolina, 222A 
Circadian fluctuations in endothelium-derived 
fibrinolytic factors in relation to the time 
of onset of myocardial infarction and 
sudden cardiac death, 27 A 
Combination of metoprolol plus lidocaine 
enhances antiarrhythmic effectiveness in a 
chronic canine infarct model, 41A 
Coronary angioplasty for acute myocardial 
infarction: a report of the 1985 NHLBI 
PTCA Registry, l31A 
Day-to-day reproducibility of response to 
programmed ventricular stimulation in 
patients with recent acute myocardial 
infarction, 5A 
Does tissue plasminogen activator reduce 
infarct size in an experimental model of 
mechanical coronary artery occlusion and 
reperfusion in dogs?, 54A 
Early hospital discharge 3 days after 
myocardial infarction: a randomized, 
controlled clinical trial in the era of 
reperfusion, 27 A 
Early and longterm patency rate of the infarct 
artery after tissue plasminogen activator 
SUBJECT INDEX 293A 
(t-PAl and coronary angioplasty for acute 
myocardial infarction, 192A 
Early post -infarction angina is a predictor of 
poor long-term prognosis after acute non 
Q wave myocardial infarction: the 
diltiazem reinfarction study, 25A 
Early prediction of infarct expansion following 
acute myocardial infarction, 194A 
Effect of chronic inferoposterior myocardial 
infarction on arterial baroreflex sensitivity 
in conscious dogs, 88A 
Effects of current strength and unipolar versus 
bipolar pacing at sites of infarction on 
myocardial activation, 58A 
Exercise assessment after myocardial 
infarction-long-term changes in patient 
selection, 122A 
Exercise treadmill test is a poor predictor of 
the risk of nonfatal myocardial infarction, 
212A 
Fifteen year comparative follow-up in patients 
with anterior and inferior myocardial 
infarction, 222A 
Incidence and prognosis of unrecognized 
myocardial infarction in the elderly: the 
Framingham study, 51A 
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in-hospital and late prognosis of transient 
acute myocardial ischemia at rest, 47 A 
Lidocaine delivery via the coronary sinus 
results in high concentrations in ischemic 
myocardium, 87 A 
Measurement of experimental pain and serum 
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myocardial scar assessed by thallium-201 
myocardial perfusion imaging in patients 
with idiopathic dilated cardiomyopathy, 
85A 
Myocardial viability 
Technetium isonitrile at rest underestimates 
viability as assessed by wall motion, 32A 
Myocarditis 
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concentrate and neomycin as therapy of 
hyperlipidemia, 224A 
Neurotoxins 
Peptidergic neurotoxin causes alternatives of 
mitral valve motion, 125A 
Neutrophil adherence 
Perftuorochemical markedly reduces neutrophil 
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J3-endorphin in patients with symptomatic 
(SMI) and asymptomatic myocardial 
ischemia (AMI)-modification by 
naloxone,47A 
He-Palmitate 
Effects of maximal and submaximal exercise 
on myocardial ltC-palmitate clearance 
associated with positron emission 
tomography,211A 
Parabromophenacyclbromide 
Relaxing factor released by phospholipase A2 
in the absence of endothelium, 124A 
Patent ductus arteriosus 
Advances in flow quantification by color flow 
mapping in an animal model of patent 
ductus arteriosus, 241A 
Elevated serum atrial natriuretic peptide in 
premature infants with respiratory distress 
and patent ductus arteriosus, 136A 
Pediatric cardiac imaging 
Cine magnetic resonance imaging for the 
evaluation of pulmonary artery banding in 
infants and children, 248A 
Evaluation of pulmonary outflow tract anatomy 
by cine magnetic resonance imaging using 
angled views, 248A 
Regional pulmonary perfusion in pigs with 
aortopulmonary shunt-estimated by high 
speed computed tomography, 248A 
Spontaneous closure rate of atrial septal 
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Pericardial pressure 
Effect of pericardial pressure elevation on 
blood flow independent of changes in 
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f3 blockade results in decreased coronary blood 
flow due to unopposed a mediated 
vasoconstriction, 23A 
Distribution of {3-adrenergic receptors in failing 
human myocardium: implications for 
mechanisms of down-regulation, 116A 
Effects of acute and chronic beta-adrenoceptor 
blockade on baroreflex sensitivity, 148A 
Evaluation of the hemodynamic effects of 
calcium channel antagonists by exercise 
Doppler: comparison of verapamil and 
nifedipine, 122A 
Improved ventricular performance following 
arrhythmia control in children with 
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automatic atrial tachycardia and dilated 
cardiomyopathy, 155A 
In vivo electrophysiologic effects of alpha 
blockade in neonatal and adult canines, 
154A 
Prostacyclin 
Clinical evaluation of prostacyc1in analogue as 
an adjunct to cardioplegia in infants and 
children, 171A 
Potentiation of serotonin induced vasospasm 
by indomethacin in isolated perfused 
coronary arteries, 124A 
Prostaglandin EI 
Addition of intracoronary prostaglandin E I to 
streptokinase improves thrombolysis and 
left ventricular function in acute 
myocardial infarction, I04A 
Protein synthesis 
Interleukin-I induced inhibition of protein 
synthesis in neonatal rat heart cell via a 
non-myocardial cell soluble mediator, 95A 
Protein turnover 
Amino acyl-t RNA validation of the in vivo 
measurement of myocardial protein 
turnover using amino acid tracer: 
eHl-phenylalanine, 142A 
Pulmonary artery banding 
Cine magnetic resonance imaging for the 
evaluation of pulmonary artery banding in 
infants and children, 248A 
Pulmonary disease 
Fetal heart disease with cardiomegaly may be 
associated with lung hypoplasia as a 
determinant of poor prognosis, 9A 
Pulmonary perfusion 
Regional pulmonary perfusion in pigs with 
aortopulmonary shunt-estimated by high 
speed computed tomography, 248A 
Pulse wave reflectious 
Effect of arterial wave reflections on 
ventricular output, 35A 
QRS interval 
Diurnal variation in summated QRS voltage in 
the normal electrocardiogram, 199A 
QTcomplex 
Antiarrhythmic drug-induced torsade de 
pointes: lack of relationship to marked 
QT prolongation, 56A 
Impaired QT shortening is associated with 
exercised-induced ventricular tachycardia 
in normal subjects, 69A 
Torsade de pointes and QT prolongation after 
orthotopic liver transplantation, 20lA 
Quinidine 
Differential epicardial-endocardial response to 
quinidine: I, 40A 
Magnesium abolishes early afterdepolarizations 
induced by cesium, 4 aminopyridine or 
quinidine in canine Purkinje fibers, 254A 
Use-dependent effects of quinidine on the 
canine His-Purkinje system: onset, 
magnitude and recovery, 255A 
Radiofrequency 
See under Ablation procedures 
Radionuclide studies 
See Angiography, radionuc1ide; 
Ventriculography, radionuc1ide; 
Scintigraphy 
Ranitidine 
Cimetidine but not ranitidine alters nifedipine 
elimination kinetics and effects, 44A 
Reentry 
Characterization and differentiation of reset 
response curves in automaticity and 
reentry, 115A 
Referral 
Changing patterns of referral after diagnostic 
cardiac catheterization, 127A 
Refractoriness 
Frequency-dependence of antiarrhythmic drug 
effect on post-repolarization refractoriness 
in vivo, 255A 
Rehabilitation 
See Exercise rehabilitation 
Relaxing factor 
Relaxing factor released by phospholipase A2 
in the absence of endothelium, 124A 
Reocclusion 
See Coronary reocc1usion 
Repolarization 
Dispersion of left ventricular repolarization in 
man,I13A 
Respiratory distress syndrome 
Elevated serum atrial natriuretic peptide in 
premature infants with respiratory distress 
and patent ductus arteriosus, I36A 
Restenosis 
Abnormal thallium-201 SPECT early after 
coronary angioplasty: a predictor of 
restenosis?, 79A 
Balloon aortic valvuloplasty-induced injury and 
repair: a possible mechanism of 
restenosis, 221A 
Balloon valvuloplasty in re-stenosis after 
surgical mitral commissurotomy, 235A 
Dietary supplementation with N-3 fatty acids 
reduces the rate of restenosis after 
coronary angioplasty, 237 A 
Does pretreatment with heparin prevent abrupt 
closure following PTCA?, 238A 
Failure of antiplatelet agents to reduce 
restenosis after PTCA in a double blind 
placebo controlled trial, 236A 
How cumulative is the risk of restenosis with 
multilesion dilatation?, 235A 
Is there really a difference in the incidence of 
restenosis after PTCA with stable and 
unstable angina, 236A 
Relation of diastolic subendocardial tissue 
pressure to coronary pressure at zero flow 
in dogs, 13A 
Ultrastructural findings of proliferating and 
migrating smooth muscle cells at the site 
of percutaneous transluminal coronary 
angioplasty, J3I A 
Retroperfusion 
See also Venous retroperfusion 
ECG and 2 D echo assessment of myocardial 
protection achieved by diastolic 
synchronized coronary sinus 
retroperfusion (DSR) during LAD 
angioplasty, I32A 
Revascularization 
Strategy of incomplete revascularization in 
multivessel PTCA: is it justified?, 61A 
Rifampin 
Near total reduction in verapamil 
bioavailability by rifampin: 
electrocardiographic correlates, 205A 
Right heart disease 
Contrast colour coded Doppler flow images for 
evaluation of right heart disease, 240A 
Risk factors 
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Evaluation of patients at risk after first acute 
myocardial infarction by programmed 
ventricular stimulation: influence of 
antiarrhythmic drug therapy, 183A 
Programmed electrical stimulation of the right 
ventricle-role of risk stratification 
following infarction, 190A 
Worksite-based mulifactorial risk intervention 
trial,207A 
mRNA 
Early increase of myosin light chain-2 mRNA 
in right ventricular pressure overload, 
141A 
R031-2848, ic 
Evidence for local intracardiac action and 
metabolism of converting enzyme 
inhibitors, 141A 
R031-3113 
Evidence for local intracardiac action and 
metabolism of converting enzyme 
inhibitors, 141A 
RP-30 
See Technetium-99m 
Sarcomere 
Unloaded sarcomere shortening velocity and 
amplitude are unaltered with age, 92A 
Scintigraphy 
See also Dipyridamole; Thallium-201 
Comparison of transesophageal 
echocardiographic and scintigraphic 
estimates of left ventricular end-diastolic 
volume and ejection fraction, 219A 
ECG gating improves the accuracy of 
radionuclide right ventricular ejection 
fraction determinations, 215A 
Scintigraphic assessment of global adrenergic 
nerve density with MIBG washout maps, 
214A 
Septal turbulence 
Septal turbulence: an important source of 
systolic murmer, 83A 
Serotonin 
Potentiation of serotonin induced vasospasm 
by indomethacin in isolated perfused 
coronary arteries, 124A 
Thromboxane and serotonin mediate 
reocclusion after thrombolysis in a canine 
model of coronary thrombosis, 30A 
Sham 
Pharmacologic modification of left ventricular 
remodeling during healing after 
myocardial infarction in the dog, 252A 
Shock, circulatory 
Left ventricular dynamics in circulatory shock, 
91A 
Shortening deactivation 
Effect of wall thickening on end-systolic 
performance: shortening deactivation in 
whole heart, 94A 
Shunts 
Glenn shunts: effect upon pleural drainage 
after Fontan procedure, 250A 
Shunt flow 
Advances in flow quantification by color flow 
mapping in an animal model of patent 
ductus arteriosus, 241A 
Color Doppler assessment of shunt flow across 
large atrial septal defects, 240A 
Color Doppler flow mapping shunt patterns in 
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AV canal defects: comparison with 
angiography, 241A 
Comparison of color flow Doppler and 
microcavitations for the detection of 
interatrial flow communications, 240A 
Contrast colour Doppler flow imaging for 
evaluation of right heart disease, 240A 
Evaluation of trans foramen ovale flow during 
the early neonatal period-a color 
Doppler echocardiographic study, 241A 
Sickle cell anemia 
Impaired cardiopulmonary function with 
exercise in sickle cell anemia, 211A 
Verapamil improves myocardial perfusion 
abnormalities in asymptomatic 
hypertrophic cardiomyopathy, 251A 
Simvastatin 
Effects of simvastatin versus probucol. 
Simvastatin Multicenter Group II, 207 A 
Sinus node dysfunction 
Sinus node dysfunction in heart transplant 
recipients, 103A 
Sinus rhythm 
Intravenous flecainide versus verapamil for 
acute conversion of atrial fibrillation or 
atrial flutter to sinus rhythm, 76A 
Maintenance of sinus rhythm in patients with 
atrial fibrillation and a dilated left atrium, 
169A 
Sleep apnea syndrome 
Effects of nocturnal hypoxemia in patients with 
coronary artery disease and sleep apnea, 
184A 
Smoking 
Smoking aggravated myocardial ischemia 
during daily life, 204A 
Smooth muscle cells 
Ultrastructural findings of proliferating and 
migrating smooth muscle cells at the site 
of percutaneous transluminal coronary 
angioplasty, l3lA 
Sodium bicarbonate 
Effects of buffer agents on myocardial 
resuscitability after cardiac arrest, 89A 
Sodium-calcium exchange 
Adriamycin limits the consequences of sodium 
mediated calcium gain in the isolated rat 
heart, 14lA 
Sodium chloride 
Effects of buffer agents on myocardial 
resuscitability after cardiac arrest, 89A 
SotaIol 
Chronic oral sotalol for patients with sustained 
ventricular arrhythmias, 167A 
Effects of d-sotalol on the His-Purkinje system, 
227A 
Sotalol and metoprolol in ventricular 
tachycardia: preliminary data of a 
double-blind prospective study, 227 A 
Sotalol for sustained ventricular 
tachyarrhythmias: predictors of 
arrhythmic outcome, 55A 
Sotalol mediated torsade de pointes, 168A 
Soyacol 
Study of heart function during a 24-hour 
preservation in a new auto perfusion 
preparation, 103A 
Spectroscopy 
Alteration of artery wall fluorescence due to 
excessive laser irradiation, 49A 
Fluorescence spectroscopy guidance of 
laser ablation of atherosclerotic plaque, 
107A 
In-vivo fluorescence spectroscopy of normal 
and atherosclerotic arteries, 173A 
MRI guided phosphorous 31 spectroscopy of 
the human ventricle, 226A 
SQ 29,548 
Influence of thromboxane A2 receptor 
antagonism on pulmonary vasoconstrictor 
responses in the newborn, 137 A 
ST segment 
Heart rate adjusted indices of ST segment 
depression identify coronary 
artery disease in patients with 
negative standard exercise test responses, 
24A 
Heart rate adjustment of exercise-induced ST 
segment depression for predicting triple 
vessel and left main coronary artery 
disease: a meta-analysis, 24A 
Importance of time-course behavior of ST 
segment and T wave changes following 
exercise. A reliable aid towards 
eliminating "false positives," 122A 
Initial ST -segment deviation can predict final 
electrocardiographic myocardial infarct 
size,68A 
ST segment depression on the admission ECG 
is a determinant of adverse long-term 
outcome in non-Q wave myocardial 
infarction: a prospective analysis rom the 
Multicenter Diltiazem Reinfarction Study 
(DRS),67A 
ST -T segment 
ST -T configuration in V 4R in acute inferior 
infarction and the site of occlusion in the 
coronary artery, 68A 
Stellate stimulation 
Differential response of early 
afterdepolarization and ventricular 
tachycardia during right and left stellate 
stimulation in the dog treated with 
cesium, 254A 
Stenosis 
See also Valve disease; Restenosis 
Effect of the shape of pre- and post-stenotic 
regions on the accuracy of Doppler in 
measuring pressure gradients across long 
segment stenosis, 21A 
Management decisions in aortic stenosis: use 
of receiver operator characteristic curves, 
63A 
Noninvasive three dimensional reconstruction 
of the spectrum of ventricular septal 
defects with pulmonary stenosis by 
magnetic resonance imaging, 134A 
Percutaneous balloon angioplasty of left main 
coronary stenosis: acute and long-term 
results,6lA 
Saphenous vein graft patency after 2 years is 
related to preoperative serum cholesterol 
and triglyceride levels, 7 A 
Validation of a digital angiographic 
vasodilation of the coronary system in 
response to stenosis at rest, 62A 
Stenting 
Analysis of complications associated with 
coronary stenting, 66A 
Combined angioplasty and vascular stenting by 
a novel heat-expandable thermoplastic 
device,65A 
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Steroids 
See also specific agent 
Regression of ventricular hypertrophy in 
cardiac transplant recipients under 
effective antihypertensive therapy, 151A 
Stethoscope 
Initial clinical experience with an ultrasound 
stethoscope (a hand-held 2 D cardiac 
ultrasound device), lOOA 
Streptokinase 
See also Thrombolytic therapy 
Addition of intracoronary prostaglandin E I to 
streptokinase improves thrombolysis and 
left ventricular function in acute 
myocardial infarction, I04A 
Multicenter double-blind trial of intravenous 
APSAC versus heparin in acute 
myocardial infarction. Final report of the 
APSIM study, 232A 
Preservation of left ventricular function and 
topography with combined reperfusion 
and intravenous nitroglycerin in acute 
myocardial infarction, 90A 
Results of large randomized trial of 
intravenous streptokinase and oral aspirin 
in acute myocardial infarction, 232A 
Stress testing 
See also Exercise testing 
Aminophylline administration after 
dipyridamole stress as a trigger of 
coronary vasospasm in variant angina, 
205A 
Stroke volume 
Is it possible to obtain an accurate Doppler 
estimate of stroke volume in patients with 
decreased forward flow?, 121A 
New technique for quantification of left and 
right ventricular stroke volumes utilizing 
rapid dynamic magnetic resonance 
imaging, 156A 
Right ventricular stroke volume assessment 
using an impedence catheter, 166A 
Sudden death 
See also Cardiac arrest 
Accuracy of invasive testing for direct 
identification of sudden death risk in the 
Wolff-Parkinson-White syndrome, 78A 
Are patients with mild heart failure at risk of 
malignant ventricular arrhythmias and 
sudden death?, 72A 
Circadian fluctuations in endothelium-derived 
fibrinolytic factors in relation to the time 
of onset of myocardial infarction and 
sudden cardiac death, 27 A 
Impact of automatic implantable cardioverter 
defibrillators on survival of patients with 
left ventricular dysfunction and malignant 
ventricular arrhythmias, 179A 
Mitral valve prolapse associated with sudden 
death: morphologic spectrum and 
distinguishing features, 125A 
Periodic heart rate dynamics in sudden cardiac 
death syndrome: spectral analysis, 199A 
Role of silent ischemia and the 
electrophysiologic substrate in the genesis 
of sudden cardiac death, 6A 
Successful reperfusion of infarcting 
myocardium is associated with reversal of 
electrical predictors of sudden cardiac 
death, 183A 
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What is the best predictor of sudden death 
following myocardial infarction?, 26A 
Superoxide dismutase 
Despite superoxide dismutase treatment, 
postischemic contractile dysfunction 
persists after 4 hours of reperfusion, I64A 
Effect of superoxide dismutase on myocardial 
free radical concentrations during 
post-ischemic reperfusion, I64A 
Long-term recovery of LV wall thickening 
after one hour of ischemia is not affected 
when superoxide dismutase and catalase 
are administered during the 1st 45 minutes 
of reperfusion, 163A 
Oxygen radical mediated membrane lipid 
peroxidation after post -ischemic 
reperfusion, 20SA 
Pharmacokinetics of human recombinant 
superoxide dismutase, I64A 
Preventive effects of human serum superoxide 
dismutase activity on reperfusion injury 
with successful thrombolysis in acute 
myocardial infarction, 187A 
Superoxide dismutase limits myocardial infarct 
size in a porcine closed-chest 
ischemia-reperfusion model, 163A 
Surgery, ablation 
See also Cryoablation 
Comparison of baseline characteristics and 
long-term quality of life in 540 
Wolff-Parkinson-White patients treated 
with pharmacologic versus surgical 
therapy, 11 OA 
Differentiation of conduction over a posterior 
paraseptal accessory pathway versus 
normal ventriculoatrial conduction system 
by retrograde atrial activation sequence at 
the atrioventricular groove, IlIA 
Importance of preoperative variables in 
predicting operative mortality in direct 
surgery for drug resistant ventricular 
tachycardia, 113A 
Intraoperative atrial mapping for localization of 
septal accessory pathways, ilIA 
Presence of a broad activation front in 
Wolff-Parkinson-White patients suggesting 
arborizing atrial insertion of accessory 
pathway, 1I0A 
Surgery for Wolff-Parkinson-White syndrome 
using the epicardial approach. Experience 
with 200 patients, 1l0A 
Surgery, antiarrhythmic 
Does ventricular tachycardia mapping influence 
the success of antiarrhythmic surgery?, 
1I2A 
Early clinical results of corridor surgery for 
treatment of chronic atrial fibrillation, 
IliA 
Surgery, cardiac 
See Cryosurgery; specific procedure 
Surgery, coronary bypass 
Benefit of retrograde coronary sinus 
cardioplegia during revascularization for 
acute myocardial infarction, I06A 
Clinical outcome ten years after coronary 
bypass: effects of cholesterol and 
triglycerides in 4913 pts., 7 A 
Coronary by-pass flow assessment and 
quantification by intraoperative Doppler, 
I77A 
Deferoxamine reduces neutrophil-mediated free 
radical production during 
cardiopulmonary bypass in man, 171A 
Favorable long term outcome of coronary 
bypass surgery before hospital discharge 
following intravenous t-PA therapy for 
myocardial infarction, 107A 
Fifteen-year survival after coronary bypass 
surgery for unstable angina, 106A 
Prognosis after myocardial infarction in 
patients with previous coronary bypass 
surgery, 189A 
Protective effects of retrograde versus 
antegrade cardioplegia on biventricular 
function during coronary bypass surgery, 
I7IA 
Quality of life after treatment for unstable 
angina pectoris: the V A Cooperative 
Study of medical vs surgical therapy for 
unstable angina pectoris, 234A 
Ten year incidence of myocardial infarction in 
the VA Cooperative Study of bypass 
surgery, 106A 
Thermal coronary angiography: a new method 
for intraoperative real-time assessment of 
coronary anatomy and blood flow, 46A 
Surgery, pediatric 
Arterial reimplantation: short and long term 
course of patients with anomalous left 
coronary artery, 138A 
Catheter assessment of left ventricular function 
after arterial switch operation at rest and 
afterload stress, 29A 
Cine magnetic resonance imaging in children 
with transposition of the great arteries 
after surgical repair, 157A 
Critical aortic stenosis in the newborn: early 
risk factors and later prognosis, 70A 
Early variations of right ventricular size and 
function after valvotomy in newborns 
with pUlmonary atresia or critical stenosis 
and intact ventricular septum, 250A 
Effect on cardiac output of a cardiac 
rehabilitation program in children after 
surgical repair of congenital heart disease, 
250A 
Evaluation of right ventricular function by 
regional wall motion analysis in patients 
after trans pulmonary transatrial repair for 
tetralogy of Fallot, 249A 
Evolving pattern of survival following 
palliative surgery for hypoplastic left 
heart syndrome, 139A 
Fate of the aortic homograft used for right 
ventricular outflow tract reconstruction 
for pulmonary atresia and severe Fallot: a 
21 st birthday celebration, 69 A 
Incidence and severity of aortic insufficiency 
and supraventricular pulmonic stenosis 
following anatomic correction of 
transposition of the great arteries, 70A 
Long-term palliation with the classic 
Blalock-Taussig shunt, 134A 
Long-term prognosis of patients undergoing 
surgical repair of isolated pulmonary 
valve stenosis: a 20-30 year follow-up, 
69A 
Myocardial performance after arterial switch 
for transposition of the great arteries, 69A 
Preoperative assessment of right ventricular 
size and morphology in tricuspid atresia, 
29A 
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Primary closure of ventricular septal defect in 
infancy,70A 
Quantitative evaluation of aortic regurgitation 
after anatomic correction of transposition 
of the great arteries, 135A 
What is the fate of the pulmonary valve 
following pulmonary artery-to-ascending 
aorta anastomosis?, 139A 
Surgery, valve 
Aortic valve salvage utilizing high frequency 
vibratory debridement, 3A 
Comparison of intraoperative transesophageal 
and epicardial color flow Doppler in 
mitral valve repair, 20A 
Late results of reconstruction mitral valve 
surgery for mitral regurgitation, 3A 
Long-term results of mitral valve reoperations, 
2A 
"Malade de Carpentier": loud murmurs 
following mitral valve repair, 3A 
Reparative surgery for tricupsid regurgitation: 
operative and follow-up evaluation by 
Doppler color flow mapping, 3A 
Ultrasonic aortic valve decalcification: Doppler 
echocardiographic evaluation, 229A 
Surgery, vascular 
Assessment of cardiac risk by exercise 
echocardiography prior to peripheral 
vascular surgery, 218A 
Sympathetic nerves 
Heart innervation and dysrhythmias elicited by 
sympathetic stimulation in two different 
canine infarct models, 38A 
Scintigraphic assessment of global adrenergic 
nerve density with MIBG washout maps, 
214A 
Sympathetic tone 
Norepinephrine kinetics in ischemic heart 
disease in man: 'pitfalls of plasma 
norepinephrine as a measure of 
sympathetic tone, 185A 
Syncope 
Cardiac asystole in patients with 
neurally-mediated hypotension-
bradycardia syndrome, 1l5A 
Neurophysiologic accompaniments of 
ventricular arrhythmias producing 
syncope,7A 
Syncope during treatment with antiarrhythmic 
drugs in patients with VTIVF, 182A 
Use of the signal averaged electrocardiogram 
to predict electrophysiologic study results 
in unexplained syncope, 183A 
Systolic function 
Dissociation between recovery of ventricular 
geometry and systolic function following 
reperfusion, 195A 
Doppler echocardiographic assessment of the 
effect of balloon aortic valvuloplasty on 
left ventricular systolic function, 121A 
End-systolic pressure-dimension relation: a 
reliable measure of left ventricular 
contractility in myopathic ventricles, 
244A 
Influence of increased myocardial collagen on 
active and passive stiffness in left 
ventricular hypertrophy, 12A 
Left ventricular systolic function and diastolic 
filling characteristics in patients with 
severe mitral stenosis, 90A 
Limitations of the end-systolic 
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pressure-diameter relationship in patients 
with severe congestive heart failure, 245A 
Noninvasive determination of late systolic 
indices of inotropy in congestive 
cardiomyopathy, 245A 
Systolic thickening 
Prediction of reversibility of perfusion defects 
with a single post-exercise 
technetium-99m RP-30A gated 
tomographic image: the role of systolic 
thickening,3lA 
Twave 
Further evidence supporting the concept of 
T -wave memory: observations in patients 
having undergone catheter ablation of the 
WoUf-Parkinson-White syndrome, 68A 
Importance of time-course behavior of ST 
segment and T wave changes following 
exercise. A reliable aid towards 
eliminating "false positives," 122A 
Precordial T -wave is determined by 
transmural, not transepicardial ventricular 
repolarization gradient, 67 A 
What are the clinical implications of 
pseudonormalization of the T waves 
during ergometric studies?, 25A 
Tachycardia 
See also Atrioventricular tachycardia; 
Ventricular tachycardia 
Concealed antegrade accessory pathway 
conduction during induction of 
orthodromic tachycardia, 180A 
Evolving concepts in the management of 
congenital junctional ectopic tachycardia: 
a multicenter study, 155A 
Flecainide for prevention of paroxysmal 
supraventricular tachycardia: a 
multicenter, double-blind, 
placebo-controlled crossover study, 77 A 
Intravenous diltiazem for termination of 
reentrant supraventricular tachycardia: a 
placebo-controlled randomized, 
double-blinded study, 77A 
Mode of orthodromic tachycardia initiations as 
a function of accessory pathway 
refractory period, 79A 
Multiple atrioventricular bypass tracts: 
presence vs participation in tachycardia, 
180A 
Computerized global mapping of the atrium in 
patients with supraventricular tachycardia 
(SVT),II2A 
Technetium 
Comparison of Tc-99m methoxy isobutyl 
isonitrile (MIBI) and thallium-201 for 
evaluation of coronary artery disease by 
SPECT and planar methods, 33A 
Contrasting flow and myocardial distribution 
characteristics of 20 I-TI and technetium 
RP-30A in a swine model of myocardial 
ischemia and infarction, 34A 
Effect of a chronic low flow state on 
myocardial uptake of RP-30 and Tl-201, 
33A 
Effect of reperfusion and pacing on the 
myocardial extraction of thallium-201 and 
a technetium-labeled isonitrile analogue 
(RP-30), 33A 
Gated and ungated tomographic perfusion 
imaging with technetium-99m RP-30A: 
comparison with TI-201 tomography in 
coronary artery disease, 32A 
Interpolative background subtraction as used 
for Tl -201 imaging creates major 
inaccuracy in quantitative Tc-99m 
isonitrile imaging, 33A 
Noninvasive assessment of myocardial 
function using a new perfusion imaging 
agent,32A 
Overestimation of perfusion in ischemic 
myocardium by RP-30, 31A 
Prediction of reversibility of perfusion defects 
with a single post-exercise 
technetium-99m RP-30A gated 
tomographic image: the role of systolic 
thickening, 31A 
Qualitative and quantitative analysis of rest 
technetium isonitrile images for detection 
of occluded coronary arteries, 31A 
Rapid transit measurement of coronary blood 
flow with intracoronary 99m 
technetium-DTPA,2I3A 
Technetium isonitrile uptake at rest 
underestimates viability as assessed by 
wall motion, 32A 
Thallium/technetium-pyrophosphate overlap: a 
new noninvasive marker of very early 
coronary reperfusion, 32A 
Telephone systems 
Initial patient experience with telephone 
remotely controlled cardioversion and 
defibrillation, 66A 
Trans-telephone monitoring and response 
system: impact on pre-hospital delay, 
185A 
Tetralogy of Fallot 
Interest of the signal averaged ECG to predict 
the issue of programmed ventricular 
stimulation in patients with tetralogy of 
Fallot after intra-cardiac repair, 138A 
Myocardial fibrosis in tetralogy of Fallot: effect 
on repair or part of natural history?, 138A 
Thallium-20t 
See also Dipyridamole thallium imaging 
Abnormal thallium-201 SPECT early after 
coronary angioplasty: a predictor of 
restenosis?, 79A 
Analysis of SPECT thallium septal perfusion 
defects assists in distinguishing isolated 
LAD or PDA disease from disease of 
both vascular beds, 80A 
Combined thallium and antimyosin SPECT 
imaging in patients with acute myocardial 
infarction, 213A 
Comparative SPECT 1-123 
metaiodobenzylguanidine (MIBG) and 
thallium 201 cardiac imaging following 
myocardial infarction in patients, 81 A 
Comparison of dipyridamole echocardiography 
test and exercise thallium-201 scanning 
for diagnosis of coronary artery disease, 
218A 
Comparison of Tc-99m methoxy isobutyl 
isonitrile (MIBl) and thallium-201 for 
evaluation of coronary artery disease by 
SPECT and planar methods, 33A 
Contrasting flow and myocardial distribution 
characteristics of201-Tl and RP-30A in a 
swine model of myocardial ischemia and 
infarction, 34A 
Dipyridamole-induced increase in pulmonary 
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thallium uptake: a marker of transient 
global left ventricular dysfunction in 
patients unable to exercise, 214A 
Effect of a chronic flow state on myocardial 
uptake of RP-30 and TI-201, 33A 
Effect of reperfusion and pacing on the 
myocardial extraction of thallium-201 and 
a technetium-labeled isonitrile analogue 
(RP 30), 33A 
Exercise thallium-201 scintigraphy for 
detecting coronary artery disease in 
asymptomatic young men, 80A 
Gated and ungated tomographic perfusion 
imaging with technetium-99m RP-30A: 
comparison with Tl-201 tomography in 
coronary artery disease, 32A 
Influence of exercise level on normal 
myocardial thallium-201 uptake and 
clearance, 213A 
Interpolative background subtraction as used 
for Tl-201 imaging creates major 
inaccuracy in quantitative Tc-99m 
isonitrile imaging, 33A 
Is Bayesian analysis valid for the interpretation 
of the exercise thallium-201 test, or 
should another approach be tried?, 80A 
Right coronary artery disease and inferoseptal 
ischemia: evaluation by tomographic 
thallium-201 exercise myocardial imaging, 
213A 
Thallium/technetium-pyrophosphate overlap: a 
new noninvasive marker of very early 
coronary reperfusion, 32A 
Visual versus quantitative analysis of 
dipyridamole thallium-201 scintigraphy, 
80A 
Thermoplastics 
Combined angioplasty and vascular stenting by 
a novel heat-expandable thermoplastic 
device,65A 
Thioftavin-S 
Massive reperfusion injury: paradoxical effect 
of combined angiotensin-converting 
enzyme inhibition plus myocardial 
reperfusion, 50A 
Thrombi 
Detection of left ventricular thrombi: 
comparison of magnetic resonance 
imaging, computed tomography, 
echocardiography, angiography and 
surgery, 158A 
Influence of clot age on the detection of left 
atrial appendage thrombi by indium-III 
platelet scintigraphy, 214A 
Positive indium-III platelet scans for left 
ventricular thrombi predict an increased 
embolic risk, 214A 
Therapy for large intracoronary thrombi in 
candidates for percutaneous transluminal 
coronary angioplasty, 238A 
Thrombolytic therapy 
See also specific agent 
Adoption of thrombolytic therapy in the 
management of acute myocardial 
infarction, 186A 
Coronary artery reperfusion: successful 
response with thrombolytic therapy 
detected by signal averaged 
electrocardiograms during acute 
myocardial infarction, 200A 
Cost -effective evaluation of thrombolytic 
302A SUBJECT INDEX 
therapy: comparison of current modalities 
and identification of critical cost factors. 
A Canadian perspective, 186A 
Early recovery of left ventricular function 
predicts survival after thrombolysis, 193A 
Echocardiographic quantitation of regional wall 
motion in the thrombolysis in acute 
myocardial infarction (TIMI) trial-phase 
II: preliminary observations, 195A 
How fast can thrombolytic therapy improve 
hemodynamic status in patients with 
massive pulmonary embolism?, 53A 
Second Mt. Sinai-NYV reperfusion trial: 
relatively late thrombolytic therapy is 
beneficial in patients with collaterals, but 
not in those with subtotal lesions, I04A 
TAMI I vs TAMI II: does choice initial 
thrombolytic therapy influence outcome 
of salvage angioplasty, 193A 
Thrombolysis in patients with unstable angina 
refractory to maximal medical therapy, 
233A 
Thrombolytic therapy (TT) in unstable angina 
(VA),49A 
Thrombosis 
Dose dependent inhibition by heparin of acute 
platelet thrombus deposition thrombus 
deposition during angioplasty, 30A 
Inhibition of thrombus formation: blockage of 
adhesive glycoprotein mechanisms versus 
blockage of the glycooxygenase pathway, 
30A 
New treatment for non-massive pulmonary 
embolism and acute deep-vein 
thrombosis: low molecular weight 
heparin, 54A 
Potential risk of thrombosis during angiography 
using non-ionic contrast media, 55A 
Prevalence of pericardial effusion and 
ventricular thrombus formation among 
acute MI patients receiving tissue 
plasminogen activator, I04A 
Prevention of left ventricular mural thrombosis 
in acute myocardial infarction: a 
double-blind trial comparing high dose 
with low dose subcutaneous calcium 
heparin,26A 
Re-thrombosis after successful thrombolysis 
and angioplasty in acute myocardial 
infarction, I92A 
Serial observation of coronary thrombosis in 
vivo by a new angioscope, 30A 
Thromboxane and serotonin mediate 
reocclusion after thrombolysis in a canine 
model of coronary thrombosis, 30A 
Thrombus formation after acute myocardial 
infarction predicted by left ventricular 
spatial flow pattern, 175A 
Visualization of clots in experimental venous 
thrombi using monoclonal antibodies, 52A 
Thromboxane 
Thromboxane and serotonin mediate 
reocclusion after thrombolysis in a canine 
model of coronary thrombosis, 30A 
Thromboxane A2 receptor inhibition 
Effect of thromboxane A2 receptor inhibition 
on myocardial blood flow during three 
grades of coronary occlusion, 140A 
Influence of thromboxane A2 receptor 
antagonism on pulmonary vasoconstrictor 
responses in the newborn, 137A 
Thyroid function 
Class III effects of amiodarone depend on 
intact thyroid function, 41A 
Hypothyroidism elevates ventricular fibrillation 
threshold in rabbits, 41A 
Thyroxine 
Thyroxine regulates the dihydropyridine 
calcium antagonist receptor in rat 
myocardium, 140A 
Tomography 
Coronary transit kinetics may hinder 
accurate measurement of perfusion with 
ultrafast computed tomography, 
226A 
Left atrial volume measurement: cine 
computed tomography and 
echocardiography, 217 A 
Tomography, positron emission 
Diagnosis of coronary artery disease by 
positron imaging: large scale clinical trial, 
lIA 
Noninvasive quantification of coronary reserve 
by N-13 ammonia and positron emission 
tomography (PET), lIA 
Noninvasive quantification of regional 
myocardial blood flow with N-13 
ammonia and dynamic positron 
tomography, lOA 
Regional myocardial oxidative metabolism 
assessed non-invasively with C-lI acetate 
and dynamic positron emission 
tomography, lOA 
Torsade de pointes 
Antiarrhythmic drug-induced torsade de 
pointes: lack of relationship to marked 
QT prolongation, 56A 
Sotalol mediated torsade de pointes, 168A 
Torsade de pointes and QT prolongation after 
orthotopic liver transplantation, 201A 
Transcutaneous nerve stimulation 
Can transcutaneous nerve stimulation be safely 
used in patients with permanent 
pacemakers?, 165A 
Transfusion 
Effect of donor specific transfusion on cardiac 
xenografts, 44A 
Transposition of the great arteries 
Myocardial performance after arterial 
switch for transposition of the great 
arteries,69A 
Transpulmonary pressure gradient 
V se of transpulmonary pressure gradient in the 
selection of cardiac transplantation 
candidates, 45A 
Triglycerides 
Clinical outcome ten years after coronary 
bypass: effects of cholesterol and 
triglycerides in 4913 pts., 7 A 
Saphenous vein graft patency after 2 years is 
related to preoperative serum cholesterol 
and triglyceride levels, 7 A 
Triphenyltetrazolium chloride 
Massive reperfusion injury: paradoxical effect 
of combined angiotensin-converting 
enzyme inhibition plus myocardial 
reperfusion, 50A 
Truncus arteriosus 
Depressed myocardial function precedes 
development of persistent truncus 
arteriosus in neural crest ablated chick 
embryos,9A 
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2: 1 block of an early afterdepolarization as a 
mechanism of TV altemans, 254A 
Tuberous sclerosis 
Echocardiographic findings in patients with 
tuberous sclerosis, 73A 
Tumors, intraeardiac 
Should cardiac catheterization be performed 
preoperatively in echo-diagnosed 
intracardiac tumors?, 163A 
Ultrasound 
See also Doppler ultrasound; 
Echocardiography 
Effects of variable ultrasonic energy duration, 
application mode and energy on 
atherosclerotic plaque ablation, 172A 
Influence on heart rate, mean arterial pressure, 
preload, and inotropic state on myocardial 
ultrasonic backscatter, 99A 
Urokinase 
Are adjunctive therapies needed when t-PA is 
used? Summary results of TAMI I, II, 
and III trials, 186A 
Combination thrombolytic therapy: improved 
predischarge vessel patency without 
increased hemorrhage, 231A 
Efficacy of single bolus intravenous urokinase 
in acute myocardial infarction: results of a 
prospective randomized trial, 42A 
How fast can thrombolytic therapy improve 
hemodynamic status in patients with 
massive pulmonary embolism?, 53A 
Lack of evidence for enhanced thrombolysis 
with combined urokinase plus tissue 
plasminogen activator compared with 
tissue plasminogen activator alone using 
quantitative angiography, 231A 
Prophylactic use of combined 
heparine-urokinase for the prevention of 
coronary artery occlusion following 
percutaneous transluminal coronary 
angioplasty, 128A 
Vagal activity 
Modulation of vagal activity during and 
immediately after exercise: investigation 
with heart rate spectral analysis, 247 A 
Valve dimensions 
Age-related changes in normal cardiac valve 
dimensions, 244A 
Valve disease 
See also Aortic valve disease; Mitral valve 
disease; Surgery, pediatric; Surgery, 
valve 
Association of tricuspid insufficiency with 
ventricular septal aneurysms: a color flow 
Doppler study, 137 A 
Asynchronous opening of the atrioventricular 
valves in the normal neonate: a cause for 
arterial desaturation, 136A 
Atrioventricular valve insufficiency: 
contraindication to the modified Fontan?, 
249A 
Detection and assessment of severity of 
tricuspid regurgitation using first pass 
radionuclide angiography: a comparison 
with pulsed Doppler echocardiography, 
64A 
Diagnostic labeling in echocardiography: an 
apparent epidemic of valvular 
regurgitation, 127 A 
Effect of mean pressure gradient, chamber 
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compliance, and orifice size upon the 
Doppler halftime method, 20A 
Incidence and severity of aortic insufficiency 
and supravalvular pUlmonic stenosis 
following anatomic correction of 
transposition of the great arteries, 70A 
Incremental value of clinical examination, 
echocardiography and cardiac 
catheterization in the evaluation of left 
ventricular dysfunction and pulmonary 
hypertension in valvular heart disease, 
64A 
Is Doppler accurate for measuring 
trans-stenotic coronary pressure 
gradients? An in vitro study, 174A 
Quantification of valvular regurgitation by 
gain-corrected Doppler in a pulsatile flow 
model,99A 
Valve prosthesis 
Color guided continuous wave Doppler 
assessment of effective prosthetic valve 
area,I77A 
Exercise training early after valve replacement, 
102A 
Experience with flat pyrolytic carbon disc 
Bjork Shiley (BS) versus St. Jude (SJ) 
valves for mitral valve replacement 
(MVR),86A 
Factors associated with progression to aortic 
valve replacement in chronic aortic 
insufficiency, 159A 
In vitro validation of the assessment by 
Doppler ultrasound of normal 
bioprosthetic function, 22A 
Late results after mUltiple valve replacement in 
513 patients with advanced valvular heart 
disease,4A 
Long-term follow-up on the St. Jude prosthetic 
valve, 229A 
Periprosthetic mitral and aortic regurgitation: 
utility of pre-and intraoperative Doppler 
color flow mapping, 20A 
Platelets and surface microstructure of 
spontaneously degenerated porcine 
bioprosthetic valves, 230A 
Reversal of left ventricular dilation, 
hypertrophy, and contractile dysfunction 
by replacement of regurgitant aortic 
valves, 158A 
Serial decreases in pressure halftime: a 
potential marker for significant prosthetic 
mitral regurgitation, 176A 
Valvular cardiac prosthesis and pregnancy: a 
high-risk situation for both the mother 
and the fetus, 230A 
Wall mass regression after aortic valve 
replacement, measured by cine computed 
tomography, 157A 
Valvotomy 
Mitral valve pressure halftime: accuracy at six 
months after mitral balloon valvotomy, 
21A 
One year follow-up results after percutaneous 
double balloon mitral valvotomy, 15A 
Percutaneous double balloon valvotomy in 
rheumatic tricuspid stenosis: immediate 
and short term follow-up results, 220A 
Valvuloplasty 
Coronary blood flow and hemodynamics during 
experimental aortic valvuloplasty: 
beneficial effects of dual catheter method, 
13A 
Valvuloplasty, balloon 
Acute hemodynamic results and clinical 
follow-up in patients undergoing balloon 
mitral valvuloplasty, 15A 
Aortic balloon valvuloplasty: therapy of choice 
for the very old symptomatic patient with 
aortic stenosis, 161A 
Balloon aortic valvuloplasty: predictors of 
clinical success, 15A 
Balloon aortic valvuloplasty of calcific aortic 
stenosis: results in 130 cases, 16A 
Balloon aortic valvuloplasty-induced injury and 
repair: a possible mechanism of 
restenosis, 221A 
Balloon valvuloplasty in re-stenosis after 
surgical mitral commissurotomy, 235A 
Determinant of best results of balloon aortic 
valvuloplasty in adults, 14A 
Doppler echocardiographic assessment of the 
effect of balloon aortic valvuloplasty on 
left ventricular systolic function, 121A 
Dual-balloon approach for percutaneous aortic 
balloon valvuloplasty, 13A 
Follow-up of patients undergoing percutaneous 
aortic balloon valvuloplasty by Doppler 
echocardiography, 234A 
Incremental changes following single and 
double catheter balloon valvuloplasty of 
12 stenotic mitral valves, 220A 
Left ventricular pressure-volume relationship 
before, during and after aortic 
valvuloplasty, 235A 
Mitral valvuloplasty: retrograde, transarterial 
double balloon technique, 14A 
Pathologic findings after in vivo aortic and 
mitral balloon valvuloplasty, 229A 
Percutaneous mitral balloon valvuloplasty-
intermediate follow-up study, 218A 
Prediction of appropriate balloon size selection 
in percutaneous aortic valvuloplasty, 13A 
Severity of stenosis, degree of calcification, 
and balloon diameter are determinants of 
successful, aortic valvuloplasty in vitro, 
221A 
Spontaneous variation and exercise-induced 
changes in measurement of mitral valve 
area using Gorlin formula: implications 
for evaluation of changes following 
catheter balloon valvuloplasty for mitral 
stenosis, 234A 
Time related changes in left ventricular 
contractility after balloon aortic 
valvuloplasty, 235A 
Two-dimensional echocardiography assessment 
of changes in mitral valve morphology 
and left atrial volumes 3 months after 
catheter balloon valvuloplasty for mitral 
stenosis, 21 A 
Postvalvuloplasty follow-up of elderly patients 
with severe aortic stenosis and low 
ejection fraction, 15A 
Valvuloplasty, percutaneoos transluminal coronary 
Early and late evaluation of percutaneous 
aortic valvuloplasty. A combined 
hemodynamic and Doppler-
echocardiographic study, 14A 
Mid-term follow-up after percutaneous 
transluminal aortic valvuloplasty in the 
elderly, 234A 
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Valvuloplasty, percutaneous transvenous aortic 
Percutaneous transvenous aortic valvuloplasty 
by a self-positioning balloon (Inoue 
balloon), 221A 
Vascular disease 
Real-time, two dimensional catheter 
ultrasound: a new technique for 
high-resolution intravascular imaging, 
130A 
Vascular injury 
Coronary vascular injury after short-term 
coronary artery occlusion and 
reperfusion, 87 A 
Prevention of coronary vascular injury induced 
by transient myocardial ischemia, 124A 
Vascular resistance 
Differential effects of experimental heart failure 
on baroreflex control of heart rate and 
vascular resistance, 142A 
Vascularization 
See Revascularization 
Vasoactive intestinal peptide 
Vasoactive intestinal peptide receptor in failing 
and nonfailing human ventricular 
myocardium: supersensitivity of failing 
heart due to increased receptor affinity: 
diminished maximal inotropic response 
from decreased receptor density, 1A 
Vasoconstriction 
Acetylcholine induced epicardial 
vasoconstriction does not reduce 
coronary flow, 48A 
Alpha-adrenergic coronary vasoconstrictor 
receptor SUbtypes in awake dogs, 23A 
{3 blockade results in decreased coronary blood 
flow due to unapposed ex mediated 
vasoconstriction, 23A 
Differences in alpha adrenergic responsiveness 
between human internal mammary 
arteries and saphenous veins, 2A 
Intravenous cocaine causes epicardial coronary 
vasoconstriction in the intact dog, 49A 
Is the response of peripheral and proximal 
veins to pressor stimuli similar?, 94A 
Nicardipine but not verapamil antagonizes 
forearm vasoconstriction to endogenous 
a-adrenergic stimulation by lower body 
suction, 205A 
Vasodilation 
Validation of a digital angiographic model to 
assess autoregulatory vasodilation of the 
coronary system in response to stenosis 
at rest, 62A 
Vasospasm 
Aminophylline administration after 
dipyridamole stress as a trigger of 
coronary vasospasm in variant angina, 
205A 
Potentiation of serotonin induced vasospasm 
by indomethacin in isolated perfused 
coronary arteries, 124A 
Vena caval collapse 
Lack of inspiratory vena caval collapse in 
pericardial effusion: a sign of 
hemodynamic compromise, 84A 
Venous pressure 
Relationship of sternal angle to right atrium in 
clinical measurement of jugular venous 
pressure, 89 A 
Venous retroperfusion 
Coronary venous retroperfusion effect on flow 
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and metabolism in acutely ischemic 
canine myocardium studied with positron 
emission tomography, 86A 
Ventilation 
Effect of ECG-gated high frequency ventilation 
on cardiac output in dogs, 246A 
Ventricular asynergy 
Clinical value of measurement of ventricular 
asynergy by multiple geometric model, 
215A 
Ventricular capture 
Rate-dependent failure of ventricular capture in 
patients treated with oral propafenone, 
228A 
Ventricular cavity obliteration 
Color flow and spectral Doppler evaluation of 
midventricular obstruction, hypertrophic 
obstructive cardiomyopathy and cavity 
obliteration, 74A 
Ventricular dilation 
Reperfusion of ischemic canine hearts prevents 
pressure mediated left ventricular dilation, 
253A 
Ventricular fibrillation 
Esmolol elevates the ventricular fibrillation 
threshold in humans during automatic 
defibrillator testing, 181A 
Hypothyroidism elevates ventricular fibrillation 
threshold in rabbits, 41A 
Prognosis of ventricular fibrillation 
complicating myocardial infarction, 26A 
Significance of inducible ventricular fibrillation 
in survivors of out-of-hospital ventricular 
fibrillation, 6A 
Ventricular filling 
Age related changes in left ventricular filling 
are related to compensatory left 
ventricular hypertrophy, 34A 
Determinants of the peak velocity of left 
ventricular filling: interaction of preload, 
afterload and relaxation, 119A 
Ventricular function 
See also Diastolic function; Systolic function 
Catheter assessment of left ventricular function 
after arterial switch operation at rest and 
afterload stress, 29A 
Changes in left ventricular output and filling 
produced by preload reduction in patients 
with congestive heart failure, 121A 
Collateral flow preserves left ventricular 
function during acute ischemia in man, 
187A 
Comparison of left ventricular mass and 
systolic and diastolic function in young 
and old normals, 244A 
Dipyridamole-induced increase in pulmonary 
thallium uptake: a marker of transient 
global left ventricular dysfunction in 
patients unable to exercise, 214A 
Early recovery of left ventricular function 
predicts survival after thrombolysis, 193A 
Early rise in aortic gradient following aortic 
valvuloplasty is due to improved left 
ventricular performance, 220A 
Early variations of right ventricular size and 
function after valvotomy in newborns 
with pulmonary atresia or critical stenosis 
and intact ventricular septum, 250A 
Early ventricular dysfunction in hypertensive 
patients with preserved aerobic capacity, 
142A 
Effect of amiodarone therapy on ventricular 
function: serial, long-term assessment, 
91A 
Effect of brief coronary occlusions on 
interstitial pH and myocardial function, 
253A 
Effect of cardiac function on hemodynamic, 
hormonal and metabolic responses to 
dynamic exercise, 246A 
Effect of arterial wave reflections on 
ventricular output, 35A 
Effects of atrial natriuretic peptide on left 
ventricular performance in man, 89A 
Effects of pericardial constraint on left 
ventricular function in acute pulmonary 
embolism, 200A 
Evaluation of right ventricular function by 
regional wall motion analysis in patients 
after transpulmonary-transatrial repair for 
tetralogy of Fallot, 249A 
Evaluation of ventricular function by 
Frank-Starling curves derived from 
Doppler-echo during lower body negative 
pressure, 245A 
Improved ventricular performance following 
arrhythmia control in children with 
automatic atrial tachycardia and dilated 
cardiomyopathy, 155A 
Incremental value of clinical examination, 
echocardiography and cardiac 
catheterization in the evaluation of left 
ventricular dysfunction and pulmonary 
hypertension in valvular heart disease, 
64A 
Is regional or global dysfunction the more 
important prognostic indicator following 
anterior myocardial infarction?, 188A 
Left ventricular dynamics in circulatory shock, 
91A 
Left ventricular function in untreated 
hypertensive patients with normal 
ambulatory blood pressure, 81A 
Loading doses of oral procainamide exert 
cardiodepressant effects and activate 
neurohormones in patients with left 
ventricular dysfunction, 91A 
Mild mitral regurgitation impairs left 
ventricular performance in patients with 
aortic stenosis, 91A 
Natural history of asymptomatic patients with 
aortic regurgitation: serial long-term 
changes in left ventricular function, 159A 
Noninvasive assessment of myocardial 
function using a new perfusion imaging 
agent,32A 
Preservation of left ventricular function and 
topography with combined reperfusion 
and intravenous nitroglycerin in acute 
myocardial infarction, 90A 
Recovery of left ventricular function following 
chronic sustained coronary occlusion, 
252A 
Relation of left ventricular filling dynamics to 
alterations in loading and compliance, 
34A 
Right and left ventricular functional response 
to supine exercise in patients with 
asymptomatic mitral regurgitation, 229A 
Significant left ventricular contribution to right 
ventricular contraction, 200A 
Silent left ventricular dysfunction during 
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ambulatory radionuclide monitoring 
following thrombolysis: a potential 
predictor of subsequent cardiac 
morbiditY,25A 
Spontaneous improvement in left ventricular 
function during the early course of acute 
non-Q wave myocardial infarction: 
evidence for "stunned myocardium," 
188A 
Ventricular mass 
Assessment of myocardial mass in chronic 
aortic insufficiency using magnetic 
resonance imaging, 157A 
Long term changes in left ventricular 
dimensions in patients with aortic 
regurgitation with and without vasodilator 
therapy, 159A 
Relationship of pre-operative left ventricular 
muscle mass to the outcome of Fontan 
procedure in patients with tricuspid 
atresia, 249A 
Serial changes in left ventricular mass of the 
donor's heart early after transplantation, 
149A 
Superior reproducibility of serial left 
ventricular mass measurements by two 
dimensional vs. M-mode 
echocardiography, 146A 
Variability of left ventricular mass 
measurements by ultrafast computed 
tomography, 157A 
Wall mass regression aortic valve replacement 
measured by cine computed tomography, 
157A 
Ventricular obstruction 
Color flow and spectral Doppler evaluation of 
midventricular obstruction, hypertensive 
obstructive cardiomyopathy and cavity 
obliteration, 74A 
Ventricular pressure 
Left ventricular pressure-volume relationship 
before, during and after aortic 
valvuloplasty, 235A 
Ventricular rate and responsive pacing using 
first derivative of right ventricular 
pressure as a sensor, 167A 
Ventricular relaxation 
Early inflation of an intra-aortic balloon 
augments left ventricular relaxation rate: 
a manifestation of load-dependent 
relaxation, 35A 
Ventricular remodeling 
Pharmacologic modification of left 
ventricular remodeling during healing 
after myocardial infarction in 
the dog, 252A 
Ventricular septal defect 
Analysis of SPECr thallium septal perfusion 
defects assists in distinguishing isolated 
LAD or PDA disease from disease of 
both vascular beds, 80A 
Association of tricuspid insufficiency with 
ventricular septal aneurysms: a color flow 
Doppler study, I37A 
Noninvasive three dimensional reconstruction 
of the spectrum of ventricular 
septal defects with pulmonary 
stenosis by magnetic resonance 
imaging, 134A 
Primary closure of ventricular septal defect in 
infancy,70A 
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Ventricular septal rupture 
Post-infarction ventricular septal rupture: 
coronary angiography anatomy, 188A 
Ventricular septal thickness 
Normal aging is accompanied by 
disproportionate thickening of the 
ventricular septum, 243A 
Ventricular "steal" 
Right ventricular "steal" during 
hyperperfusion of the left anterior 
descending artery in swine, 23A 
Ventricular stimulation 
Day-to-day reproducibility of response to 
programmed ventricular stimulation in 
patients with recent acute myocardial 
infarction, 5A 
Interest of the signal averaged ECG to predict 
the issue of programmed ventricular 
stimulation in patients with tetralogy of 
Fallot after inter-cardiac repair, 138A 
Prognostic significance of programmed 
ventricular stimulation in high risk 
patients surviving acute myocardial 
infarction, 6A 
Ventricular tachyarrhythmias 
Magnesium suppresses early 
afterdepolarizations and ventricular 
tachyarrhythmias induced in dogs by 
cesium, 254A 
Parenteral magnesium therapy in intractable 
ventricular tachyarrhythmias, 169A 
Sotalol for sustained ventricular 
tachyarrhythmias: predictors of 
arrhythmic outcome, 55A 
Ventricular tachycardia 
Antiarrhythmic drug treatment in high risk 
patients with sustained ventricular 
tachycardia following myocardial 
infarction, I90A 
Areas of slow conduction common to 
ventricular tachycardias of different 
morphologies, 114A 
Automatic antitachycardia pacemaker and the 
automatic implantable cardioverter 
defibrillator as therapy for recurrent drug 
refractory ventricular tachycardia, 17 A 
Catheter ablation of right bundle branch: a 
highly effective technique for control of 
bundle branch reentrant ventricular 
tachycardia, 114A 
Clinical, electrophysiologic determinants and 
survival of patients with sustained 
ventricular tachycardia early 
post-myocardial infarction, 182A 
Common clinical and e1ectrophysiologic 
characteristics in patients with bundle 
branch reentrant ventricular tachycardia, 
114A 
Computerized potential distribution mapping 
during ventricular tachycardia in 
experimental myocardial infarction, 112A 
Differential response of early 
afterdepolarization and ventricular 
tachycardia during right and left stellate 
stimulation in the dog treated with 
cesium, 254A 
Efficacy of cryoablation alone for refractory 
ventricular tachycardia related to inferior 
infarction, 112A 
Electrophysiologic and morphologic 
determinants of intramural reentry in 
human ventricular tachycardia, I13A 
Hereditary autosomal dominant ventricular 
tachycardia, 181A 
Identification and catheter ablation of a zone of 
slow conduction in the reentry circuit of 
ventricular tachycardia, 16A 
Importance of preoperative variables in 
predicting operative mortality in direct 
surgery for drug resistant ventricular 
tachycardia, 113A 
Increased release of atrial natriuretic factor 
during sustained ventricular tachycardia, 
240A 
Limited effectiveness of lidocaine in 
termination of sustained ventricular 
tachycardia, 55A 
Proarrhythmic potential of moderate-dose 
flecainide therapy for sustained 
ventricular tachycardia, 168A 
Randomized study comparing catheter ablation 
to medical therapy in patients with 
ventricular tachycardia. Preliminary 
results, 179A 
Sotalol and metoprolol in ventricular 
tachycardia: preliminary data of a 
double-blind prospective study, 227 A 
Ventricular function predicts drug response of 
ventricular tachycardia, 168A 
Ventricular tachycardia in patients without 
underlying structural heart disease: 
evidence for triggered activity in humans, 
I13A 
Ventricular volumes 
Abnormal left ventricular volume response 
predicts impaired exercise performance in 
hypertension, 198A 
Comparison of left ventricular volumes derived 
from an impedence catheter with that 
derived from dynamic spatial 
reconstructor, 200A 
Comparison of transesophageal 
echocardiographic and scintigraphic 
estimates of left ventricular end-diastolic 
volume and ejection fraction, 219A 
Effect of aortic compliance on left ventricular 
volume and function in patients with 
aortic insufficiency, I60A 
Validation of two-dimensional 
echocardiographic determinants of left 
ventricular volumes in the fetal heart, 9A 
Ventricular waH motion 
Clinical evaluation of hibernating 
myocardium-short-term effects of 
coronary angioplasty on regional left 
ventricular wall motion, 133A 
Echocardiographic quantitation of regional wall 
motion in the thrombolysis in acute 
myocardial infarction (TIM!) 
trial-phase II: preliminary observations, 
195A 
Hemodynamic consequences of the 
electronically silent right ventricle, 94A 
Hyperkinesis with Frank-Starling mechanism 
in a non-ischemic region of acutely 
ischemic canine heart, 92A 
Left ventricular wall motion after coronary 
bypass graft surgery in patients with 
collaterals, 7 A 
Left ventricular wall motion analysis by cine 
NMR,156A 
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Left ventricular wall motion assessment by 
cine nuclear magnetic resonance imaging: 
comparison with two-dimensional 
echocardiography and thallium-201 
tomography, 156A 
Prevention of regional wall motion 
abnormalities during coronary angioplasty 
(PTCA) , 195A 
Radionuclide assessment of regional wall 
motion abnormalities in healthy master 
athletes, 212A 
Regional left ventricular wall stress: a new 
approach to detecting regional ischemia 
during exercise, 212A 
Ventricular waH thickening 
Effect of wall thickening on end-systolic 
performance: shortening deactivation in 
whole heart, 94A 
Long term recovery of LV wall thickening 
after one hour of ischemia is not affected 
when superoxide dismutase and catalase 
are administered during the 1st 45 minutes 
of reperfusion, 163A 
Ventriculography, radionuclide 
Dipyridamole radionuclide ventriCUlography 
has high sensitivity for detecting severe 
multivessel coronary atherosclerosis, 
216A 
Prospective prediction of clinical coronary 
disease in patients with Type I diabetes 
mellitus by exercise radionuclide 
ventriculography,215A 
Verapamil 
Comparative effects of verapamil and 
nitroprusside on left ventricular function 
in patients with hypertension, 37 A 
Comparison of the effects of intravenous 
isradipine and verapamil on coronary and 
systemic hemodynamics in man, 242A 
Drug of choice for acute management of 
paroxysmal atrioventricular reentrant 
tachycardia: ATP? Verapamil?, 170A 
Effects of verapamil on left ventricular 
diastolic function in patients with 
coronary artery disease, 36A 
Esmolol vs verapamil for the treatment of 
recent-onset atrial fibrillation/flutter: a 
multicenter study, 170A 
Evaluation of the hemodynamic effects of 
calcium channel antagonists by exercise 
Doppler: comparison of verapamil and 
nifedipine, 122A 
Influence of verapamil on limb intravascular 
volume, 124A 
Intravenous flecainide versus verapamil for 
acute conversion of atrial fibrillation or 
atrial flutter to sinus rhythm, 76A 
Near total reduction in verapamil 
bioavailability by rifampin: 
electrocardiographic correlates, 205A 
Nicardipine but not verapamil antagonizes 
forearm vasoconstriction to endogenous 
a-adrenergic stimulation by lower body 
suction, 205A 
Phase analysis preexcitation index and its 
augmentation by verapamil: a new 
method for localization of accessory 
pathway in the WolfI-Parkinson-White 
syndrome,216A 
Regression of ventricular hypertrophy in 
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cardiac transplant recipients under 
effective antihypertensive therapy, 151A 
Reversibility of acute alcohol cardiac 
depression and the protective effect of 
verapamil, 202A 
Verapamil improves silent myocardial 
perfusion abnormalities in asymptomatic 
hypertrophic cardiomyopathy, 251A 
Verapamil increases cyclosporin-A blood 
trough levels in cardiac transplant 
recipients, 206A 
VEST 
Ambulatory monitoring of left ventricular 
function post infarction predicts residual 
ischemia,216A 
Videodensitometry 
Geometric validation of a semi-automated 
method of serial coronary 
videodensitometry analysis in humans, 
62A 
Viscous properties 
Viscous properties of the in-situ completely 
relaxed ventricle are insignificant at 
normal strain rates, 12A 
Wolff-Parklnson-White syndrome 
Accuracy of invasive testing for direct 
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